Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3001788	s-aldos	pmol/l (pmol/l)	3270	4134	1.11%
3001788	p-aldos	pmol/l (pmol/l)	776	960	0.00%
3001788	s-aldos	— (—)	742	911	100.00%	Distribution not available
3001788	fp-aldos	pmol/l (—)	550	657	100.00%	Distribution not available
3001788	s-aaldos	pmol/l (—)	100	110	100.00%	Distribution not available
3001788	s-valdos	pmol/l (—)	99	143	100.00%	Distribution not available
3001788	p-aldos	— (—)	68	71	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Cardiovascular diseases (excluding rheumatic etc)

1066

894

7.01

307.65

1.6

1.3

517.06

367.60

pmol/l

0.83

962

778

Benign neoplasm: Adrenal gland

1001

265

56.17

307.65

1.4

1.3

318.93

297.58

pmol/l

0.28

944

225

Other disorders of fluid, electrolyte and acid-base balance

961

1060

9.13

307.65

1.5

1.3

537.72

289.18

pmol/l

1.38

763

918

Disorders of other endocrine glands

974

1965

5.04

307.65

1.9

1.2

698.13

308.93

pmol/l

2.11

876

1687

Hypertension

1635

1212

7.84

307.65

1.5

1.3

505.96

311.88

pmol/l

1.49

1460

1055

Antihypertensive medication - note that there are other indications

870

617

7.61

307.65

1.5

1.3

539.95

392.22

pmol/l

0.60

771

552

Hypertensive diseases (excluding secondary)

1276

708

10.86

307.65

1.6

1.3

556.19

362.00

pmol/l

1.00

1152

612

Hypertensive diseases

1634

1214

7.82

307.65

1.5

1.3

506.20

312.03

pmol/l

1.49

1459

1056

Benign neoplasm of other and unspecified endocrine glands

1089

485

27.63

307.65

1.4

1.3

406.12

307.12

pmol/l

0.55

1025

409

Hypokalaemia

650

395

18.58

307.65

1.7

1.3

659.16

292.53

pmol/l

1.34

501

347

Hypertension, essential

1620

1186

7.97

307.65

1.5

1.3

496.48

304.38

pmol/l

1.46

1449

1031

Cardiovascular diseases

879

764

6.29

307.65

1.5

1.3

534.31

341.15

pmol/l

0.98

790

662

Metabolic disorders

1517

2611

3.61

307.65

1.4

1.3

435.10

347.94

pmol/l

0.55

1306

2313

Hyperaldosteronism

333

54.54

307.65

2.9

1.2

1319.01

305.92

pmol/l

1.99

321

Secondary hypertension

403

130

34.26

307.65

2.5

1.1

1076.14

542.37

pmol/l

0.72

374

102

Endocrine, nutritional and metabolic diseases

983

1289

3.91

259.67

1.5

1.2

622.64

297.54

pmol/l

1.51

856

1141

Other disorders of adrenal gland

209

142

16.51

239.25

1.5

1.2

843.43

316.28

pmol/l

0.54

181

123

Other heart diseases

557

701

5.27

230.10

1.4

1.3

318.38

365.02

pmol/l

0.51

504

605

Exclusions for E4_PCOS_BROAD

422

744

5.93

228.68

1.4

584.28

325.64

pmol/l

0.54

368

649

Anaemias

287

181

10.54

205.17

1.4

1.2

783.19

370.05

pmol/l

0.59

242

160

Diseases of arteries, arterioles and capillaries (FINNGEN)

346

331

7.40

199.44

1.3

1.2

287.97

367.25

pmol/l

0.45

295

279

Hypertensive heart and/or renal disease

350

389

6.87

196.66

1.4

319.59

327.15

pmol/l

0.04

306

327

Cerebrovascular diseases (FINNGEN)

390

460

6.11

192.86

1.4

1.2

337.78

344.89

pmol/l

0.04

336

393

Adrenocortical insufficiency

167

122

15.40

183.75

1.5

1.2

367.09

334.62

pmol/l

0.16

141

107

Disorders of lipoprotein metabolism and other lipidaemias

971

2237

2.72

158.42

1.4

1.3

308.77

287.51

pmol/l

0.40

864

1973

Heart failure and antihypertensive medication

283

256

7.37

158.29

1.3

329.91

402.76

pmol/l

0.28

241

225

Benign neoplasms

1139

2502

2.53

156.76

1.4

467.80

373.66

pmol/l

0.44

1014

2130

Hypothyroidism (congenital or acquired)

271

188

8.25

152.34

1.5

1.2

1179.60

312.77

pmol/l

1.01

236

167

Hypothyroidism and >3 levothyroxin purchases

267

187

8.18

149.29

1.5

1.2

806.35

312.77

pmol/l

0.70

232

167

Hypothyroidism, levothyroxine purchases

267

187

8.18

149.29

1.5

1.2

806.35

312.77

pmol/l

0.70

232

167

Type 2 diabetes, wide definition

995

2515

2.57

146.15

1.3

1.4

302.39

358.48

pmol/l

0.69

864

2188

Hypertensive Heart Disease

281

367

6.11

145.55

1.4

307.95

330.52

pmol/l

0.11

247

307

All chronic kidney diseases

715

2079

2.86

137.37

1.4

1.3

379.07

398.51

pmol/l

0.10

610

1785

Diabetes mellitus

1204

3155

2.25

130.90

1.3

1.4

310.06

405.56

pmol/l

1.34

1027

2777

Type 2 diabetes

1160

3011

2.27

128.79

1.3

1.4

309.55

404.70

pmol/l

1.25

999

2645

Diabetes, varying definitions

1194

3163

2.24

127.56

1.3

1.4

309.71

404.85

pmol/l

1.34

1018

2784

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1117

2989

2.27

125.20

1.3

1.4

308.11

402.23

pmol/l

1.21

947

2627

Sleep apnoea

1125

3327

2.21

120.31

1.3

317.65

354.87

pmol/l

0.55

992

2878

Diabetes medication

1196

3334

2.15

116.45

1.3

1.4

308.18

399.40

pmol/l

1.36

1012

2940

Atrial fibrillation and flutter

313

434

4.74

115.68

1.4

1.2

343.15

341.29

pmol/l

0.01

281

369

Sleep apnoea, including avohilmo

1159

3384

2.14

113.40

1.4

1.3

320.68

385.53

pmol/l

0.81

1021

2932

Hypo-osmolality and hyponatraemia

266

578

4.70

112.47

1.3

461.64

281.66

pmol/l

0.90

232

497

Pure hypercholesterolaemia

784

2075

2.49

109.76

1.4

1.3

282.11

284.29

pmol/l

0.07

699

1822

Abnormalities of breathing

987

2546

2.27

109.60

1.4

532.43

341.25

pmol/l

0.74

868

2216

Type 2 diabetes, definitions combined

1070

2893

2.19

109.37

1.3

1.4

319.38

403.87

pmol/l

0.98

929

2534

Diabetes, insulin treatment (Kela reimbursement)

1155

3326

2.12

109.17

1.3

1.4

305.17

390.63

pmol/l

1.22

983

2920

Type 2 diabetes, strict (exclude DM1)

1074

2911

2.19

109.15

1.3

1.4

318.57

403.83

pmol/l

1.00

933

2549

Pain in throat and chest

944

2486

2.30

108.89

1.3

1.4

337.34

336.38

pmol/l

0.01

833

2160

General symptoms and signs

1187

2821

2.13

107.81

1.3

1.4

516.72

334.48

pmol/l

0.85

1019

2476

Hypothyroidism, drug reimbursement

154

117

9.44

107.78

1.5

1.2

977.94

305.28

pmol/l

0.55

139

102

Episodal and paroxysmal disorders

1185

2871

2.12

107.13

1.4

514.78

332.47

pmol/l

0.88

1040

2489

Depression medications

245

197

6.31

105.81

1.4

1.2

398.83

314.77

pmol/l

1.42

209

177

Atrial fibrillation and flutter with reimbursement

262

326

5.19

105.78

1.4

1.2

338.87

367.80

pmol/l

0.13

233

275

Headache

770

2587

2.40

104.84

1.3

1.4

442.76

340.60

pmol/l

0.35

663

2273

Other nutritional deficiencies

811

3340

2.31

104.74

1.4

467.70

370.86

pmol/l

0.34

717

2917

All kidney diseases

1122

3716

2.08

104.73

1.4

371.93

374.25

pmol/l

0.02

976

3250

Other (not insulin) diabetes medications

1096

3098

2.12

103.30

1.3

1.4

304.47

397.41

pmol/l

1.25

946

2721

Malaise and fatigue

612

1880

2.65

102.43

1.3

1.4

351.26

327.35

pmol/l

0.20

524

1629

Abnormal blood-pressure reading, without diagnosis

123

138

9.45

100.85

1.7

1.3

329.40

337.12

pmol/l

0.06

110

117

Heart failure, not strict

878

2665

2.26

100.34

1.3

380.71

320.25

pmol/l

0.61

754

2310

Cardiac arrhythmias

650

1634

2.61

100.00

1.4

345.65

445.57

pmol/l

0.85

585

1454

Other CVD (FINNGEN)

152

149

8.10

99.77

1.4

1.3

287.96

453.34

pmol/l

0.40

123

119

Type 2 diabetes, definitions combined, including avohilmo

1050

2906

2.12

99.12

1.3

1.4

318.31

405.53

pmol/l

1.03

913

2548

Obesity

751

3257

2.25

91.41

1.3

1.4

453.95

374.05

pmol/l

0.25

671

2841

Obesity and other hyperalimentation

753

3265

2.25

91.36

1.3

1.4

453.46

373.53

pmol/l

0.25

673

2849

Symptoms and signs involving the circulatory and respiratory systems

1041

2554

2.06

87.30

1.4

552.78

341.27

pmol/l

0.89

907

2224

Tramadol

892

2587

2.14

86.99

1.3

1.4

416.54

365.86

pmol/l

0.17

774

2258

Chronic kidney disease

375

1211

3.09

86.77

1.3

381.95

386.83

pmol/l

0.02

318

1019

Neoplasms

756

1750

2.31

84.97

1.4

512.76

409.85

pmol/l

0.31

666

1491

Obesity due to excess calories

576

2405

2.43

84.00

1.3

1.4

321.23

400.58

pmol/l

1.04

510

2099

Other heart diseases, wide

1001

3064

2.01

83.56

1.4

325.24

411.93

pmol/l

1.08

876

2677

Biguanides

1026

3159

2.00

83.46

1.3

1.4

300.73

397.24

pmol/l

1.35

885

2761

Renal failure

525

1843

2.55

83.12

1.3

369.65

343.93

pmol/l

0.16

440

1558

Sleep disorders (combined)

1171

3238

1.91

81.25

1.3

1.4

336.57

388.68

pmol/l

0.56

1027

2812

Glucagon-like peptide-1 (GLP-1) analogues

384

1344

2.91

80.23

1.3

1.4

313.87

395.99

pmol/l

0.53

327

1169

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

384

1344

2.91

80.23

1.3

1.4

313.87

395.99

pmol/l

0.53

327

1169

Dyspnoea

966

3650

1.97

79.34

1.3

528.24

326.41

pmol/l

0.76

838

3177

STROKE

622

1804

2.37

79.24

1.3

1.4

301.34

323.18

pmol/l

0.43

547

1585

Paroxysmal tachycardia

198

369

4.55

77.09

1.4

1.3

276.36

367.24

pmol/l

0.61

180

311

Hyperlipidaemia, other/unspecified

410

1389

2.75

76.29

1.4

1.3

352.69

279.96

pmol/l

0.67

350

1199

Hypertensive Renal Disease

15.09

76.22

1.5

1.4

401.49

220.01

pmol/l

1.53

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1040

3802

1.90

75.74

1.3

1.4

431.03

354.15

pmol/l

0.34

868

3349

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

333

656

3.23

74.08

1.4

1.3

332.52

355.43

pmol/l

0.20

293

570

Renal tubulo-interstitial diseases

922

3551

1.95

73.46

1.3

1.4

361.59

383.56

pmol/l

0.20

794

3094

Abnormalities of heart beat

398

1474

2.68

71.37

1.3

295.37

333.34

pmol/l

0.86

349

1272

Any reimbursement code in KELA

543

1097

2.50

71.24

1.5

1.4

554.01

389.04

pmol/l

0.41

475

997

Statin medication

706

1841

2.17

70.40

1.4

402.76

393.41

pmol/l

0.05

613

1643

Non-invasive ventilation

255

676

3.41

68.33

1.3

1.5

346.66

418.66

pmol/l

0.60

239

603

Implicit Sepsis

861

3263

1.94

67.90

1.3

1.4

435.51

359.11

pmol/l

0.28

748

2842

Nausea and vomiting

335

1170

2.85

67.30

1.4

304.90

451.06

pmol/l

0.94

275

1020

Condition for Implicit Sepsis (Organ dysfunction codes)

938

3456

1.89

66.72

1.3

1.4

438.43

360.65

pmol/l

0.32

821

3019

Hard cardiovascular diseases

885

2746

1.94

66.05

1.3

1.4

414.77

324.84

pmol/l

0.37

766

2396

Hyperkalaemia

101

148

7.08

65.92

1.4

341.82

288.52

pmol/l

0.53

132

Implicit Sepsis

791

3046

1.98

65.71

1.3

446.16

356.32

pmol/l

0.30

681

2644

First line medication for Crohn's disease

1119

3380

1.80

65.27

1.4

453.48

353.90

pmol/l

0.49

959

2961

Neurological diseases

836

2125

1.99

64.49

1.4

488.22

354.00

pmol/l

0.54

727

1858

Other soft tissue disorders, not elsewhere classified

950

2998

1.87

63.68

1.3

1.4

361.84

360.89

pmol/l

0.01

814

2632

GASTRO-related operations

766

1896

2.04

63.16

1.4

500.77

343.69

pmol/l

0.59

664

1667

Any gastric operation

766

1896

2.04

63.16

1.4

500.77

343.69

pmol/l

0.59

664

1667

Insulin medication

603

2409

2.12

62.41

1.3

1.4

297.85

414.65

pmol/l

1.19

495

2101

Condition for Implicit Sepsis (Organ dysfunction codes)

878

3344

1.87

60.99

1.3

1.4

439.60

357.62

pmol/l

0.31

766

2916

Hypopituitarism

123

240

5.30

59.91

1.4

1.3

1172.20

303.07

pmol/l

0.56

111

207

Asthma, unspecified (mode), excluding more controls

559

1952

2.16

59.09

1.4

708.66

337.28

pmol/l

0.84

491

1720

Disorders of mineral metabolism

129

269

4.94

58.15

1.3

1242.02

296.20

pmol/l

0.63

109

233

Neurological diseases, wide definition

294

473

3.15

58.02

1.5

718.01

401.35

pmol/l

0.44

254

426

Medical observation and evaluation for suspected diseases and conditions

669

1667

2.07

57.49

1.4

392.60

303.43

pmol/l

1.26

569

1457

Pain in limb

817

2928

1.88

57.43

1.3

1.4

336.09

362.22

pmol/l

0.24

691

2568

Symptoms and signs involving cognition, perception, emotional state and behaviour

974

3769

1.77

56.98

1.3

1.4

303.35

386.20

pmol/l

1.38

847

3284

Other headache syndromes

434

1904

2.30

56.52

1.4

348.96

346.59

pmol/l

0.02

385

1650

Oedema, not elsewhere classified

350

1379

2.54

56.26

1.3

323.20

319.98

pmol/l

0.03

301

1188

Migraine

496

1843

2.20

55.86

1.4

556.27

360.08

pmol/l

0.48

441

1611

Used for control exclusion in common control thyroid runs

1010

2893

1.77

55.37

1.4

563.83

318.94

pmol/l

1.04

871

2514

Asthma, unspecified (mode)

568

2071

2.08

54.75

1.4

699.79

332.49

pmol/l

0.85

500

1813

Symptoms and signs involving the nervous and musculoskeletal systems

600

3022

2.00

54.73

1.3

1.4

281.86

404.11

pmol/l

1.79

534

2600

Other arrhythmias

656

2526

1.98

54.69

1.3

1.4

300.20

415.79

pmol/l

1.27

583

2197

Dipeptidyl peptidase 4 (DPP-4) inhibitors

548

2115

2.10

54.20

1.2

1.3

290.74

342.63

pmol/l

0.51

458

1818

Insulin, intermediate and long-acting

564

2727

2.03

53.06

1.3

1.4

294.62

395.09

pmol/l

1.11

463

2350

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

394

1709

2.34

53.02

1.4

1.3

586.13

412.71

pmol/l

0.30

352

1476

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

128

288

4.58

52.67

1.5

1292.53

424.48

pmol/l

0.57

115

257

Parasetamol

706

1836

1.96

52.59

1.4

461.74

409.44

pmol/l

0.13

599

1615

Codeine

906

2768

1.79

52.06

1.4

353.92

369.16

pmol/l

0.12

794

2423

Disorders of parathyroid gland

245

840

2.93

52.04

1.3

1.2

765.77

300.58

pmol/l

0.59

211

724

Ischemic heart diseases

836

2786

1.82

51.47

1.3

1.4

414.38

305.67

pmol/l

0.43

709

2437

Other metabolic disorders

163

451

3.68

50.42

1.4

1.3

306.89

310.80

pmol/l

0.05

147

393

Asthma, excluding more controls

751

2093

1.88

50.21

1.4

628.25

337.39

pmol/l

0.91

664

1852

ILD medications: prednisolone, methylprednisolone, prednisone

1060

3534

1.69

50.03

1.4

469.11

347.78

pmol/l

0.60

916

3082

Dizziness and giddiness

747

3261

1.83

49.92

1.3

1.4

303.28

393.11

pmol/l

1.25

651

2829

Codeine or tramadol medication

1093

3593

1.67

49.83

1.3

1.4

344.88

382.57

pmol/l

0.35

966

3120

Other diseases of intestines

1013

3402

1.70

49.67

1.3

1.4

370.59

388.18

pmol/l

0.12

887

2981

Persons encountering health services in other circumstances, wide

1127

3507

1.66

49.50

1.3

1.4

313.58

388.59

pmol/l

1.06

975

3060

Inflammatory bowel disease treatment related agents

1103

3732

1.66

49.26

1.4

450.46

350.42

pmol/l

0.50

962

3256

Postprocedural endocrine and metabolic disorders, not elsewhere classified

153

414

3.77

48.93

1.4

1.3

310.96

315.21

pmol/l

0.05

141

361

Oral corticosteroids

1030

3650

1.68

48.91

1.4

465.49

350.18

pmol/l

0.55

894

3180

ILD medications

1090

3568

1.67

48.69

1.4

460.93

348.15

pmol/l

0.57

946

3114

Other bacterial diseases

989

3730

1.69

48.52

1.3

1.4

324.72

383.55

pmol/l

0.76

860

3260

Asthma

776

2227

1.84

48.27

1.4

618.04

333.32

pmol/l

0.93

687

1960

Percutaneous Coronary Intervention

781

2661

1.81

48.09

1.3

1.4

410.88

303.71

pmol/l

0.39

677

2322

Disorders of gallbladder, biliary tract and pancreas

957

3566

1.70

47.92

1.3

1.4

415.09

354.39

pmol/l

0.24

845

3084

Obesity related asthma

392

1772

2.24

47.86

1.3

604.99

324.61

pmol/l

0.56

349

1526

Persons encountering health services for specific procedures and health care

1044

3778

1.67

47.78

1.4

433.58

360.10

pmol/l

0.32

896

3309

Complications of surgical and medical care, not elsewhere classified

961

3916

1.69

47.72

1.3

1.4

440.62

351.90

pmol/l

0.38

840

3409

Coronary revascularization (ANGIO or CABG)

780

2662

1.81

47.59

1.3

1.4

411.85

303.69

pmol/l

0.40

673

2323

Insulin, combination of fast acting with intermediate-acting or long-acting

603

2904

1.91

47.53

1.3

1.4

297.85

392.72

pmol/l

1.11

495

2505

Asthma (mode)

766

2255

1.83

47.28

1.4

628.59

332.80

pmol/l

0.96

677

1986

Syncope and collapse

433

1732

2.16

47.11

1.4

1.3

553.35

318.53

pmol/l

0.50

370

1492

Opioids

924

2795

1.73

46.65

1.4

477.74

368.48

pmol/l

0.43

795

2447

Asthma (only as main-diagnosis), excluding more controls

683

2093

1.88

46.39

1.4

642.45

337.39

pmol/l

0.85

599

1852

Emergency coronary revascularization (for ACS)

824

2885

1.75

44.98

1.3

1.4

400.65

302.59

pmol/l

0.38

712

2503

Major coronary heart disease event

819

2843

1.75

44.85

1.3

1.4

409.23

303.99

pmol/l

0.41

709

2471

Spondylopathies

762

2570

1.78

44.35

1.3

1.4

278.60

363.84

pmol/l

1.32

671

2219

Exclusions for E4_PCOS_CONSORTIUM

716

2500

1.81

43.94

1.4

1.3

505.77

353.26

pmol/l

0.54

630

2209

Complications of procedures, not elsewhere classified

787

3793

1.73

43.86

1.3

1.4

477.13

350.81

pmol/l

0.46

685

3298

Care involving use of rehabilitation procedures

646

3285

1.82

43.84

1.4

1.3

322.99

358.88

pmol/l

0.50

564

2869

Other symptoms and signs involving the nervous and musculoskeletal systems

436

2126

2.07

43.76

1.3

278.44

450.20

pmol/l

1.80

389

1835

Hyperparathyroidism

207

716

2.90

43.44

1.3

1.2

844.26

303.26

pmol/l

0.57

178

617

Other bacterial diseases

910

3677

1.67

43.41

1.4

315.56

382.52

pmol/l

0.89

786

3210

Diseases of oesophagus, stomach and duodenum

1002

3686

1.63

42.66

1.4

347.44

379.06

pmol/l

0.29

869

3221

Ischaemic heart disease, wide definition

750

2652

1.76

42.46

1.3

1.4

289.38

339.58

pmol/l

0.65

632

2313

Asthma (only as main-diagnosis)

693

2227

1.81

42.32

1.4

637.19

333.32

pmol/l

0.86

606

1960

Disorders of the thyroid gland

883

3447

1.68

42.29

1.4

1.3

615.99

315.73

pmol/l

1.17

771

2988

Mood disorders, excluding more controls

903

3238

1.67

42.16

1.3

1.4

347.13

377.16

pmol/l

0.28

792

2838

Other functional intestinal disorders

441

2026

2.04

41.87

1.3

1.4

360.28

419.08

pmol/l

0.27

369

1763

Implicit viral Sepsis

303

1302

2.35

41.75

1.4

1.3

689.09

317.17

pmol/l

0.59

265

1106

Benzodiazepine use

953

4039

1.63

41.63

1.3

1.4

440.13

352.65

pmol/l

0.37

815

3538

Asthma (diagnoses ohter than nonallergic)

824

4093

1.68

41.47

1.4

597.63

323.99

pmol/l

0.95

727

3559

Fibromyalgia

137

386

3.64

41.45

1.5

1.3

462.38

343.69

pmol/l

0.44

124

352

Pain, not elsewhere classified

286

1203

2.40

41.36

1.3

1.4

300.74

358.60

pmol/l

1.04

254

1050

Symptoms and signs involving the digestive system and abdomen

913

2745

1.68

41.09

1.3

1.4

322.41

398.67

pmol/l

0.67

785

2400

Autoimmune diseases excluding thyroid diseases

963

3218

1.64

40.92

1.3

1.4

409.26

328.27

pmol/l

0.35

838

2810

Disorders of thyroid, IBD co-morbidities

166

351

3.36

40.81

1.4

1.5

331.73

389.91

pmol/l

0.89

145

311

Depression or dysthymia

656

1995

1.83

40.63

1.3

1.4

306.83

409.31

pmol/l

0.79

565

1748

Autoimmune diseases

1023

3228

1.62

40.61

1.4

535.80

328.51

pmol/l

0.84

880

2819

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1032

3503

1.61

40.50

1.3

1.4

325.50

388.80

pmol/l

0.82

904

3057

Insulin, fast-acting

370

1748

2.14

40.40

1.3

1.4

320.47

381.72

pmol/l

0.47

291

1506

Intracranial trauma

495

1783

1.96

40.36

1.3

1.4

312.31

361.14

pmol/l

1.17

431

1565

Obesity, other/unspecified

358

1677

2.16

40.04

1.4

595.74

437.76

pmol/l

0.24

322

1458

Mood disorders

973

3926

1.61

39.90

1.3

1.4

347.75

373.65

pmol/l

0.28

854

3431

Abdominal and pelvic pain

905

2745

1.66

39.83

1.3

1.4

318.61

398.67

pmol/l

0.72

785

2400

Other antidepressants

944

2964

1.64

39.43

1.3

1.4

322.33

380.56

pmol/l

0.60

808

2590

Abnormal findings on examination of blood, without diagnosis

453

2125

1.98

39.36

1.4

1.3

347.07

353.93

pmol/l

0.04

388

1796

Mood [affective] disorders

969

3927

1.61

39.31

1.3

1.4

346.99

373.66

pmol/l

0.29

851

3431

Implicit bacterial Sepsis

424

1823

2.03

39.19

1.3

320.29

293.25

pmol/l

0.34

362

1550

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

624

3161

1.78

39.05

1.3

323.53

343.92

pmol/l

0.21

551

2715

Dorsalgia

908

2969

1.65

38.94

1.4

328.34

406.70

pmol/l

0.82

812

2577

Malignant neoplasm of endocrine gland

113

296

3.93

38.13

1.5

1.4

277.83

346.90

pmol/l

1.60

103

259

Insulin, fast-acting or short human

372

1802

2.08

38.06

1.3

1.4

319.01

376.87

pmol/l

0.45

293

1555

Concussion

427

1750

2.00

38.04

1.3

1.4

322.59

361.39

pmol/l

0.77

371

1535

Depression

909

3833

1.62

37.99

1.4

350.82

377.34

pmol/l

0.28

799

3355

Low back pain

696

2909

1.73

37.95

1.4

310.27

407.97

pmol/l

1.21

618

2521

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

315

668

2.38

37.81

1.5

1.4

304.50

347.72

pmol/l

0.89

273

589

Lower back pain or/and sciatica

979

4049

1.59

37.75

1.3

1.4

307.65

381.78

pmol/l

1.28

870

3513

Volume depletion

104

258

4.11

37.65

1.3

478.96

281.93

pmol/l

0.89

223

Chronic lower respiratory diseases

1109

3817

1.55

37.51

1.4

527.68

327.96

pmol/l

0.91

970

3339

Implicit viral Sepsis

212

817

2.63

37.08

1.3

891.57

321.17

pmol/l

0.63

181

692

Viral Sepsis

212

820

2.62

36.81

1.3

891.57

321.44

pmol/l

0.63

181

695

Type 1 diabetes

249

1037

2.42

36.78

1.3

1.4

271.45

446.61

pmol/l

1.08

195

914

Infections, IBD-co-morbidities

142

297

3.45

36.62

1.4

434.00

390.82

pmol/l

0.18

123

263

Disorders of calcium metabolism

197

4.59

36.53

1.3

1619.29

308.17

pmol/l

0.60

166

Hypothyroidism, other/unspecified

811

3254

1.65

36.50

1.4

1.3

617.99

317.30

pmol/l

1.06

707

2832

Bacterial Sepsis

433

1903

1.96

36.47

1.3

325.29

294.63

pmol/l

0.41

370

1614

Implicit bacterial Sepsis

385

1689

2.04

36.40

1.3

328.28

293.13

pmol/l

0.42

329

1431

Autoimmune diseases excluding thyroid diseases, strict definition

905

3083

1.62

36.25

1.4

303.78

329.42

pmol/l

0.83

785

2691

Fever of other and unknown origin

481

2303

1.87

35.58

1.3

1.4

539.06

335.75

pmol/l

0.45

402

2003

Complications of medical and surgical care

690

3811

1.68

35.03

1.3

482.31

348.57

pmol/l

0.43

608

3305

Nerve, nerve root and plexus disorders

973

3829

1.56

34.88

1.3

1.4

303.60

383.83

pmol/l

1.27

843

3333

Hypothyreosis and Thyroxine purchase for inclusion criteria

839

3431

1.61

34.67

1.4

1.3

606.91

324.18

pmol/l

1.01

731

2986

Spondylosis

511

2297

1.83

34.46

1.2

1.3

276.74

361.13

pmol/l

1.09

454

1977

General examination and investigation of persons without complaint and reported diagnosis

573

1666

1.80

33.87

1.4

317.67

303.57

pmol/l

0.29

507

1456

Persons encountering health services in other circumstances

387

1974

1.97

33.84

1.3

1.4

292.25

453.73

pmol/l

1.44

314

1719

Diverticular disease of intestine

648

2424

1.72

33.83

1.3

310.27

330.95

pmol/l

0.15

575

2099

Cholelithiasis

763

3240

1.63

33.44

1.3

437.85

358.83

pmol/l

0.25

676

2790

Diseases of arteries, arterioles and capillaries

599

2567

1.74

33.37

1.3

273.80

335.78

pmol/l

0.82

513

2190

Other disorders of kidney and ureter

159

562

2.88

33.05

1.4

1.3

468.83

293.52

pmol/l

0.67

142

475

Cholelithiasis, broad definition with cholecystitis

786

3294

1.61

32.84

1.3

434.61

358.34

pmol/l

0.25

698

2835

Other CVD

197

781

2.56

32.57

1.3

296.48

282.20

pmol/l

0.25

161

651

Other intervertebral disc disorders

750

2776

1.64

32.26

1.3

1.4

298.70

406.00

pmol/l

1.31

670

2400

Coronary atherosclerosis

595

2183

1.74

32.24

1.3

271.50

297.85

pmol/l

0.79

487

1893

Heart failure,strict

470

1814

1.84

31.71

1.2

1.3

311.49

332.34

pmol/l

0.14

384

1547

Combinations of oral blood glucose lowering drugs

269

1237

2.20

31.71

1.3

297.34

389.65

pmol/l

0.54

221

1054

Pain in joint

517

1844

1.80

31.69

1.4

544.58

365.01

pmol/l

0.41

450

1613

Hypotension

173

653

2.69

31.64

1.3

282.28

278.80

pmol/l

0.05

138

538

Acute renal failure

213

894

2.41

31.17

1.3

380.86

405.27

pmol/l

0.07

186

754

Migraine without aura

189

751

2.54

31.09

1.5

1.4

903.08

435.57

pmol/l

0.43

172

670

Spinal stenosis

459

1917

1.83

30.88

1.2

1.3

275.37

352.69

pmol/l

0.77

404

1639

Hypothyroidism, strict autoimmune

633

2492

1.68

30.78

1.4

1.3

532.60

331.25

pmol/l

0.67

544

2171

Genitourinary diseases

524

1468

1.80

30.46

1.4

316.07

365.47

pmol/l

0.32

448

1290

Sciatica+with lumbago

475

2472

1.78

30.12

1.3

1.4

303.54

417.04

pmol/l

1.18

428

2136

Type 1 diabetes, wide definition, subgroup 1

203

848

2.42

29.94

1.3

1.4

281.74

481.16

pmol/l

0.97

155

744

Migraine with aura

224

978

2.31

29.91

1.3

1.4

772.46

408.26

pmol/l

0.39

204

855

Examination and observation for other reasons

510

1663

1.78

29.87

1.3

1.4

818.09

303.80

pmol/l

1.11

435

1453

Continuous positive airway pressure

162

505

2.73

29.59

1.3

1.5

274.31

374.46

pmol/l

1.03

142

447

Asthma, hospital admission 2, infections

521

2987

1.72

29.53

1.3

1.4

695.42

330.16

pmol/l

0.74

454

2591

Asthma-related infections

521

2987

1.72

29.53

1.3

1.4

695.42

330.16

pmol/l

0.74

454

2591

Any mental disorder

988

3283

1.51

29.42

1.3

1.4

347.23

379.18

pmol/l

0.26

841

2875

Recurrent or chronic depression

384

1418

1.92

29.39

1.4

347.17

474.33

pmol/l

0.67

335

1249

Disorder of lipoprotein metabolism, unspecified

130

439

3.01

29.33

1.5

1.3

292.25

277.66

pmol/l

0.22

110

375

Other dorsopathies, not elsewhere classified

877

2976

1.55

29.31

1.4

335.42

406.52

pmol/l

0.71

771

2583

Other pulmonary diagnosis

725

2246

1.63

29.29

1.3

1.4

483.02

332.54

pmol/l

0.54

617

1978

Other special examinations and investigations of persons without complaint or reported diagnosis

568

1667

1.73

29.27

1.4

546.55

303.43

pmol/l

0.71

493

1457

Anxiety disorders, excluding more controls

748

3076

1.59

29.26

1.3

1.4

350.39

384.07

pmol/l

0.30

650

2710

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

871

3711

1.54

29.24

1.3

1.4

345.50

384.93

pmol/l

0.43

764

3250

Vocal cord dysfunction

123

356

3.13

29.19

1.3

1.4

315.66

507.66

pmol/l

1.02

113

316

Type 1 diabetes, wide definition

210

901

2.35

29.16

1.3

1.4

280.55

468.26

pmol/l

0.97

159

792

Valvular heart disease excluding rheumatic fever

411

1602

1.87

29.09

1.2

1.4

280.93

368.72

pmol/l

0.71

348

1371

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

557

3297

1.68

28.93

1.3

346.21

356.64

pmol/l

0.09

496

2851

Cerebrovascular diseases

656

2847

1.63

28.69

1.3

308.12

326.75

pmol/l

0.20

551

2465

Aplastic and other anaemias

401

2044

1.84

28.57

1.3

591.54

304.58

pmol/l

0.56

329

1736

Non-rheumatic valve diseases

407

1591

1.86

28.50

1.2

1.4

281.66

368.53

pmol/l

0.70

344

1361

Symptoms and signs involving the urinary system

677

3233

1.60

28.27

1.4

1.3

309.06

386.80

pmol/l

0.98

591

2795

Gastrointestinal diseases

506

1436

1.77

28.15

1.4

533.84

353.69

pmol/l

0.42

435

1275

Asthma, including avohilmo

1042

3984

1.47

28.12

1.4

540.93

325.16

pmol/l

0.95

920

3465

Cholecystectomy

637

3422

1.61

27.91

1.3

469.56

352.56

pmol/l

0.33

570

2958

Benign neoplasm: Pituitary gland, craniopharyngeal duct

193

4.10

27.73

1.5

1.4

1590.10

362.36

pmol/l

0.47

167

Excluding asthma or asthma-COPD overlap

716

2246

1.60

27.55

1.3

1.4

488.42

332.54

pmol/l

0.56

608

1978

Finngen Rheumatological endpoints

848

3166

1.53

27.37

1.4

572.04

342.34

pmol/l

0.76

743

2755

Diarrhoea and gastroenteritis of presumed infectious origin

622

3494

1.61

27.26

1.4

341.53

389.87

pmol/l

0.54

525

3067

Diseases of the skin and subcutaneous tissue

890

2951

1.52

27.06

1.4

461.07

370.55

pmol/l

0.33

765

2572

Dorsopathies

890

2992

1.52

27.06

1.4

341.03

405.94

pmol/l

0.63

780

2599

Diarrhoea and gastroenteritis of presumed infectious origin

894

3948

1.50

26.99

1.4

1.3

336.64

375.25

pmol/l

0.48

767

3463

Nutritional anaemias

432

2373

1.77

26.98

1.2

1.3

352.75

416.88

pmol/l

0.43

351

2046

Intestinal infectious diseases

1011

3945

1.47

26.95

1.4

336.79

375.63

pmol/l

0.46

873

3452

Anxiety disorders

817

3754

1.52

26.89

1.4

357.66

382.89

pmol/l

0.26

712

3304

Other and unspecified iron deficiency

309

1594

1.95

26.69

1.2

1.3

322.08

343.02

pmol/l

0.28

254

1369

Neurotic, stress-related and somatoform disorders

808

3728

1.52

26.60

1.4

359.18

384.18

pmol/l

0.26

703

3283

Other anaemias

367

1904

1.85

26.45

1.3

607.09

307.52

pmol/l

0.53

302

1624

Intestinal infectious diseases

826

4170

1.51

26.43

1.4

1.3

357.81

373.63

pmol/l

0.16

704

3655

Other and unspecified anaemias

363

1883

1.85

26.40

1.3

606.88

304.66

pmol/l

0.53

300

1604

Other diseases of liver

194

843

2.33

26.37

1.4

1.3

324.78

342.06

pmol/l

0.18

171

729

Functional dyspepsia

267

1317

2.05

26.30

1.3

324.48

416.87

pmol/l

0.58

236

1130

Constipation

780

3544

1.53

26.20

1.3

472.83

348.00

pmol/l

0.44

666

3087

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

516

3119

1.66

26.01

1.3

351.57

392.39

pmol/l

0.33

460

2689

Convulsions, not elsewhere classified

214

960

2.22

25.99

1.3

1.4

775.85

335.42

pmol/l

0.45

181

835

Asthma, hospital admissions , main diagnosis only

720

4140

1.54

25.99

1.4

624.96

330.38

pmol/l

0.87

629

3619

Pain (limb, back, neck, head abdominally)

613

1880

1.64

25.85

1.3

1.4

337.18

369.76

pmol/l

0.19

523

1644

Other septicaemia

330

1690

1.89

25.77

1.3

371.42

367.70

pmol/l

0.02

280

1445

Soft tissue disorders

879

3022

1.50

25.67

1.4

502.82

360.41

pmol/l

0.57

742

2652

Explicit Sepsis

379

1967

1.81

25.67

1.3

1.4

357.71

371.05

pmol/l

0.07

320

1681

Exposure to unspecified factor

873

4247

1.49

25.63

1.3

1.4

452.13

352.70

pmol/l

0.39

737

3729

ILD differential diagnosis

708

2255

1.58

25.62

1.3

1.4

489.46

332.80

pmol/l

0.55

603

1986

Bleeding

719

3319

1.55

25.59

1.3

306.05

377.40

pmol/l

0.89

623

2872

COPD differential diagnosis

707

2257

1.58

25.35

1.3

1.4

490.00

332.60

pmol/l

0.56

602

1988

Angina pectoris

497

1965

1.70

25.25

1.3

281.94

298.65

pmol/l

0.38

429

1693

Iron deficiency anaemia

372

2048

1.80

25.01

1.2

1.3

335.04

439.96

pmol/l

0.77

304

1767

Diseases of liver

328

1766

1.87

24.99

1.4

1.3

333.62

367.65

pmol/l

0.23

292

1516

Osteopathies and chondropathies

502

2834

1.66

24.93

1.3

518.56

362.61

pmol/l

0.34

422

2486

Lumbar disc prolapse

563

2672

1.62

24.92

1.3

1.4

303.40

407.51

pmol/l

1.16

499

2306

Abnormal findings on diagnostic imaging of other body structures

153

614

2.53

24.87

1.4

1.3

316.67

346.85

pmol/l

0.24

141

533

Hernia of abdominal wall, postoperative

167

697

2.42

24.85

1.2

1.3

352.04

309.47

pmol/l

0.58

147

597

Glomerular disorders in diseases classified elsewhere

130

484

2.73

24.62

1.3

1.4

309.14

292.94

pmol/l

0.19

105

421

Bacterial infection, other or unspecified

495

2528

1.67

24.52

1.4

1.3

313.52

350.92

pmol/l

0.39

411

2175

Pregnancy hypertension

374

1880

1.80

24.43

1.4

683.29

373.08

pmol/l

0.62

340

1677

Infections of the skin and subcutaneous tissue

513

3128

1.63

24.16

1.3

1.4

523.55

370.25

pmol/l

0.35

445

2718

Epilepsy

257

1285

2.01

24.14

1.2

1.4

723.67

356.84

pmol/l

0.46

223

1106

Psychiatric diseases

866

2923

1.49

24.09

1.3

1.4

349.11

387.36

pmol/l

0.28

732

2566

391

2226

1.75

24.01

1.3

1.4

837.08

344.43

pmol/l

0.77

344

1937

Polycystic ovarian syndrome, consortium definition

627

2356

1.59

23.89

1.3

564.86

348.08

pmol/l

0.69

542

2110

Visual disturbances and blindness

460

2764

1.67

23.88

1.4

1.3

541.38

371.95

pmol/l

0.36

402

2391

Polyarthropathies

590

2421

1.60

23.86

1.3

1.4

528.15

334.49

pmol/l

0.56

510

2110

Selective serotonin reuptake inhibitors

847

2979

1.49

23.83

1.3

1.4

370.04

380.26

pmol/l

0.06

724

2605

Glomerular diseases

183

811

2.29

23.80

1.3

1.4

354.32

431.60

pmol/l

0.26

148

684

Other specific joint derangements/joint disorders

640

2650

1.57

23.73

1.3

1.4

539.70

339.19

pmol/l

0.62

549

2319

Nonalcoholic fatty liver disease

117

422

2.82

23.59

1.4

307.36

322.59

pmol/l

0.21

106

368

Other/unspecified dorsalgia

330

1797

1.83

23.54

1.3

1.4

345.72

461.69

pmol/l

0.61

298

1553

Other general symptoms and signs

140

4.33

23.36

1.2

1.4

340.99

447.26

pmol/l

0.50

122

779

3158

1.50

23.31

1.3

1.4

314.95

336.87

pmol/l

0.43

658

2782

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

779

3158

1.50

23.31

1.3

1.4

314.95

336.87

pmol/l

0.43

658

2782

Anxiety (asthma-related co-morbidities)

522

2501

1.62

23.09

1.4

393.66

424.94

pmol/l

0.21

453

2220

Certain infectious and parasitic diseases

856

2911

1.48

22.98

1.4

593.74

330.15

pmol/l

0.89

723

2556

Disorders of eyelid, lacrimal system and orbit

737

3748

1.50

22.97

1.3

282.78

386.44

pmol/l

1.93

646

3244

COPD/asthma/ILD related infections

916

3158

1.46

22.93

1.3

1.4

536.31

336.87

pmol/l

0.67

779

2782

COPD/asthma related infections

916

3158

1.46

22.93

1.3

1.4

536.31

336.87

pmol/l

0.67

779

2782

Cough

331

1732

1.82

22.91

1.4

1.3

327.63

330.49

pmol/l

0.04

292

1499

Erysipelas

621

3064

1.55

22.88

1.3

302.35

348.66

pmol/l

0.64

540

2658

Use of hypnotics and sedatives

921

3666

1.45

22.87

1.4

445.25

351.48

pmol/l

0.39

798

3185

Influenza and pneumonia

913

4038

1.44

22.72

1.3

1.4

321.59

384.82

pmol/l

0.91

772

3554

Septicaemia

359

1907

1.77

22.71

1.3

357.05

360.90

pmol/l

0.02

305

1635

Acute tubulo-interstitial nephritis

519

2794

1.61

22.70

1.3

344.63

404.24

pmol/l

0.54

449

2427

Autoimmune diseases related-to ILD

735

4235

1.49

22.69

1.4

310.35

376.12

pmol/l

1.09

647

3687

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

410

2101

1.71

22.49

1.4

647.35

365.76

pmol/l

0.61

372

1872

Heart failure, strict

491

2121

1.64

22.41

1.2

1.3

307.00

339.28

pmol/l

0.27

400

1810

Systemic connective tissue disorders

315

1736

1.83

22.33

1.3

326.22

330.36

pmol/l

0.05

271

1497

Haemorrhage from respiratory passages

269

1263

1.93

22.31

1.4

1.3

302.24

283.10

pmol/l

0.45

236

1068

Visual disturbances

428

2575

1.67

22.21

1.4

1.3

329.37

380.05

pmol/l

0.56

378

2221

Dermatitis and eczema

949

4136

1.43

22.19

1.4

420.98

357.13

pmol/l

0.25

830

3604

Major coronary heart disease event excluding revascularizations

504

2075

1.63

21.97

1.3

255.99

301.62

pmol/l

1.64

426

1777

Gastro-oesophageal reflux disease

586

3271

1.55

21.95

1.4

1.3

307.78

381.32

pmol/l

0.94

500

2846

Primary hyperparathyroidism

126

493

2.60

21.70

1.3

333.40

356.98

pmol/l

0.15

110

422

Rheumatism, unspecified

146

613

2.41

21.58

1.3

343.54

310.40

pmol/l

0.31

129

546

Asthma/COPD (KELA code 203)

808

3814

1.46

21.57

1.4

469.43

328.15

pmol/l

0.58

711

3336

Stroke, including SAH

527

2409

1.60

21.54

1.3

305.63

337.41

pmol/l

0.31

447

2062

Sub-endpoint used in defining T1D endpoints

258

1327

1.93

21.51

1.3

1.4

272.65

411.30

pmol/l

1.06

201

1153

Stroke, excluding SAH

498

2264

1.61

21.41

1.3

306.01

336.90

pmol/l

0.27

423

1930

Bacterial infection, other or unspecified

446

2367

1.64

21.23

1.4

1.3

315.09

346.45

pmol/l

0.29

369

2033

Non-selective monoamine reuptake inhibitors

332

1821

1.77

21.01

1.3

302.60

366.98

pmol/l

0.55

287

1591

Pneumonia, organism unspecified

784

3792

1.46

20.79

1.3

1.4

306.13

385.82

pmol/l

1.16

652

3326

Other disorders of urethra and urinary system

586

2758

1.54

20.62

1.4

340.19

376.07

pmol/l

0.40

502

2406

All-cause Heart Failure

477

2092

1.62

20.62

1.2

1.3

307.31

340.72

pmol/l

0.27

388

1784

Substance abuse, excluding more controls

459

2427

1.62

20.60

1.2

1.4

317.65

399.61

pmol/l

0.72

380

2108

Symptoms and signs involving the skin and subcutaneous tissue

601

3898

1.52

20.54

1.4

1.3

311.83

381.57

pmol/l

1.09

540

3379

Erysipelas

470

2600

1.61

20.54

1.3

292.23

334.56

pmol/l

0.49

410

2238

Provisional assignment of new diseases of uncertain etiology

443

2740

1.62

20.48

1.3

1.4

305.64

426.33

pmol/l

1.47

381

2366

Codes for special purposes

444

2749

1.62

20.44

1.3

1.4

305.73

425.72

pmol/l

1.46

382

2375

Other and unspecified dermatitis

442

2739

1.62

20.43

1.3

307.17

376.40

pmol/l

0.99

382

2378

Diseases of pulp and periapical tissues, including avohilmo

886

3217

1.43

20.38

1.4

325.17

398.29

pmol/l

0.90

751

2816

Covid-19 confirmed case

315

1787

1.78

20.30

1.3

310.62

454.51

pmol/l

1.02

263

1520

Other endocrine disorders

154

3.87

20.29

1.3

2057.43

355.48

pmol/l

0.53

136

All anxiety disorders

530

2692

1.56

20.21

1.4

392.91

425.56

pmol/l

0.24

461

2381

All pneumoniae

865

4078

1.42

20.19

1.3

1.4

314.72

383.44

pmol/l

1.04

729

3588

Unspecified kidney failure

329

2.90

20.06

1.3

1.4

275.50

285.17

pmol/l

0.11

279

Elevated blood glucose level

324

2.92

20.06

1.4

304.44

310.98

pmol/l

0.06

277

Caries of dentine

212

1033

2.01

20.06

1.3

1.4

311.87

394.21

pmol/l

0.38

182

885

Hypocalcemia

5.41

20.02

1.3

1.4

3256.60

351.59

pmol/l

0.58

Other systemic involvement of connective tissue (FG)

233

1193

1.94

19.97

1.3

292.44

357.25

pmol/l

1.14

205

1030

Extracorporeal dialysis

208

3.44

19.76

1.4

513.80

316.57

pmol/l

1.81

182

Pneumonias (Asthma/COPD co-morbidities)

858

4076

1.42

19.72

1.3

1.4

314.36

383.09

pmol/l

1.04

723

3584

Dermatitis

520

3364

1.55

19.66

1.3

309.29

366.87

pmol/l

0.97

450

2916

139

596

2.36

19.63

1.4

403.52

574.40

pmol/l

0.45

114

529

Dental caries

234

1181

1.92

19.28

1.3

1.4

334.03

391.21

pmol/l

0.27

200

1017

Shoulder lesions

638

2593

1.50

19.07

1.3

1.4

341.59

348.17

pmol/l

0.04

550

2267

Hypothyroidism, strict autoimmune, 3 medication purchases required

692

3202

1.47

18.99

1.4

1.3

364.56

360.97

pmol/l

0.03

596

2792

ILD medications: immunosuppressive drugs

536

3281

1.52

18.76

1.4

345.58

350.54

pmol/l

0.05

478

2866

Atherosclerosis, excluding cerebral and coronary sclerosis

322

1476

1.74

18.64

1.2

1.3

272.01

364.91

pmol/l

0.68

264

1244

Irritable bowel syndrome

242

1302

1.87

18.63

1.3

1.4

318.03

494.08

pmol/l

0.93

212

1133

Myalgia

212

1093

1.96

18.59

1.2

1.4

322.05

427.87

pmol/l

0.55

186

960

Symptoms and signs concerning food and fluid intake

360

2.72

18.50

1.3

1.4

293.56

333.19

pmol/l

0.34

316

Disorders of vestibular function (Vertigo)

397

2418

1.63

18.44

1.3

293.22

358.09

pmol/l

0.80

351

2089

Carpal tunnel syndrome

524

3041

1.53

18.31

1.3

303.63

400.20

pmol/l

1.11

464

2655

Cervical disc disorders

305

1768

1.74

18.29

1.4

1.3

327.81

384.37

pmol/l

0.43

273

1515

Rotator cuff syndrome

511

2384

1.55

18.28

1.3

1.4

360.82

298.45

pmol/l

0.55

443

2076

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

832

4053

1.40

18.23

1.3

1.4

314.50

383.10

pmol/l

1.02

697

3569

Somatoform disorder

163

771

2.14

18.18

1.4

318.53

355.09

pmol/l

0.40

144

686

Other neurological diseases

595

3154

1.49

18.17

1.3

289.79

381.27

pmol/l

1.21

512

2725

Diseases of the eye and adnexa

672

2290

1.48

18.03

1.4

625.32

365.86

pmol/l

0.65

580

2040

Disorders of choroid and retina

665

3253

1.46

18.02

1.3

271.98

342.08

pmol/l

1.35

561

2811

Personality disorders, excluding more controls

217

1140

1.92

17.98

1.4

531.51

543.37

pmol/l

0.02

191

1006

Dialysis, with operation codes

123

521

2.39

17.92

1.4

491.99

304.68

pmol/l

2.84

104

441

Persons encountering health services for examination and investigation

516

1667

1.56

17.86

1.4

327.68

303.43

pmol/l

0.49

448

1457

Diseases of the ear and mastoid process

981

3594

1.37

17.85

1.4

411.74

370.57

pmol/l

0.15

857

3146

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

307

2.85

17.79

1.3

378.96

305.37

pmol/l

0.75

266

Myocardial infarction

396

1716

1.63

17.78

1.2

1.3

236.01

307.94

pmol/l

2.88

335

1465

Osteoporosis

232

1166

1.88

17.74

1.3

756.13

314.45

pmol/l

0.50

196

1018

Ovarian cyst

303

991

1.77

17.70

1.4

1.3

451.12

330.12

pmol/l

0.69

269

888

Paralytic ileus and intestinal obstruction

213

1119

1.92

17.64

1.3

335.27

398.22

pmol/l

0.25

180

957

Migraine without aura and triptan purchases

151

702

2.17

17.60

1.4

1.5

1050.94

441.66

pmol/l

0.46

137

619

Early onset COPD, excluding more controls

178

880

2.04

17.59

1.2

1.3

225.30

309.45

pmol/l

1.76

147

751

Other retinal disorders

516

2664

1.52

17.19

1.3

271.82

339.51

pmol/l

0.98

430

2291

Sicca syndrome [Sjögren]

370

2.64

17.15

1.3

260.50

382.07

pmol/l

1.00

327

Other diseases of pancreas

342

2.71

17.10

1.2

1.3

303.36

307.31

pmol/l

0.04

295

Care involving dialysis

331

2.74

17.06

1.4

489.52

307.84

pmol/l

2.10

279

Other disorders of lacrimal gland

302

1782

1.71

17.04

1.3

278.35

354.00

pmol/l

2.16

267

1542

Non-ischemic cardiomyopathy

255

1143

1.81

16.99

1.2

1.4

296.80

394.74

pmol/l

0.53

213

983

Irregular menses

392

1936

1.61

16.94

1.4

636.42

367.28

pmol/l

0.52

343

1743

Myocarditis

4.99

16.88

1.4

1.1

343.48

353.47

pmol/l

0.04

Other disorders of skin and subcutaneous tissue

567

3432

1.47

16.83

1.4

1.3

312.01

376.65

pmol/l

0.81

486

2976

Sequelae of external causes of morbidity and mortality

232

1276

1.83

16.74

1.2

1.3

292.49

401.91

pmol/l

0.68

192

1084

Gonarthrosis [arthrosis of knee](FG)

624

2487

1.46

16.70

1.3

1.4

440.94

319.59

pmol/l

0.36

550

2146

Nephropathy related operations

122

532

2.33

16.68

1.3

1.4

483.77

300.25

pmol/l

2.76

104

456

Periodontitis

809

3907

1.39

16.64

1.3

1.4

314.67

374.12

pmol/l

0.62

709

3388

Adverse effects, not elsewhere classified

179

907

1.99

16.59

1.4

862.47

399.71

pmol/l

0.40

161

794

Chronic periodontitis, including avohilmo

807

3907

1.39

16.58

1.3

1.4

315.44

373.69

pmol/l

0.61

707

3388

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

440

2780

1.55

16.57

1.4

564.00

324.48

pmol/l

0.56

403

2410

Certain disorders involving the immune mechanism

178

901

2.00

16.56

1.2

1.4

405.24

351.05

pmol/l

0.31

152

780

Migraine with aura and triptan purchases

143

667

2.17

16.56

1.3

1.5

1029.46

439.92

pmol/l

0.41

130

593

COPD (mode)

253

1116

1.79

16.35

1.2

1.3

224.39

289.25

pmol/l

1.56

204

949

Other reaction to severe stress, and adjustment disorders

305

1827

1.68

16.27

1.3

1.4

370.26

480.72

pmol/l

0.71

263

1610

Other anxiety disorders

381

2079

1.60

16.26

1.5

1.4

394.40

460.32

pmol/l

0.42

332

1825

949

3621

1.36

16.19

1.3

1.4

533.12

330.90

pmol/l

0.74

817

3165

Fall on same level

949

3840

1.35

16.01

1.4

340.99

384.08

pmol/l

0.43

818

3369

Cystitis

691

2899

1.42

15.94

1.4

491.20

377.09

pmol/l

0.34

604

2528

Cervicocranial syndrome

104

433

2.43

15.80

1.4

1.3

350.53

384.04

pmol/l

0.19

374

Other symptoms and signs involving the digestive system and abdomen

150

727

2.08

15.75

1.3

370.98

372.66

pmol/l

0.01

127

632

Other systemic involvement of connective tissue

237

1340

1.78

15.63

1.3

293.54

340.08

pmol/l

0.80

208

1160

Vascular disorders of the intestines

224

3.04

15.62

1.1

1.4

375.52

308.57

pmol/l

0.38

189

Diseases of the respiratory system

546

1841

1.49

15.58

1.3

1.4

328.87

338.73

pmol/l

0.14

475

1625

Hernia

775

3769

1.38

15.54

1.3

1.4

426.74

355.35

pmol/l

0.23

668

3297

Disorders resulting from impaired renal tubular function

122

3.87

15.47

1.5

1.3

368.47

319.46

pmol/l

0.29

111

Certain infectious and parasitic diseases

616

2130

1.45

15.45

1.4

335.62

324.04

pmol/l

0.19

525

1863

Other and unspecified effects of external causes

239

1360

1.77

15.42

1.4

737.53

403.76

pmol/l

0.36

209

1189

Fracture of rib(s), sternum and thoracic spine

248

1427

1.75

15.39

1.3

257.69

388.15

pmol/l

1.02

202

1207

Other chronic obstructive pulmonary disease, including avohilmo

418

2248

1.54

15.37

1.2

1.3

305.23

332.40

pmol/l

0.13

343

1919

Benign neoplasm of colon, rectum, anus and anal canal

505

2976

1.48

15.31

1.3

291.77

328.47

pmol/l

0.47

449

2545

COPD

346

1764

1.61

15.29

1.2

1.3

231.84

291.04

pmol/l

2.20

284

1485

Aortic aneurysm

176

895

1.94

15.24

1.3

1.4

239.20

401.33

pmol/l

0.78

150

749

Mental and behavioural disorders due to psychoactive substance use

474

2956

1.49

15.12

1.2

1.4

323.55

397.44

pmol/l

0.78

391

2569

Disorders of synovium and tendon

433

2507

1.52

14.96

1.3

1.4

293.71

361.23

pmol/l

0.93

380

2200

Dysphagia

198

1076

1.85

14.90

1.2

1.3

297.58

427.39

pmol/l

0.72

164

917

Sequelae with surgical and medical care as external cause

183

971

1.90

14.87

1.2

1.3

272.85

321.01

pmol/l

0.78

150

824

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

100

421

2.41

14.87

1.3

243.93

302.55

pmol/l

1.59

353

Other joint disorders

713

2691

1.40

14.86

1.4

530.40

342.44

pmol/l

0.67

615

2355

Diseases of inner ear

442

2853

1.51

14.81

1.3

299.97

353.63

pmol/l

0.74

390

2463

Cervicalgia

180

953

1.90

14.71

1.3

333.27

445.54

pmol/l

0.49

153

814

Abnormal findings on diagnostic imaging of lung

375

2319

1.56

14.70

1.3

325.89

338.28

pmol/l

0.08

329

1971

Dental pulpitis, including avohilmo

756

3577

1.38

14.69

1.4

338.78

395.59

pmol/l

0.72

648

3149

Disorders of lacrimal system

350

2221

1.58

14.69

1.3

280.00

431.58

pmol/l

1.60

309

1941

Other or unspecified ileus, impaction or obstruction

152

761

2.01

14.61

1.3

360.42

310.80

pmol/l

0.24

127

645

Gingival hyperplasia

118

3.82

14.58

1.8

1.4

396.11

355.49

pmol/l

0.26

104

Injuries to the knee and lower leg

969

4059

1.33

14.57

1.4

306.49

385.33

pmol/l

1.42

839

3550

Substance abuse

459

2908

1.49

14.57

1.2

1.4

317.65

399.71

pmol/l

0.89

380

2526

Disturbances of skin sensation

242

1406

1.73

14.55

1.5

1.4

310.74

525.90

pmol/l

1.33

221

1201

Soft tissue disorders related to use, overuse and pressure

228

1303

1.76

14.53

1.3

700.86

307.00

pmol/l

0.46

207

1137

Diabetic nephropathy, excluding more controls

170

724

1.96

14.46

1.2

1.3

294.18

302.16

pmol/l

0.11

140

622

Other disorders of eyelid

354

2156

1.57

14.41

1.3

277.68

350.25

pmol/l

0.83

309

1854

Other aneurysm

172

3.25

14.40

1.5

1.4

248.99

339.44

pmol/l

1.39

153

Peripheral artery disease

325

1612

1.61

14.38

1.2

1.3

265.15

356.58

pmol/l

0.75

265

1359

Chronic pancreatitis

117

536

2.21

14.28

1.3

272.60

305.28

pmol/l

0.49

456

Persons with potential health hazards related to communicable diseases

303

1859

1.62

14.26

1.4

379.44

496.38

pmol/l

0.61

271

1634

Falls/tendency to fall

901

3372

1.34

14.22

1.4

464.05

366.14

pmol/l

0.38

772

2968

Undetermined asthma, excluding more controls

117

537

2.20

14.17

1.4

2077.88

333.23

pmol/l

0.87

107

475

Presence of other functional implants

468

2190

1.49

14.15

1.3

276.76

331.85

pmol/l

0.57

387

1885

Ischaemic Stroke, excluding all haemorrhages

435

2158

1.51

14.12

1.3

305.00

338.58

pmol/l

0.28

369

1828

Urticaria and erythema

304

1891

1.62

14.06

1.4

651.69

420.83

pmol/l

0.31

268

1647

Asthma-related pneumonia

280

1704

1.65

14.02

1.2

1.3

273.22

315.68

pmol/l

1.08

238

1460

Cyst of kidney

278

2.71

14.00

1.3

1.4

607.01

302.37

pmol/l

0.53

241

Asthma-related pneumonia or sepsis

280

1708

1.65

13.89

1.2

1.3

273.22

315.36

pmol/l

1.07

238

1463

Asthma, hospital admissions 3, pneumonia

280

1708

1.65

13.89

1.2

1.3

273.22

315.36

pmol/l

1.07

238

1463

Other blood glucose lowering drugs, excl. Insulins

133

649

2.07

13.79

1.2

1.3

296.68

332.08

pmol/l

0.29

107

544

Other external causes of accidental injury

691

2493

1.39

13.78

1.4

397.61

372.53

pmol/l

0.17

586

2202

Other arthritis (FG)

254

1518

1.68

13.78

1.3

1.4

413.79

344.91

pmol/l

0.41

220

1301

Other chronic obstructive pulmonary disease

328

1709

1.59

13.77

1.2

1.3

232.07

290.22

pmol/l

2.03

267

1441

Benign neoplasm of other and ill-defined parts of digestive system

162

848

1.93

13.77

1.4

1.3

291.13

315.85

pmol/l

0.25

146

722

Gestational [pregnancy-induced] hypertension

206

1160

1.78

13.73

1.4

341.03

410.84

pmol/l

1.09

189

1030

External causes of morbidity and mortality

548

1903

1.45

13.56

1.4

582.78

318.51

pmol/l

0.75

470

1690

Thyroiditis, ILD-related definition

106

478

2.24

13.47

1.4

362.02

383.17

pmol/l

0.11

421

Abnormalities of gait and mobility

105

473

2.25

13.38

1.3

1.4

281.75

306.66

pmol/l

0.36

392

Undetermined asthma

117

550

2.15

13.37

1.4

2077.88

331.53

pmol/l

0.87

107

479

Gonarthrosis,primary

706

3182

1.37

13.36

1.3

423.94

308.79

pmol/l

0.39

617

2745

Vitamin deficiency, wide

155

3.28

13.31

1.3

655.35

333.50

pmol/l

0.62

134

Vitamin deficiency

155

3.28

13.31

1.3

655.35

333.50

pmol/l

0.62

134

Other symptoms and signs involving the urinary system

405

2.35

13.31

1.4

249.86

302.90

pmol/l

1.04

342

Benign neoplasm: Colon

423

2733

1.48

13.28

1.3

310.88

327.73

pmol/l

0.16

373

2332

Viral and other specified intestinal infections

218

1217

1.74

13.24

1.4

384.11

488.54

pmol/l

0.48

184

1081

Diseases of the musculoskeletal system and connective tissue

421

1394

1.52

13.24

1.4

547.34

344.17

pmol/l

0.39

364

1221

Disorders of skin appendages

388

2583

1.51

13.22

1.3

1.4

361.04

418.46

pmol/l

0.32

345

2246

Arthrosis

583

2262

1.42

13.22

1.4

507.50

323.25

pmol/l

0.55

514

1966

Other diseases of urinary system

794

3324

1.35

13.17

1.4

466.95

365.59

pmol/l

0.34

673

2895

Pruritus

101

451

2.27

13.16

1.4

1.3

258.89

322.44

pmol/l

1.53

394

Chronic apical periodontitis

902

3900

1.32

13.15

1.3

1.4

314.22

383.11

pmol/l

1.01

778

3410

Disorders of conjunctiva

669

3934

1.37

13.12

1.4

474.77

363.24

pmol/l

0.33

590

3441

Gout

212

1070

1.75

13.12

1.3

1.4

318.69

279.50

pmol/l

0.59

175

878

Diabetic nephropathy

172

922

1.86

13.10

1.2

1.3

294.18

298.77

pmol/l

0.06

140

778

Acute upper respiratory infections

838

3889

1.33

13.09

1.3

1.4

578.93

327.91

pmol/l

0.84

725

3394

Cutaneous abscess, furuncle and carbuncle

218

1270

1.73

13.04

1.2

1.4

773.50

426.83

pmol/l

0.33

187

1091

Diabetic maculopathy, excluding more controls

392

2.35

12.89

1.3

1.4

241.25

327.78

pmol/l

1.54

336

Immunodeficiencies

179

3.08

12.89

1.2

1.4

602.62

400.70

pmol/l

0.44

159

Gonarthrosis

526

2093

1.44

12.87

1.3

1.4

474.12

316.45

pmol/l

0.40

461

1809

Viral and other specified intestinal infections

166

874

1.87

12.81

1.4

412.07

476.73

pmol/l

0.19

141

778

Transient ischemic attack

397

2157

1.50

12.70

1.3

280.91

341.44

pmol/l

0.63

348

1839

Unspecified haematuria

318

1691

1.57

12.61

1.4

1.3

292.38

363.67

pmol/l

0.56

276

1411

Kidney transplant status

176

3.06

12.61

1.5

1.4

553.26

353.09

pmol/l

1.44

157

Heart failure and coronary heart disease

310

1392

1.59

12.60

1.2

1.3

317.76

306.01

pmol/l

0.14

257

1181

Nontoxic multinodular goitre

166

903

1.85

12.57

1.2

1.3

282.65

289.31

pmol/l

0.14

150

780

L04AD Calcineurin inhibitors

104

480

2.19

12.53

1.5

1.4

481.59

340.69

pmol/l

1.58

424

Other disorders of ear

740

3616

1.34

12.50

1.3

1.4

288.41

382.86

pmol/l

1.55

638

3151

Menorrhagia

276

937

1.64

12.35

1.4

1.3

479.90

317.00

pmol/l

0.91

243

839

COPD related to multimorbidity

293

1567

1.59

12.33

1.2

1.3

231.56

360.07

pmol/l

1.19

240

1322

Congenital malformations of the urinary system

200

2.90

12.30

1.2

1.5

456.33

410.31

pmol/l

0.20

176

Diaphragmatic hernia

284

1798

1.59

12.29

1.2

1.3

291.16

309.29

pmol/l

0.34

240

1538

Injuries to the thorax

350

2319

1.52

12.29

1.3

255.66

352.30

pmol/l

1.33

293

1987

Malignant neoplasm of kidney, except renal pelvis

365

2.36

12.18

1.3

1.4

230.78

301.50

pmol/l

1.83

308

Intestinal stricture

242

1478

1.65

12.15

1.3

337.24

388.21

pmol/l

0.24

204

1258

Congenital malformations, deformations and chromosomal abnormalities

506

3321

1.41

12.04

1.3

1.4

377.98

407.19

pmol/l

0.25

453

2908

Other specified/unspecified arthritis

223

1337

1.68

12.04

1.3

1.4

432.76

336.14

pmol/l

0.57

194

1148

Missing teeth due to accident, extraction or parodontitis

468

3101

1.43

12.03

1.3

307.53

324.99

pmol/l

0.19

392

2684

Unknown and unspecified causes of morbidity

236

2.70

12.01

1.3

1.4

420.27

324.79

pmol/l

0.69

203

Follow-up examination after treatment for conditions other than malignant neoplasms

327

1401

1.55

11.99

1.4

1.3

398.65

300.76

pmol/l

0.86

282

1220

Thiazolidinediones

437

2.22

11.98

1.3

1.4

252.25

286.12

pmol/l

0.52

365

Chronic rhinitis, nasopharyngitis and pharyngitis

266

1669

1.60

11.97

1.4

786.63

335.81

pmol/l

0.63

235

1447

Generalized anxiety disorder

129

657

1.98

11.93

1.3

1.4

441.30

599.50

pmol/l

0.45

110

584

Disorders of lens

532

2367

1.41

11.89

1.3

493.62

338.59

pmol/l

0.35

443

2072

Congenital malformations of the urinary system

215

2.79

11.88

1.3

1.4

457.13

400.91

pmol/l

0.27

189

Abnormal involuntary movements

114

557

2.07

11.86

1.3

1.4

281.56

368.58

pmol/l

0.93

102

472

Chronic periodontitis, complicated

433

2988

1.44

11.85

1.3

339.91

322.69

pmol/l

0.09

376

2566

Brachial plexus disorders

376

2.31

11.83

1.6

1.4

367.05

413.53

pmol/l

0.25

336

Malignant neoplasm of urinary organs

395

2.28

11.82

1.3

229.97

300.88

pmol/l

1.99

335

Myocardial infarction, strict

344

1614

1.52

11.81

1.2

1.3

241.64

304.97

pmol/l

2.08

288

1381

Oxycodone

284

1636

1.58

11.81

1.5

1.3

315.14

343.92

pmol/l

0.15

248

1394

Mixed hyperlipidaemia

102

3.69

11.81

1.5

1.3

288.00

286.29

pmol/l

0.01

Myocardial infarction, without ST-elevation

293

1714

1.57

11.79

1.2

1.3

237.98

352.36

pmol/l

1.12

247

1438

Arthropathies

715

2696

1.35

11.75

1.4

683.57

342.72

pmol/l

1.00

613

2358

Nontoxic goitre/thyroid nodule

243

1500

1.63

11.73

1.3

399.86

300.63

pmol/l

0.45

217

1303

Cluster headache, wide

112

3.54

11.72

1.4

346.38

340.25

pmol/l

0.03

Diseases of the digestive system

340

2257

1.51

11.60

1.3

619.95

354.53

pmol/l

0.41

290

1928

Gout, strict definition

142

755

1.90

11.59

1.3

328.82

422.54

pmol/l

0.29

114

632

Other diseases of blood and blood-forming organs, wide

187

1081

1.74

11.58

1.3

413.14

430.05

pmol/l

0.05

154

912

Intracerebral haemorrhage

457

2.16

11.51

1.4

291.33

280.97

pmol/l

0.11

394

Other symptoms and signs involving cognitive functions and awareness

335

2027

1.51

11.50

1.3

295.65

350.97

pmol/l

0.52

279

1745

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

188

2.62

11.50

1.2

1.5

319.46

315.71

pmol/l

0.03

162

Excessive, frequent and irregular menstruation

296

1028

1.59

11.48

1.4

1.3

488.32

335.23

pmol/l

0.90

257

922

Intracranial injury

445

2960

1.43

11.46

1.3

1.4

305.96

367.96

pmol/l

0.89

384

2578

Gout, idiopatic and unspecified

188

1093

1.73

11.41

1.2

1.3

325.05

380.77

pmol/l

0.23

154

914

Osteoporosis with pathological fracture (FG)

284

2.50

11.40

1.2

1.3

251.52

292.25

pmol/l

0.67

238

Deforming dorsopathies

223

1358

1.65

11.36

1.3

334.39

498.95

pmol/l

0.85

202

1171

Behavioural syndromes associated with physiological disturbances and physical factors

733

3938

1.32

11.36

1.3

1.4

347.17

384.51

pmol/l

0.45

650

3444

Psychotic depression

209

2.76

11.35

1.2

1.4

237.06

294.71

pmol/l

0.82

187

Accidents

671

2493

1.35

11.28

1.4

427.07

372.53

pmol/l

0.37

573

2202

Phobic anxiety disorders

106

513

2.08

11.27

1.4

446.41

553.18

pmol/l

0.22

460

Other noninfective gastroenteritis and colitis

197

1165

1.70

11.20

1.4

1.3

333.47

336.67

pmol/l

0.03

179

997

Subjective visual disturbances

210

1265

1.67

11.19

1.4

1.3

345.22

352.91

pmol/l

0.07

185

1081

Panic disorder

117

590

2.00

11.17

1.3

1.5

399.05

545.70

pmol/l

0.39

101

525

Other diseases of blood and blood-forming organs

269

2.53

11.16

1.3

1.4

340.36

313.08

pmol/l

0.23

233

Personality disorders

217

1319

1.66

11.15

1.4

531.51

517.72

pmol/l

0.03

191

1161

Abnormal results of function studies

356

2.30

11.04

1.4

322.83

325.27

pmol/l

0.02

304

Thoracic aortic aneurysm

117

593

1.99

11.04

1.4

253.27

300.60

pmol/l

0.89

101

497

Enthesopathies of lower limb, excluding foot

180

1044

1.74

11.03

1.3

332.18

450.97

pmol/l

0.49

161

895

Polyneuropathies and other disorders of the peripheral nervous system

173

993

1.76

11.02

1.2

1.3

287.66

429.74

pmol/l

0.70

147

836

Persons encountering health services for specific procedures, not carried out

332

2.35

10.97

1.6

1.4

368.35

348.56

pmol/l

0.13

289

Pain in thoracic spine

126

657

1.93

10.93

1.3

343.39

372.87

pmol/l

0.23

111

562

Gout, FINNGEN

212

1285

1.66

10.90

1.3

318.69

357.27

pmol/l

0.18

175

1065

Pulmonary heart disease, diseases of pulmonary circulation

240

1504

1.60

10.90

1.4

1.3

271.90

380.47

pmol/l

0.87

209

1278

Amenorrhoea

225

2.65

10.90

1.4

1.5

2187.80

401.68

pmol/l

0.50

202

Mouth breathing

321

2144

1.50

10.89

1.4

303.65

361.87

pmol/l

0.58

290

1836

Ulcer of lower limb, not elsewhere classified

118

603

1.98

10.87

1.2

1.3

270.06

293.20

pmol/l

0.31

505

Urticaria

241

1515

1.60

10.82

1.3

1.4

745.49

381.01

pmol/l

0.42

213

1321

Familial hypercholesterolemia

101

489

2.08

10.79

1.3

287.65

286.21

pmol/l

0.01

418

Sequelae of cerebrovascular disease

258

1415

1.58

10.79

1.3

276.14

367.46

pmol/l

0.64

219

1204

Cardiodefibrillation

264

1693

1.56

10.77

1.3

331.75

349.38

pmol/l

0.10

227

1420

Noninfective enteritis and colitis

358

2449

1.47

10.76

1.4

334.31

425.72

pmol/l

0.80

318

2126

Benign paroxysmal vertigo

236

1480

1.61

10.72

1.3

268.19

320.29

pmol/l

1.52

205

1269

Other diseases of upper respiratory tract

870

3520

1.29

10.71

1.3

1.4

578.24

324.54

pmol/l

0.92

765

3055

Neuromuscular dysfunction of bladder

393

2.22

10.70

1.3

272.67

318.07

pmol/l

0.86

336

Other and unspecified nerve root and plexus disorders, also in other diseases

165

943

1.76

10.68

1.3

321.34

452.26

pmol/l

0.61

147

812

Malignant neoplasm, wide definition for exclusion

700

3106

1.33

10.65

1.4

348.81

394.09

pmol/l

0.33

615

2698

Pulmonary embolism

223

1382

1.62

10.62

1.4

1.3

278.50

386.90

pmol/l

0.77

195

1173

Spondylolisthesis/Spondylolysis

152

851

1.80

10.56

1.3

326.33

456.12

pmol/l

0.52

138

727

Pre-eclampsia or poor fetal growth

232

1449

1.60

10.55

1.5

1.4

868.45

401.79

pmol/l

0.56

210

1285

Pulmonary heart disease

223

1385

1.62

10.53

1.4

1.3

278.50

386.33

pmol/l

0.76

195

1176

Artificial joint operation, meniscal resection

712

3521

1.32

10.53

1.3

1.4

279.87

344.70

pmol/l

1.35

621

3049

Clear cell adenocarcinoma of kidney

168

2.91

10.48

1.3

1.4

236.41

341.99

pmol/l

1.64

143

Extreme obesity with alveolar hypoventilation

147

3.05

10.43

1.3

364.90

330.55

pmol/l

0.20

133

Gingivitis and periodontal diseases

811

3231

1.30

10.41

1.3

1.4

388.78

341.80

pmol/l

0.37

691

2808

Congenital malformations, deformations and chromosomal abnormalities

452

3092

1.40

10.37

1.4

389.83

414.35

pmol/l

0.19

406

2713

COPD, hospital admissions

327

1866

1.49

10.36

1.2

1.3

232.03

352.28

pmol/l

1.40

266

1578

Other congenital malformations

335

2.29

10.30

1.6

1.4

395.74

409.11

pmol/l

0.07

295

Sleep disorders

697

3847

1.31

10.29

1.4

346.35

385.86

pmol/l

0.46

621

3362

Implicit fungal Sepsis

238

2.55

10.28

1.3

335.83

319.47

pmol/l

0.13

201

Intestinal malabsorption

170

2.87

10.26

1.5

1.4

254.62

360.07

pmol/l

1.90

149

COPD, early/later onset

329

1879

1.48

10.22

1.2

1.3

231.51

351.82

pmol/l

1.41

268

1589

Other and unspecified drugs and medicaments

356

2.25

10.19

1.3

1.4

1567.56

357.24

pmol/l

0.47

311

Substance use, excluding alcohol

163

942

1.74

10.17

1.2

1.4

344.68

443.86

pmol/l

0.42

136

830

Blepharochalasis

232

1469

1.59

10.15

1.3

275.95

310.76

pmol/l

0.79

204

1266

Other and unspecified polyneuropathies, also in other diseases

152

862

1.78

10.14

1.2

1.3

283.40

299.70

pmol/l

0.23

131

723

Post-traumatic stress disorder

282

2.40

10.10

1.4

342.66

725.47

pmol/l

0.56

256

Appendectomy

512

3610

1.36

10.02

1.4

303.87

398.34

pmol/l

1.54

458

3154

Meniscus derangement

437

2098

1.41

10.01

1.3

1.4

266.04

320.14

pmol/l

2.57

373

1818

L01XX Other antineoplastic agents

207

2.65

9.94

1.3

1.4

250.55

325.55

pmol/l

0.82

182

Hernia of abdominal wall

348

2410

1.45

9.94

1.3

1.4

317.03

364.98

pmol/l

0.47

303

2064

Monoamine oxidase A inhibitors

104

526

2.00

9.93

1.4

1.3

405.53

294.09

pmol/l

0.92

455

Cerebral aneurysm, nonruptured

367

2.21

9.90

1.2

1.4

368.92

380.46

pmol/l

0.05

327

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

143

710

1.80

9.87

1.4

1.5

418.92

557.10

pmol/l

0.45

127

630

Cervicobrachial syndrome

173

1025

1.70

9.87

1.3

296.15

463.71

pmol/l

0.94

158

885

Heart failure and bmi 25plus

284

1262

1.53

9.85

1.2

1.3

296.04

276.50

pmol/l

0.39

236

1072

Hyperhidrosis

3.67

9.85

1.2

1.4

317.00

343.28

pmol/l

0.17

Status epilepticus

3.66

9.84

1.2

1.3

3789.04

281.41

pmol/l

0.50

Senile cataract

476

2110

1.39

9.83

1.3

298.95

340.44

pmol/l

0.38

396

1843

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

200

1227

1.63

9.80

1.3

1.4

389.66

535.42

pmol/l

0.61

173

1081

Conduction disorders

208

1041

1.63

9.78

1.2

1.3

276.94

399.55

pmol/l

0.62

186

880

Conjunctivitis

588

3703

1.33

9.75

1.4

493.89

369.79

pmol/l

0.32

518

3249

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

376

2.18

9.73

1.3

1.4

1547.20

349.69

pmol/l

0.47

326

Focal epilepsy

168

993

1.70

9.67

1.2

1.4

879.34

346.73

pmol/l

0.44

147

851

All influenza

190

1160

1.65

9.66

1.2

1.4

335.06

410.83

pmol/l

0.37

164

996

Ventral hernia

188

1146

1.65

9.64

1.3

335.80

329.19

pmol/l

0.06

165

974

Agoraphobia

3.46

9.63

1.5

533.11

446.75

pmol/l

0.19

Injuries to the abdomen, lower back, lumbar spine and pelvis

295

1969

1.49

9.62

1.3

341.35

424.94

pmol/l

0.54

247

1695

Venous thromboembolism

399

2749

1.41

9.62

1.4

1.3

362.21

333.30

pmol/l

0.17

347

2360

449

2874

1.38

9.56

1.3

1.4

379.86

387.95

pmol/l

0.04

377

2479

Insomnia

678

3800

1.30

9.55

1.3

1.4

345.16

387.63

pmol/l

0.50

608

3328

Transplanted organ and tissue status

419

2.10

9.51

1.4

549.57

293.44

pmol/l

2.60

355

Peripheral arterial reconstruction

121

654

1.86

9.47

1.2

1.3

243.07

281.42

pmol/l

0.73

549

Polyuria

166

985

1.70

9.45

1.5

1.3

330.86

323.41

pmol/l

0.07

152

828

ILD medications: azathioprine

120

648

1.87

9.43

1.3

1.4

347.23

317.06

pmol/l

0.41

107

562

L04AA Selective immunosuppressants

184

1123

1.65

9.41

1.4

393.73

344.97

pmol/l

0.54

165

965

426

2785

1.39

9.37

1.3

1.4

321.86

399.36

pmol/l

0.76

356

2403

Insulin, fast-acting (human)

113

600

1.90

9.36

1.3

1.4

259.33

332.66

pmol/l

1.07

531

Alcohol use disorder, Swedish definition

406

2675

1.40

9.32

1.3

1.4

378.26

391.34

pmol/l

0.05

344

2299

Other congenital malformations

102

524

1.96

9.31

1.6

1.4

360.70

364.92

pmol/l

0.03

463

Specific personality disorders

180

1096

1.65

9.29

1.4

422.04

574.30

pmol/l

0.56

159

969

Early onset COPD

178

1082

1.66

9.26

1.2

1.4

225.30

416.45

pmol/l

1.29

147

925

Azathioprine

120

653

1.85

9.22

1.3

1.4

347.23

323.40

pmol/l

0.30

107

566

Allergic asthma (mode), excluding more controls

170

999

1.67

9.21

1.4

390.29

371.39

pmol/l

0.14

148

889

Other disorders of bladder

499

1.98

9.21

1.4

1.3

301.71

288.58

pmol/l

0.14

411

Disorders of adult personality and behaviour

220

1409

1.57

9.21

1.4

410.53

530.00

pmol/l

0.55

194

1239

Nontraumatic intracranial haemmorrhage

145

835

1.75

9.20

1.4

1.3

285.40

307.00

pmol/l

0.22

122

711

Injuries to the head

862

4209

1.26

9.18

1.3

1.4

433.23

357.88

pmol/l

0.27

739

3688

Nonorganic sleeping disorders, excluding more controls

143

821

1.75

9.18

1.5

1.4

387.56

502.08

pmol/l

0.39

131

733

Asthma mixed form (mode), excluding more controls

158

2.82

9.17

1.3

1.4

266.46

295.84

pmol/l

0.31

138

Other symptoms and signs involving the circulatory and respiratory systems

216

2.53

9.12

1.2

1.3

334.47

366.63

pmol/l

0.19

180

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

132

720

1.79

9.03

1.3

1.4

408.11

385.64

pmol/l

0.14

117

626

Factors influencing health status and contact with health services

215

670

1.62

9.01

1.4

337.92

288.46

pmol/l

0.70

187

595

Injuries to the ankle and foot

540

3624

1.33

9.00

1.3

1.4

291.11

403.75

pmol/l

2.08

458

3192

Diseases of salivary glands

252

1673

1.51

8.97

1.3

292.94

464.90

pmol/l

1.24

223

1438

Hyperkinetic disorders, excluding more controls

364

2.12

8.97

1.5

1.4

372.55

668.73

pmol/l

0.56

331

Focal epilepsy, strict definition

154

909

1.71

8.96

1.2

1.4

294.61

345.03

pmol/l

0.61

135

774

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

138

766

1.76

8.95

1.3

1.4

400.35

378.14

pmol/l

0.15

123

669

Cluster headache, wide,, including avohilmo

195

2.60

8.93

1.3

1.5

358.32

383.93

pmol/l

0.16

172

Sequelae of injuries, of poisoning and of other consequences of external causes

185

1147

1.62

8.91

1.4

1.3

834.77

334.97

pmol/l

0.44

157

991

Chronic gastritis

201

1271

1.59

8.91

1.3

332.29

287.38

pmol/l

0.96

168

1082

Need for other prophylactic measures

231

2.46

8.90

1.6

1.4

616.29

382.15

pmol/l

0.33

199

Disorders of psychological development

428

2.01

8.90

1.5

1.4

326.31

415.48

pmol/l

1.04

378

Faecal incontinence

371

2.12

8.85

1.2

1.3

365.68

318.60

pmol/l

0.29

320

Other diseases of stomach and duodenum

250

2.39

8.84

1.3

243.29

311.81

pmol/l

0.80

217

Other disorders involving the immune mechanism, not elsewhere classified

103

3.27

8.81

1.3

1.4

383.15

485.21

pmol/l

0.36

Contact with and exposure to communicable diseases

224

1450

1.55

8.78

1.4

1.5

389.81

549.51

pmol/l

0.65

201

1278

Dermatographic urticaria

257

2.36

8.77

1.4

2007.09

339.23

pmol/l

0.49

234

Gout, unspecified

149

878

1.71

8.75

1.3

325.43

405.62

pmol/l

0.28

123

731

Extrapyramidal and movement disorders

278

1893

1.48

8.74

1.3

292.69

359.21

pmol/l

0.59

232

1617

Cardiac murmurs and other cardiac sounds

310

2.22

8.74

1.3

296.49

374.83

pmol/l

0.70

266

Inflammatory diseases of female pelvic organs

466

2533

1.36

8.73

1.4

1.3

603.19

353.78

pmol/l

0.57

409

2258

Radiculopathy

124

696

1.79

8.64

1.3

274.72

491.68

pmol/l

0.79

112

579

Glomerulonephritis

402

2.06

8.60

1.3

1.4

448.85

293.17

pmol/l

1.72

348

Abnormal serum enzyme levels

209

1310

1.56

8.59

1.4

1.3

300.39

355.34

pmol/l

0.29

183

1092

Mental and behavioural disorders due to alcohol

371

2567

1.39

8.54

1.3

1.4

317.28

403.38

pmol/l

0.80

305

2224

Any event in cancer register

712

3282

1.28

8.54

1.4

378.40

389.83

pmol/l

0.06

619

2859

COPD, hospital admission 2, with asthma infections

223

1245

1.54

8.51

1.2

1.3

226.00

388.71

pmol/l

1.21

181

1044

Haemorrhoids and perianal venous thrombosis

225

1472

1.53

8.50

1.3

332.13

364.52

pmol/l

0.18

197

1273

Personal history of other diseases and conditions

456

1.98

8.49

1.4

367.25

611.93

pmol/l

0.56

407

Supplementary factors related to causes of morbidity and mortality classified elsewhere

239

1589

1.51

8.48

1.3

282.21

478.73

pmol/l

1.40

211

1358

Bronchitis

826

4157

1.25

8.43

1.3

1.4

462.04

349.83

pmol/l

0.42

715

3627

Other arthrosis

401

2015

1.38

8.41

1.3

1.4

332.70

311.89

pmol/l

0.17

357

1739

Leiomyoma of uterus

484

2039

1.35

8.41

1.4

1.3

330.89

348.53

pmol/l

0.31

432

1806

Candidiasis

218

1424

1.54

8.41

1.3

364.53

378.07

pmol/l

0.13

179

1233

Collagenous colitis

379

2.08

8.39

1.4

1.3

299.66

334.13

pmol/l

0.29

321

Speech and linguistic disorders, excluding more controls

263

2.27

8.39

1.4

363.94

387.84

pmol/l

0.13

240

Allergic asthma (mode)

170

1026

1.63

8.36

1.4

390.29

366.66

pmol/l

0.18

148

911

Other diseases of anus and rectum

210

1359

1.55

8.35

1.3

1.4

355.82

374.57

pmol/l

0.08

176

1176

Type 1 diabetes, definitions combined

365

2.09

8.35

1.4

1.6

325.33

386.83

pmol/l

0.58

329

Viral hepatitis, IBD co-morbidity

122

2.98

8.35

1.3

1.4

299.60

352.25

pmol/l

0.50

114

Gastroduodenal ulcer

182

1140

1.60

8.32

1.3

341.70

385.23

pmol/l

0.19

150

959

Gonarthrosis, primary, with knee surgery

419

2451

1.37

8.31

1.2

1.3

285.61

292.78

pmol/l

0.16

364

2096

Primary gonarthrosis, bilateral

372

2301

1.39

8.29

1.2

1.3

282.03

294.58

pmol/l

0.30

330

1980

Other diseases of pleura

313

1924

1.43

8.29

1.2

1.3

331.05

353.76

pmol/l

0.13

274

1614

Triptan medication for migraine, min. 3 purchases

427

2400

1.36

8.28

1.4

592.63

410.10

pmol/l

0.36

387

2132

Acute upper respiratory infections of multiple and unspecified sites

565

3210

1.31

8.28

1.4

350.57

342.27

pmol/l

0.11

495

2815

Aneurysms, operations, SAH

127

728

1.76

8.26

1.3

337.07

321.64

pmol/l

0.12

106

639

Other abnormal findings of blood chemistry

162

2.69

8.25

1.1

1.4

628.19

335.37

pmol/l

0.51

143

Other disorders of white blood cells

197

2.52

8.25

1.4

382.08

326.87

pmol/l

0.33

169

Conjunctivitis (acute, non atopic)

214

1394

1.54

8.22

1.3

1.4

766.10

462.05

pmol/l

0.29

191

1206

Asthma mixed form (mode)

168

2.65

8.20

1.3

1.4

266.46

292.52

pmol/l

0.27

148

Disease of hard tissues of teeth, NOS

443

1703

1.37

8.17

1.3

308.40

352.38

pmol/l

0.32

381

1462

Other acute lower respiratory infections

374

2589

1.38

8.16

1.3

1.4

610.81

381.83

pmol/l

0.38

318

2236

Pre-eclampsia or eclampsia

166

1026

1.63

8.15

1.5

1.4

1047.44

407.40

pmol/l

0.55

151

902

Oxicams

176

611

1.64

8.14

1.3

1.4

416.85

375.61

pmol/l

0.13

147

525

Acute sinusitis

392

2656

1.37

8.14

1.3

1.4

833.35

355.88

pmol/l

0.72

338

2332

Nephrotic syndrome

3.22

8.12

1.3

1.4

547.83

353.90

pmol/l

0.79

Type 1 diabetes, strict (exclude DM2)

363

2.08

8.09

1.4

1.6

328.89

387.50

pmol/l

0.53

327

Focal epilepsy, mode (most common among epilepsy diagnosis)

143

852

1.69

8.09

1.2

1.4

979.57

318.67

pmol/l

0.48

127

727

Malignant neoplasm

656

3030

1.28

8.08

1.4

1.3

334.28

361.05

pmol/l

0.21

576

2628

Spontaneous rupture of synovium and tendon

338

2.12

8.08

1.2

1.3

254.60

302.35

pmol/l

0.90

300

Benign neoplasm of brain and other parts of central nervous system

242

2.34

8.06

1.3

1.4

276.43

334.36

pmol/l

0.59

209

Benign neoplasm of meninges

441

1.97

8.00

1.6

1.3

293.49

299.34

pmol/l

0.06

375

Type of accident

222

1474

1.51

7.96

1.3

284.24

470.48

pmol/l

1.18

198

1263

Asthma and allergy, excluding more controls

504

1.89

7.95

1.5

1.4

417.88

441.49

pmol/l

0.10

453

Asthma and allergy

504

1.89

7.95

1.5

417.88

439.18

pmol/l

0.09

455

Adjustment and management of implanted device

132

774

1.72

7.94

1.3

270.98

289.90

pmol/l

0.30

118

637

Necrosis of pulp, including avohilmo

435

3245

1.34

7.93

1.4

301.20

415.12

pmol/l

1.75

372

2845

Non-allergic asthma (mode), excluding more controls

136

796

1.70

7.92

1.3

1.4

352.66

330.92

pmol/l

0.21

115

698

Disorders of continuity of bone

408

2.00

7.92

1.4

1486.18

323.08

pmol/l

0.49

356

conjunctival haemorrhage

308

2.17

7.92

1.4

1.3

347.94

313.67

pmol/l

0.26

265

Cardiomyopathy

123

708

1.75

7.90

1.2

1.4

317.47

464.68

pmol/l

0.48

103

600

Symptoms and signs involving speech and voice

251

1712

1.47

7.89

1.3

308.36

342.83

pmol/l

0.57

220

1475

Mental and behavioural disorders due to alcohol, excluding acute intoxication

322

2287

1.41

7.89

1.3

1.4

312.66

402.91

pmol/l

0.74

267

1968

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

100

3.16

7.87

1.3

1.4

377.54

490.87

pmol/l

0.40

DVT of lower extremities and pulmonary embolism

295

2066

1.43

7.86

1.4

1.3

285.67

352.21

pmol/l

0.66

258

1759

Other diseases of pericardium

144

2.75

7.79

1.2

1.4

313.56

283.41

pmol/l

0.16

124

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

199

1281

1.54

7.79

1.4

1.5

319.30

503.29

pmol/l

1.44

172

1134

Otalgia

310

2.15

7.79

1.2

1.4

245.19

374.40

pmol/l

1.93

267

Pre-eclampsia

153

938

1.64

7.78

1.5

1.4

1123.03

418.44

pmol/l

0.56

138

828

Trochanteric bursitis

111

625

1.79

7.71

1.3

290.19

297.35

pmol/l

0.09

102

553

Ptosis of eyelid

476

1.91

7.65

1.5

1.3

291.58

292.62

pmol/l

0.01

411

Other inflammation of eyelid

105

583

1.82

7.65

1.3

1.4

284.13

356.21

pmol/l

0.79

508

Other problems related to primary support group, including family circumstances

449

1.92

7.63

1.4

1.5

352.93

391.42

pmol/l

0.33

407

Acute pharyngitis

112

629

1.78

7.61

1.4

304.20

343.51

pmol/l

0.72

101

555

Retention of urine

227

1248

1.50

7.60

1.4

1.3

277.57

373.52

pmol/l

0.58

190

1034

Malignant neoplasm of thyroid gland, including Hilmo

314

2.13

7.56

1.5

1.3

323.43

343.38

pmol/l

0.26

275

Persistent mood disorders

145

884

1.65

7.55

1.3

360.97

338.78

pmol/l

0.20

127

768

Periapical abscess

340

2469

1.38

7.55

1.3

1.4

281.61

417.37

pmol/l

1.55

288

2142

Mycoses

640

4404

1.27

7.53

1.3

1.4

660.51

327.43

pmol/l

0.86

550

3853

Other local infections of skin and subcutaneous tissue

416

1.96

7.52

1.2

1.4

344.45

332.04

pmol/l

0.07

363

Fungal Sepsis

119

2.90

7.50

1.2

1.3

261.22

302.32

pmol/l

0.36

105

Other and unspecified local infections of skin and subcutaneous tissue

389

2.00

7.49

1.2

1.4

343.30

341.03

pmol/l

0.01

337

Mental disorders, not otherwise specified

342

2.07

7.47

1.3

1.4

362.27

344.75

pmol/l

0.17

304

Diseases of the myoneural junction and muscle

530

1.85

7.46

1.2

1.3

272.05

299.03

pmol/l

0.38

455

Liquid cancers, helper endpoint

269

1635

1.44

7.43

1.3

316.01

355.17

pmol/l

0.25

229

1387

Unstable angina pectoris

251

1358

1.46

7.43

1.2

1.3

273.58

294.45

pmol/l

0.33

209

1149

Hypermobility syndrome

189

2.46

7.43

1.5

1.4

338.39

386.23

pmol/l

0.36

171

Urolithiasis

228

1546

1.48

7.41

1.4

1.3

308.96

378.09

pmol/l

0.48

198

1307

Atopic dermatitis, strict definition with reimbursement

215

1390

1.50

7.39

1.4

1.5

810.41

488.54

pmol/l

0.30

187

1222

Melanocytic naevi

224

1515

1.49

7.39

1.4

348.76

510.25

pmol/l

0.96

201

1297

Enlarged lymph nodes

113

648

1.75

7.38

1.4

1164.67

340.19

pmol/l

0.46

565

Disorders of vitreous body

372

2655

1.36

7.38

1.3

255.11

337.58

pmol/l

1.36

319

2301

AV-block

118

597

1.74

7.37

1.2

1.4

290.56

273.49

pmol/l

0.21

103

494

Polyarthrosis

157

910

1.61

7.36

1.3

290.12

297.15

pmol/l

0.12

142

777

Postmenopausal osteoporosis with pathological fracture

266

2.21

7.31

1.2

1.3

228.82

293.99

pmol/l

1.26

229

Caries of dentine, including avohilmo

595

2369

1.29

7.30

1.4

1.3

313.59

405.57

pmol/l

0.84

499

2068

Other shoulder lesions

393

1.98

7.29

1.2

1.4

323.92

330.18

pmol/l

0.04

350

Pacemaker

216

1392

1.49

7.28

1.3

289.84

276.52

pmol/l

0.25

186

1165

Cluster headache, strict, including avohilmo

179

2.49

7.27

1.3

1.5

373.56

393.28

pmol/l

0.11

158

Other disorders of nervous system

267

2.20

7.23

1.3

1.4

323.33

326.14

pmol/l

0.02

233

Later onset COPD, excluding more controls

146

690

1.64

7.22

1.1

1.3

244.17

290.19

pmol/l

0.47

116

577

Other extrapyramidal and movement disorders in other diseases

177

1145

1.55

7.22

1.3

309.61

326.39

pmol/l

0.19

159

970

Hypoglycaemia, other or unspecified

248

2.24

7.20

1.3

1.4

219.04

377.77

pmol/l

1.57

215

Tinnitus

179

1162

1.55

7.19

1.4

1.3

253.46

411.29

pmol/l

1.08

157

1001

Speech therapy

200

1331

1.51

7.16

1.3

327.66

326.32

pmol/l

0.02

181

1131

Anaemia in chronic diseases classified elsewhere

3.50

7.16

1.2

1.3

312.12

329.06

pmol/l

0.07

Other disorders of glucose regulation and pancreatic internal secretion

315

2.08

7.10

1.3

1.4

220.76

350.47

pmol/l

1.52

270

Algoneurodystrophy

123

2.81

7.10

1.1

1.4

292.81

390.09

pmol/l

0.98

108

Mental and behavioural disorders due to tobacco

377

1.98

7.06

1.2

1.4

398.92

318.72

pmol/l

0.78

327

Abnormal weight loss

377

1.98

7.06

1.3

1.4

294.17

314.01

pmol/l

0.15

329

Solid cancers, helper endpoint

639

2990

1.26

7.04

1.4

1.3

338.03

357.45

pmol/l

0.14

561

2597

Smoking dependency

378

1.98

7.01

1.2

1.4

398.92

318.65

pmol/l

0.78

329

Artrosis, including avohilmo

627

2711

1.27

7.00

1.4

497.41

340.61

pmol/l

0.49

552

2355

Disorders of vitreous body and globe

376

2696

1.34

6.99

1.3

255.49

336.79

pmol/l

1.36

322

2333

Acute bronchitis

284

1990

1.40

6.95

1.3

700.91

394.02

pmol/l

0.39

241

1720

Other and unspecified tonsillitis

240

1398

1.45

6.84

1.4

1.5

713.99

387.24

pmol/l

0.37

215

1235

Carbimazole or st.post thyroidectomy, condition for graves disease

162

1041

1.57

6.84

1.4

1.3

290.10

371.79

pmol/l

1.45

140

910

Diplopia

101

575

1.77

6.82

1.5

1.3

338.19

300.82

pmol/l

0.46

490

Other enthesopathies

215

1467

1.47

6.82

1.3

1.4

851.79

315.62

pmol/l

0.60

187

1282

Thyrotoxicosis, other and/or unspecified

147

924

1.60

6.82

1.4

1.3

313.97

331.80

pmol/l

0.18

128

802

Implicit fungal Sepsis

109

2.88

6.81

1.2

1.3

270.08

312.45

pmol/l

0.35

Non-allergic asthma (mode)

136

831

1.63

6.79

1.3

1.4

352.66

324.70

pmol/l

0.30

115

726

Pain and other conditions associated with female genital organs and menstrual cycle

138

784

1.63

6.76

1.5

1.4

766.98

362.91

pmol/l

1.03

118

706

Endometriosis

242

976

1.46

6.76

1.4

1.3

411.88

328.22

pmol/l

0.53

213

874

Aortic valve malfunction, age under 60 years

412

1.91

6.72

1.2

1.4

326.27

554.67

pmol/l

0.46

362

Benign neoplasm: Colon, unspecified

183

1213

1.52

6.71

1.3

328.94

309.04

pmol/l

0.25

159

1032

Other sleep disorders

398

1.92

6.70

1.4

352.50

301.17

pmol/l

0.47

338

Hyperplasia of prostate

235

913

1.47

6.69

1.4

1.3

277.39

395.20

pmol/l

0.51

193

759

Diseases of pulp and periapical tissues and dental caries

486

1913

1.30

6.69

1.4

1.3

302.40

427.34

pmol/l

0.97

412

1664

Heartburn

455

1.86

6.69

1.2

1.4

314.81

366.98

pmol/l

0.62

391

Weight loss

413

1.91

6.67

1.3

1.4

307.26

312.34

pmol/l

0.04

357

Hypertrophic cardiomyopathy

139

2.63

6.65

1.2

1.3

255.48

331.36

pmol/l

0.82

126

Left ventricular outflow tract obstruction (LVOTO), broad definition

442

1.87

6.64

1.2

1.4

327.97

557.07

pmol/l

0.50

390

Dislocation, sprain and strain of joints and ligaments of knee

448

3181

1.30

6.64

1.3

1.4

303.88

411.42

pmol/l

1.58

407

2797

Diseases of male genital organs

353

1308

1.37

6.60

1.5

1.4

299.29

357.59

pmol/l

0.34

293

1121

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

182

2.39

6.56

1.3

247.84

293.96

pmol/l

0.52

152

Cerebral palsy and other paralytic syndromes

451

1.85

6.55

1.4

295.63

319.65

pmol/l

0.28

390

Conductive and sensorineural hearing loss

576

3084

1.26

6.47

1.3

282.41

341.96

pmol/l

0.96

497

2676

Thyrotoxicosis

188

1264

1.50

6.46

1.4

1.3

322.46

348.17

pmol/l

0.28

166

1099

Sulfonylureas

208

1128

1.47

6.45

1.2

1.3

253.19

289.27

pmol/l

0.59

168

948

Other bacterial intestinal infections

129

797

1.63

6.45

1.4

1.3

432.90

336.43

pmol/l

0.46

112

686

Other disorders of conjunctiva

107

631

1.71

6.41

1.5

1.3

339.97

339.61

pmol/l

0.00

541

Injury, poisoning and certain other consequences of external causes

403

1521

1.33

6.40

1.4

360.34

321.64

pmol/l

0.54

345

1343

Other diseases of intestine

106

624

1.71

6.39

1.2

1.4

283.09

465.80

pmol/l

0.57

527

Type 1 diabetes, strict definition

294

2.05

6.36

1.4

1.6

338.75

418.07

pmol/l

0.60

263

Other noninflammatory disorders of uterus, except cervix

160

693

1.56

6.35

1.2

1.3

343.47

277.30

pmol/l

1.67

137

617

Cellulitis

161

1052

1.54

6.34

1.3

1.4

315.66

424.87

pmol/l

0.52

136

901

Noninfectious colitis NAS

101

588

1.73

6.34

1.3

1.4

357.96

369.46

pmol/l

0.06

506

Speech and linguistic disorders

316

1.99

6.29

1.4

1.5

368.20

406.25

pmol/l

0.23

281

Acute pancreatitis

137

866

1.59

6.25

1.3

286.96

444.07

pmol/l

0.69

119

735

Mental and behavioural disorders due to sedatives or hypnotics

264

2.10

6.22

1.1

1.5

240.85

346.21

pmol/l

2.25

229

Disorders of muscles

423

1.86

6.22

1.2

1.4

308.63

326.37

pmol/l

0.17

371

Other and unspecified disorders of white blood cells

144

2.54

6.21

1.4

417.21

351.54

pmol/l

0.31

126

Leisure time condition

133

837

1.60

6.19

1.3

1.4

291.92

315.26

pmol/l

0.36

117

722

Vascular diseases of the intestine

121

2.68

6.17

1.1

1.3

308.52

301.92

pmol/l

0.02

106

Other and unspecified visual disturbances

425

1.85

6.14

1.3

268.94

302.00

pmol/l

0.66

365

Acute appendicitis, no complications

405

3105

1.30

6.13

1.4

393.65

404.38

pmol/l

0.05

360

2718

Fracture of foot, except ankle

179

1206

1.49

6.11

1.4

311.06

516.94

pmol/l

1.02

143

1049

Voice disturbances

196

1345

1.46

6.10

1.4

1.3

311.11

337.14

pmol/l

0.34

174

1160

Alcohol use disorder, ICD-based

290

2131

1.37

6.09

1.3

1.4

313.34

361.02

pmol/l

0.42

238

1843

Atopic dermatitis, strict definition

204

1381

1.45

6.08

1.4

1.5

832.82

420.25

pmol/l

0.39

179

1216

KRA_PSY_EATING, excluding more controls

245

2.13

6.08

1.3

1.4

525.72

850.37

pmol/l

0.38

224

Unspecified mental disorder

289

2124

1.37

6.05

1.3

1.4

428.13

444.35

pmol/l

0.08

240

1846

Special screening examination for other diseases and disorders

434

1.83

6.04

1.2

1.3

293.61

335.17

pmol/l

0.26

368

Viral infections of the central nervous system

308

2.00

6.03

1.3

1.4

1919.44

368.99

pmol/l

0.46

267

Ovarian dysfunction

228

2.17

6.00

1.5

1.3

478.14

415.66

pmol/l

0.32

205

Calculus of kidney and ureter

206

1432

1.44

5.99

1.5

1.3

306.73

387.79

pmol/l

0.54

179

1211

Other pleural conditions

393

1.87

5.97

1.1

1.4

257.30

299.63

pmol/l

0.61

330

Other and unspecified rosacea

358

1.92

5.96

1.3

1.4

327.51

324.87

pmol/l

0.03

315

135

807

1.58

5.96

1.2

250.78

270.01

pmol/l

0.51

115

676

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

200

867

1.47

5.95

1.4

1.5

535.23

545.21

pmol/l

0.02

175

781

Other and unspecified urticaria

143

924

1.56

5.95

1.3

1.4

340.05

359.53

pmol/l

0.20

127

805

Coxibs

191

675

1.49

5.95

1.4

839.13

373.93

pmol/l

0.42

169

585

N06DA Anticholinesterases

1183

0.58

5.94

1.1

1.3

220.41

268.36

pmol/l

1.17

989

Use of anticholinesterases

1183

0.58

5.94

1.1

1.3

220.41

268.36

pmol/l

1.17

989

Other gastritis (incl. Duodenitis)

160

1060

1.52

5.94

1.2

1.3

432.98

391.70

pmol/l

0.08

133

898

Calcific aortic valvular stenosis

182

1199

1.48

5.93

1.2

1.3

248.17

275.87

pmol/l

0.64

159

995

Calcific aortic valvular stenosis, operated

182

1199

1.48

5.93

1.2

1.3

248.17

275.87

pmol/l

0.64

159

995

Excessive vomiting in pregnancy

310

1.98

5.93

1.7

1.4

339.44

372.17

pmol/l

0.28

274

Other postsurgical states

256

2.09

5.92

1.2

1.4

535.10

354.09

pmol/l

0.38

219

COPD, hospital admissions 3, with asthma pneumonia sepsis

171

978

1.50

5.90

1.1

1.3

227.19

313.72

pmol/l

1.86

133

823

Chronic sinusitis

308

2295

1.35

5.89

1.3

1.4

1021.43

333.31

pmol/l

0.85

267

2001

Diseases of oral cavity, salivary glands and jaws

436

1731

1.30

5.88

1.3

297.23

358.59

pmol/l

0.50

373

1488

Other obstetric conditions, not elsewhere classified

205

897

1.46

5.88

1.4

1.5

538.91

541.98

pmol/l

0.01

179

810

Other disorders of bone

147

959

1.54

5.87

1.4

310.95

353.76

pmol/l

0.57

118

837

Open wound of forearm

360

1.90

5.86

1.3

1.4

284.46

320.77

pmol/l

0.47

305

Acute appendicitis

514

3830

1.26

5.86

1.4

369.83

381.64

pmol/l

0.07

456

3340

Localized swelling, mass and lump of skin and subcutaneous tissue

227

1614

1.41

5.84

1.4

1.3

328.45

402.37

pmol/l

0.54

204

1383

Dystonia

218

2.18

5.83

1.3

1.4

270.27

343.42

pmol/l

1.25

192

Inflammatory disease of uterus

103

618

1.68

5.82

1.5

1.4

315.04

430.70

pmol/l

1.30

542

Other diseases of hard tissues of teeth

433

1730

1.30

5.82

1.3

318.88

358.77

pmol/l

0.29

369

1487

Obsessive-compulsive disorder

231

2.14

5.82

1.6

1.5

516.43

377.96

pmol/l

0.63

206

Transport accidents

332

2151

1.33

5.82

1.3

1.4

338.88

387.41

pmol/l

0.29

294

1899

Temporomandibular joint disorders, including avohilmo

314

2320

1.34

5.80

1.4

349.21

459.54

pmol/l

0.98

272

2053

Invasive ventilation

265

2.06

5.79

1.5

1.4

2460.34

315.82

pmol/l

0.50

224

Type 1 diabetes, strict definition, subgroup 1

278

2.03

5.77

1.3

1.6

351.32

418.27

pmol/l

0.43

247

Rosacea

485

1.77

5.77

1.4

329.72

319.24

pmol/l

0.13

422

Appendicitis, broad definition

544

3955

1.25

5.75

1.3

1.4

361.18

377.76

pmol/l

0.10

480

3448

Mycoses

189

1304

1.46

5.75

1.3

900.76

408.58

pmol/l

0.42

161

1112

Diseases of appendix

549

3982

1.25

5.75

1.3

1.4

359.91

376.71

pmol/l

0.11

484

3472

Misadventures to patients during surgical and medical care

105

636

1.66

5.74

1.3

299.97

338.18

pmol/l

0.32

550

Other necrotizing vasculopathies (FG)

207

2.20

5.70

1.2

1.3

505.05

340.26

pmol/l

0.77

172

Abdominal aortic aneurysm (AAA)

278

2.01

5.67

1.3

212.46

269.75

pmol/l

1.43

228

Benign neoplasm: Caecum

466

1.77

5.66

1.2

1.3

268.04

298.69

pmol/l

0.55

397

Postprocedural disorders of nervous system

288

2.00

5.65

1.5

1.4

336.28

366.20

pmol/l

0.23

257

Diabetes mellitus in pregnancy

213

953

1.44

5.64

1.4

1.5

818.28

457.12

pmol/l

0.34

184

862

Perforation of tympanic membrane

408

1.83

5.64

1.3

1.4

302.89

320.04

pmol/l

0.19

351

Viral pneumonia

563

1.70

5.64

1.3

1.4

351.82

324.32

pmol/l

0.23

480

Fracture of lower leg, including ankle

395

3038

1.29

5.63

1.3

302.71

397.25

pmol/l

1.16

322

2657

Other bacterial intestinal infections

160

1073

1.50

5.63

1.4

1.3

392.84

339.34

pmol/l

0.29

142

921

Calcific aortic valvular stenosis, diagnosis (helper)

180

1198

1.46

5.60

1.2

1.3

243.14

275.87

pmol/l

0.81

157

995

Operations 2 for CAVS

180

1198

1.46

5.60

1.1

1.3

243.14

275.87

pmol/l

0.81

157

995

Calcific aortic valvular stenosis, including rheumatic fever

180

1198

1.46

5.57

1.1

1.3

243.14

275.87

pmol/l

0.81

157

995

Umbilical hernia

191

1329

1.44

5.57

1.2

1.4

335.47

336.38

pmol/l

0.01

159

1136

Traumatic subdural haemorrhage

413

1.80

5.57

1.2

1.4

246.25

269.02

pmol/l

0.46

346

Other diseases of the digestive system

207

1462

1.42

5.55

1.2

1.3

317.84

386.53

pmol/l

0.40

177

1234

Other and unspecified myopathies

325

1.92

5.53

1.2

1.4

274.15

316.14

pmol/l

0.63

278

Pain associated with micturition

484

1.75

5.53

1.4

1.3

351.98

337.68

pmol/l

0.11

416

Emotionally unstable personality disorder

484

1.75

5.52

1.3

1.4

434.84

572.74

pmol/l

0.28

432

Hypertrophy of breast in women and men

143

941

1.53

5.52

1.4

313.12

370.65

pmol/l

0.77

125

828

Melanocytic naevi of trunk

507

1.73

5.51

1.3

1.4

359.21

320.67

pmol/l

0.61

440

Noninflammatory disorders of female genital tract

282

1035

1.37

5.50

1.3

1.4

742.24

337.63

pmol/l

0.57

242

929

Triptan medication for migraine, single purchase ok

575

3153

1.24

5.50

1.4

562.70

367.62

pmol/l

0.56

520

2769

Migraine, single triptan purchase ok & required. ICD-code if available is included

575

3153

1.24

5.50

1.4

562.70

367.62

pmol/l

0.56

520

2769

Use of pramipexole

159

1072

1.49

5.47

1.3

410.26

320.72

pmol/l

0.88

135

911

Nonorganic sleeping disorders

143

943

1.52

5.47

1.5

1.4

387.56

477.00

pmol/l

0.33

131

828

Female infertility, associated with anovulation

245

2.05

5.39

1.6

1.5

2736.51

434.34

pmol/l

0.60

227

Coxarthrosis [arthrosis of hip](FG)

373

2025

1.30

5.38

1.3

289.08

301.07

pmol/l

0.25

336

1727

Other diseases of biliary tract

343

1.88

5.36

1.3

303.89

304.59

pmol/l

0.00

293

Unspecific neurodegenerative disorder

130

1352

0.65

5.35

1.1

1.3

236.74

271.09

pmol/l

1.06

106

1135

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

262

1928

1.36

5.35

1.4

294.72

482.49

pmol/l

1.80

221

1695

Idiopathic gout

358

1.86

5.33

1.1

1.4

331.77

294.15

pmol/l

0.30

303

Chronic laryngitis and laryngotracheitis

102

628

1.63

5.27

1.3

307.86

342.77

pmol/l

0.26

531

Impotence

188

2.20

5.26

1.6

1.3

302.91

284.79

pmol/l

0.12

158

Viral infections of the central nervous system

289

1.96

5.26

1.3

1.4

2092.82

378.28

pmol/l

0.46

250

Dental caries, including avohilmo

539

2217

1.25

5.25

1.4

1.3

310.93

413.09

pmol/l

0.88

453

1935

Other diseases of lip and oral mucosa

289

2179

1.33

5.20

1.4

1.3

333.78

426.40

pmol/l

0.73

250

1888

D07AA Corticosteroids, weak (group I)

107

668

1.61

5.19

1.3

1.4

365.41

353.43

pmol/l

0.10

582

COPD-related respiratory insufficiency

449

1.75

5.18

1.2

1.3

269.16

290.48

pmol/l

0.20

380

Disturbance of activity and attention

425

1.76

5.17

1.5

381.47

653.71

pmol/l

0.59

378

Other benign neoplasms of skin

257

1906

1.35

5.17

1.3

307.50

367.68

pmol/l

0.53

226

1635

Fissure and fistula of anal and rectal regions

164

1126

1.46

5.16

1.4

387.88

402.89

pmol/l

0.05

149

967

Other peripheral vertigo

391

1.81

5.16

1.5

1.3

274.59

297.65

pmol/l

0.32

339

Dental operations

447

1811

1.27

5.15

1.4

1.3

291.17

432.42

pmol/l

1.05

387

1550

Other disorders of eye and adnexa

101

624

1.63

5.15

1.5

1.4

353.84

370.51

pmol/l

0.11

547

Bipolar affective disorders

128

836

1.54

5.14

1.3

1.4

543.09

634.14

pmol/l

0.20

114

743

Benign neoplasm: Rectum, anus and anal canal

142

949

1.50

5.13

1.3

254.01

319.93

pmol/l

1.17

128

801

Fracture of lumbar spine and pelvis

144

964

1.50

5.11

1.2

1.3

262.60

316.98

pmol/l

0.96

123

812

Fibroblastic disorders

152

1031

1.48

5.10

1.2

1.3

260.49

301.36

pmol/l

0.90

131

884

Bacterial intestinal infections, IBD co-morbidities

124

806

1.55

5.10

1.3

1.4

439.70

342.60

pmol/l

0.44

108

692

Trigeminal neuralgia

224

2.07

5.08

1.3

1.4

351.63

342.28

pmol/l

0.06

199

Gastric ulcer

118

759

1.56

5.08

1.3

333.74

283.44

pmol/l

0.69

641

Benign neoplasm: Rectum

128

839

1.53

5.07

1.3

265.22

329.12

pmol/l

0.95

114

705

Other necrotizing vasculopathies

272

1.97

5.07

1.2

1.3

466.42

305.16

pmol/l

0.97

236

Other diseases of the respiratory system

131

863

1.53

5.06

1.2

1.3

307.30

303.25

pmol/l

0.04

114

722

Other respiratory disorders and diseases

131

863

1.53

5.06

1.2

1.3

307.30

303.25

pmol/l

0.04

114

722

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

394

3018

1.27

5.06

1.4

1.3

328.87

383.90

pmol/l

0.72

347

2658

Disorders of ocular muscles, binocular movement, accommodation and refraction

327

2496

1.30

5.05

1.3

1.4

358.31

442.69

pmol/l

0.68

276

2176

Benign neoplasm: Cerebral meninges

416

1.77

5.04

1.5

1.3

310.08

299.85

pmol/l

0.10

358

Melanocytic naevi, other sites/unspecified

315

1.89

5.02

1.6

1.4

294.82

329.78

pmol/l

0.44

276

Benign lipomatous neoplasm

211

1525

1.39

5.01

1.3

415.96

367.56

pmol/l

0.14

191

1305

Benign neoplasm: Carotid body

8.35

4.97

1.2

1.1

203.40

289.46

pmol/l

—

Other and unspecified disorders of vitreous body

304

2293

1.31

4.95

1.3

254.53

345.22

pmol/l

1.29

266

1996

Other abnormal uterine and vaginal bleeding

155

754

1.48

4.93

1.3

378.75

308.35

pmol/l

1.37

134

670

Injuries to the shoulder and upper arm

604

4019

1.21

4.93

1.3

1.4

298.80

370.69

pmol/l

1.15

527

3489

Benign neoplasm of middle ear and respiratory system

303

1.90

4.93

1.5

1.4

253.73

345.83

pmol/l

1.15

263

Hyperkinetic disorders

469

1.70

4.88

1.5

368.54

647.32

pmol/l

0.69

413

Biological medication for rheuma

122

799

1.53

4.87

1.5

1.4

307.28

361.37

pmol/l

0.57

111

703

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

200

1440

1.39

4.87

1.3

1.4

389.66

529.86

pmol/l

0.68

173

1255

Reimbursement for rheumatic diseases

408

3233

1.26

4.87

1.3

1.4

584.52

360.69

pmol/l

0.43

361

2806

Restless leg syndrome

572

1.64

4.86

1.4

1.3

295.41

318.29

pmol/l

0.26

492

GI-bleeding

203

1467

1.39

4.83

1.2

1.3

328.48

387.07

pmol/l

0.33

173

1240

Achilles tendinitis

444

1.72

4.82

1.2

1.3

421.23

599.80

pmol/l

0.28

386

Sensorineural hearing loss

530

2935

1.23

4.79

1.3

286.45

335.94

pmol/l

0.70

454

2547

Sarcoidosis

613

1.61

4.79

1.3

413.67

348.33

pmol/l

0.20

529

Trigger finger

103

652

1.59

4.79

1.2

1.3

256.14

310.69

pmol/l

1.58

568

Myeloproliferative diseases

335

1.84

4.78

1.1

1.4

292.19

322.29

pmol/l

0.32

289

Type1 diabetes, definitions combined, early onset

263

1.95

4.77

1.5

352.68

395.09

pmol/l

0.22

228

Other cataract

302

1748

1.31

4.77

1.3

654.84

356.89

pmol/l

0.39

252

1516

Sequelae of injuries of upper limb

416

1.74

4.76

1.3

1.4

227.82

323.93

pmol/l

2.76

366

Disorders of refraction and accommodation

187

1332

1.40

4.75

1.4

352.36

456.31

pmol/l

0.62

155

1167

Superficial injury of lower leg

171

1204

1.43

4.75

1.5

1.4

285.18

514.48

pmol/l

1.22

152

1045

Social phobias

314

1.86

4.74

1.3

1.5

387.79

370.65

pmol/l

0.11

282

Budesonide

615

1.60

4.73

1.4

305.16

318.30

pmol/l

0.16

532

Other skin changes

126

838

1.51

4.70

1.3

295.23

325.20

pmol/l

0.34

108

704

Visual impairment including blindness (binocular or monocular)

238

1.99

4.69

1.5

1.3

2620.76

304.52

pmol/l

0.49

204

Diabetic retinopathy, excluding more controls

234

962

1.37

4.69

1.3

278.12

297.81

pmol/l

0.34

193

837

Other and unspecified injuries of lower leg

287

1.90

4.69

1.5

1.4

344.26

339.44

pmol/l

0.03

256

Other disorders of pigmentation

165

2.21

4.67

1.2

1.3

335.68

311.49

pmol/l

0.22

142

Internal derangement of knee

260

1954

1.33

4.67

1.3

1.4

295.57

324.82

pmol/l

0.66

228

1696

Osteomyelitis

225

2.02

4.66

1.1

1.4

260.26

332.40

pmol/l

0.71

190

Dislocation, sprain and strain of joints and ligaments at neck level

103

657

1.58

4.64

1.3

1.4

490.58

491.04

pmol/l

0.00

575

Decubitus ulcer and pressure area

205

2.07

4.64

1.1

1.3

278.25

285.98

pmol/l

0.04

177

Arthropathies in other diseases classified elsewhere

140

2.31

4.63

1.4

1.3

257.73

362.98

pmol/l

0.92

122

Colectomy operation

116

761

1.53

4.62

1.3

308.02

327.08

pmol/l

0.16

105

638

Acute pancreatitis (for exclusion)

137

931

1.48

4.61

1.3

286.96

433.18

pmol/l

0.68

119

784

Thyrotoxicosis with toxic multinodular goitre

254

1.95

4.60

1.3

341.27

321.07

pmol/l

0.12

214

Poisoning by drugs, medicaments and biological substances

164

1154

1.43

4.59

1.3

1.4

379.22

454.71

pmol/l

0.33

142

1018

Adenomyosis (Endometriosis of uterus)

581

1.61

4.58

1.4

1.3

332.49

296.17

pmol/l

0.52

513

Diseases of peritoneum

421

1.72

4.58

1.4

1.3

336.30

302.14

pmol/l

0.41

363

Viral infections characterized by skin and mucous membrane lesions

618

4410

1.20

4.57

1.4

624.44

332.49

pmol/l

0.69

539

3847

Allergic conjunctivitis

409

3197

1.25

4.56

1.4

1.3

328.73

411.91

pmol/l

0.99

359

2818

Other medical care

305

2121

1.30

4.56

1.4

1.3

611.81

360.89

pmol/l

0.33

261

1817

Lesion of ulnar nerve

598

1.60

4.54

1.3

228.00

526.32

pmol/l

1.05

513

Poisoning by medicine

148

1024

1.45

4.54

1.3

1.4

393.24

452.26

pmol/l

0.22

128

906

Iron deficiency anaemia secondary to blood loss (chronic)

102

653

1.57

4.53

1.2

1.3

369.16

359.22

pmol/l

0.06

557

176

1091

1.41

4.53

1.2

1.3

293.90

293.44

pmol/l

0.00

153

913

Injuries to the wrist and hand

731

4284

1.18

4.52

1.4

315.97

377.81

pmol/l

1.03

631

3743

Other and/or unspecified nontoxic goitre

364

1.77

4.49

1.3

636.56

297.37

pmol/l

0.42

310

Other specified/unspecified soft tissue disorders

168

2.16

4.47

1.3

230.37

345.88

pmol/l

1.82

149

Vitamin B12 deficiency anaemia

402

1.73

4.45

1.3

483.83

293.91

pmol/l

0.49

342

Unspecified/other endometriosis

343

1.79

4.44

1.5

607.97

372.01

pmol/l

0.38

313

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

243

1.95

4.42

1.2

1.3

319.43

303.22

pmol/l

0.09

209

Coxarthrosis

347

1800

1.28

4.41

1.3

1.4

289.03

294.14

pmol/l

0.11

311

1538

Degeneration of macula and posterior pole

304

1876

1.29

4.39

1.2

1.3

289.75

292.83

pmol/l

0.05

260

1585

Enterocolitis due to Clostridium difficile

419

1.70

4.38

1.4

1.3

309.08

334.90

pmol/l

0.21

354

Methotrexate

636

1.56

4.36

1.4

1.3

1331.46

301.44

pmol/l

0.52

548

Cholecystitis

551

1.60

4.32

1.3

333.66

292.38

pmol/l

0.48

464

Paralytic ileus

107

2.45

4.31

1.4

1.5

172.14

354.09

pmol/l

2.35

Arterial embolism and thrombosis

171

2.12

4.28

1.3

331.58

310.36

pmol/l

0.08

148

Glaucoma

375

2581

1.25

4.26

1.3

307.18

335.32

pmol/l

0.27

336

2204

Intestinal adhesions without obstruction

304

1.82

4.26

1.4

273.12

294.04

pmol/l

0.19

256

Retinal vascular disorders

499

1.63

4.26

1.4

1.3

278.27

296.26

pmol/l

0.21

421

Supervision of normal pregnancy

655

0.60

4.25

1.3

1.4

397.95

371.47

pmol/l

0.21

591

Other complications of surgical and medical care, not elsewhere classified

408

1.70

4.24

1.4

341.17

335.28

pmol/l

0.04

357

Ocular pain

334

1.78

4.23

1.4

377.67

343.89

pmol/l

0.25

297

Preterm labour and delivery

182

1324

1.38

4.23

1.3

1.4

325.14

395.77

pmol/l

1.14

156

1186

Other disorders of the musculoskeletal system and connective tissue

104

681

1.54

4.22

1.2

1.3

300.82

337.40

pmol/l

0.36

586

Abnormal findings on diagnostic imaging of central nervous system

166

2.13

4.20

1.6

1.5

395.89

373.58

pmol/l

0.09

142

Sequelae of other external causes

214

1.98

4.17

1.2

1.4

299.95

332.12

pmol/l

0.25

186

Disorders of sclera, cornea, iris and ciliary body

380

3060

1.24

4.16

1.4

303.80

401.22

pmol/l

1.26

326

2657

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

418

1.69

4.16

1.3

1.4

280.47

309.36

pmol/l

0.39

362

Hypertrophy of breast

123

837

1.48

4.16

1.4

314.67

377.82

pmol/l

0.78

106

742

Alzheimer’s disease, strict definition

798

0.58

4.15

1.1

1.2

216.90

268.02

pmol/l

1.54

660

Otitis media, unspecified

398

1.67

4.13

1.6

1.5

334.42

405.49

pmol/l

0.63

353

Fenamates

102

448

1.55

4.10

1.2

1.4

367.74

412.14

pmol/l

0.22

393

Retinal vascular occlusion

489

1.63

4.09

1.5

1.3

274.79

296.15

pmol/l

0.25

411

Vulvovaginal ulceration/inflammation in other diseases

223

1.94

4.06

1.5

1.4

463.81

364.75

pmol/l

0.58

198

Deficiency of other B group vitamins

2.80

4.04

1.2

1064.93

347.95

pmol/l

0.47

Candidiasis

585

1.56

4.03

1.3

1.4

404.80

361.97

pmol/l

0.24

510

Presence of cardiac and vascular implants and grafts

280

1616

1.29

4.01

1.2

1.3

301.37

349.02

pmol/l

0.31

244

1366

Separation of retinal layers (serosa)

156

2.14

4.01

1.1

1.4

247.04

362.62

pmol/l

1.39

145

Oter anti-inflammatory and antirheumatic agents, non-steroids

145

556

1.44

4.00

1.3

266.89

355.62

pmol/l

0.98

123

476

Covid-19 suspected case

149

1060

1.41

3.98

1.2

1.4

300.40

509.22

pmol/l

1.34

137

936

Neuralgia and neuritis, unspecified

197

2.00

3.98

1.3

322.91

344.98

pmol/l

0.14

173

Familial hypercholesterolemia, with ischemic heart disease

341

1.74

3.96

1.2

1.3

277.81

282.09

pmol/l

0.03

290

Erosion of teeth , including avohilmo

168

1222

1.38

3.94

1.3

1.4

310.65

475.79

pmol/l

1.10

149

1060

Fall on same level involving ice and snow

397

3234

1.23

3.93

1.4

1.3

298.87

388.26

pmol/l

1.15

346

2812

Alzheimer disease

961

0.65

3.92

1.1

1.2

228.32

262.01

pmol/l

0.93

791

Other disorders of optic [2nd] nerve and visual pathways

219

1.93

3.92

1.3

1.4

253.67

342.81

pmol/l

1.17

191

Atopic dermatitis

395

2631

1.23

3.89

1.4

585.51

406.05

pmol/l

0.31

343

2310

All influenza (not pneumonia)

638

1.53

3.88

1.3

318.32

303.23

pmol/l

0.12

551

Disorders of breast

344

2508

1.25

3.85

1.4

1.3

380.17

390.14

pmol/l

0.04

313

2221

Second line medication for Crohn's disease

404

3304

1.23

3.85

1.4

331.17

400.34

pmol/l

0.82

353

2889

Seropositive rheumatoid arthritis

164

1189

1.38

3.84

1.3

316.90

324.68

pmol/l

0.09

145

1019

Allergic colitis

2.86

3.79

1.5

264.52

559.75

pmol/l

0.95

Salpingitis and oophoritis

127

887

1.44

3.79

1.5

1.3

1132.36

306.31

pmol/l

0.51

110

781

Striking against or struck by other objects

218

1659

1.32

3.78

1.4

312.79

461.48

pmol/l

1.01

185

1440

Other bursopathies

579

1.55

3.76

1.3

269.41

309.63

pmol/l

0.63

499

Acetic acid derivatives and related substances

177

668

1.38

3.76

1.3

1.4

315.38

375.87

pmol/l

0.60

155

580

Exposure to other specified factors

527

4065

1.19

3.75

1.4

322.83

386.06

pmol/l

0.89

468

3548

COPD, hospital admissions 1, only main diagnosis

212

1375

1.32

3.75

1.2

1.3

220.87

379.33

pmol/l

1.34

176

1152

Benign neoplasm: Stomach

431

1.64

3.74

1.2

1.3

269.69

296.30

pmol/l

0.42

370

Dermatophytosis

572

1.55

3.74

1.3

1430.11

304.59

pmol/l

0.49

489

Alzheimer disease, including avohilmo

111

1133

0.69

3.72

1.1

1.3

233.09

271.79

pmol/l

1.33

944

Anorexia (incl.atypical)

195

1.96

3.72

1.2

1.5

542.94

417.97

pmol/l

0.88

178

Female genital prolapse

196

823

1.35

3.71

1.3

507.13

297.42

pmol/l

0.79

169

732

Use of donepezil

725

0.55

3.71

1.0

1.2

199.15

260.74

pmol/l

0.79

604

Poor fetal growth

502

1.58

3.71

1.5

473.26

687.23

pmol/l

0.47

449

Zoster [herpes zoster]

120

833

1.45

3.70

1.3

279.94

324.84

pmol/l

0.56

104

707

Other noninflammatory disorders of vulva and perineum

356

1.70

3.69

1.3

378.38

350.60

pmol/l

0.20

315

Rheumatoid arthritis

214

1462

1.32

3.68

1.3

1.4

331.72

324.01

pmol/l

0.10

189

1257

Impingement syndrome of shoulder

158

1153

1.38

3.67

1.3

1.4

271.33

301.29

pmol/l

0.80

134

1001

Injuries to the neck

149

1077

1.39

3.66

1.3

1.4

1086.26

450.20

pmol/l

0.46

130

927

Redundant prepuce, phimosis and paraphimosis

128

892

1.43

3.66

1.4

291.41

400.07

pmol/l

0.46

106

772

Lichen simplex chronicus and prurigo

261

1.82

3.64

1.4

393.85

322.07

pmol/l

0.57

225

Injury of unspecified body region

305

1.75

3.64

1.3

1.4

276.38

323.55

pmol/l

0.37

263

Other disorders starting during childhood or adolecense, excluding more controls

142

2.10

3.64

1.4

1.5

258.67

463.90

pmol/l

1.59

132

Anterior Iridocyclitis

135

961

1.41

3.64

1.4

1.3

324.63

444.60

pmol/l

0.55

123

824

Complications of internal orthopaedic prosthetic devices, implants and grafts

148

1071

1.39

3.62

1.4

1.3

259.86

305.85

pmol/l

0.84

124

914

Glaucoma suspect

237

1839

1.29

3.61

1.3

325.80

363.31

pmol/l

0.26

215

1571

Congenital malformations and deformations of the musculoskeletal system

448

1.61

3.61

1.3

1.5

514.77

374.51

pmol/l

0.94

397

Other and unspecified vascular occlusions

351

1.69

3.60

1.5

1.3

305.96

291.93

pmol/l

0.12

300

Vitreous haemorrhage

420

1.63

3.60

1.4

1.3

274.73

307.28

pmol/l

0.30

363

Schizophrenia or delusion, excluding more controls

189

1408

1.33

3.59

1.3

1.4

393.51

486.18

pmol/l

0.38

152

1227

Other female pelvic inflammatory diseases

111

765

1.46

3.58

1.4

1.3

565.48

315.23

pmol/l

0.55

666

Abscess of anal and rectal regions

352

1.69

3.57

1.2

1.4

250.53

325.20

pmol/l

1.48

306

Fall involving bed

2.42

3.57

1.1

1.3

238.07

281.80

pmol/l

0.45

Otitis externa, unspecified

460

1.60

3.57

1.3

1.4

306.35

328.82

pmol/l

0.27

398

Giant cell arteritis

137

2.14

3.56

1.2

1.3

477.04

288.76

pmol/l

0.60

123

Speech disturbances, not elsewhere classified

360

1.68

3.56

1.2

1.3

276.45

307.44

pmol/l

0.28

305

Iridocyclitis

154

1126

1.37

3.55

1.4

1.3

316.59

428.44

pmol/l

0.61

138

964

Encephalitis

105

2.31

3.54

1.2

1.5

4938.01

375.38

pmol/l

0.47

Unspecified fall

329

2627

1.24

3.47

1.3

587.84

371.27

pmol/l

0.31

278

2268

L04AX Other immunosuppressants

391

3226

1.21

3.46

1.3

1.4

329.81

401.46

pmol/l

0.83

340

2816

Alzheimer’s disease (Late onset)

731

0.60

3.45

1.1

1.2

220.80

259.77

pmol/l

0.97

599

Amputation of toe

251

1.81

3.45

1.1

1.3

242.16

289.61

pmol/l

0.45

216

Adalimumab

410

1.62

3.43

1.6

1.5

311.04

340.81

pmol/l

0.20

364

Viral infections characterized by skin and mucous membrane lesions

281

2240

1.26

3.43

1.3

1.4

1031.78

342.33

pmol/l

0.76

243

1928

Dementia in Alzheimer disease

538

0.53

3.42

1.1

1.3

236.34

250.75

pmol/l

0.17

448

Other hearing loss

165

1200

1.35

3.42

1.3

290.24

304.47

pmol/l

0.16

140

1015

Explicit bacterial Sepsis

387

1.64

3.42

1.2

1.3

348.81

294.95

pmol/l

0.29

325

Chondrocostal junction syndrome [Tietze]

133

2.13

3.40

1.2

1.4

290.13

359.28

pmol/l

0.83

120

Other condition

650

1.48

3.40

1.4

271.42

313.57

pmol/l

0.86

568

Problems related to lifestyle

450

1.59

3.40

1.4

396.35

321.19

pmol/l

0.45

391

Spasmodic torticollis

120

2.19

3.40

1.2

1.4

313.10

353.32

pmol/l

0.33

107

Other diseases of oesophagus

388

1.63

3.39

1.4

1.3

236.93

321.64

pmol/l

1.31

323

Fall on and from stairs and steps

172

1290

1.34

3.38

1.4

1.3

286.81

415.47

pmol/l

0.90

144

1101

Drug-induced osteoporosis with pathological fracture

2.88

3.38

1.5

1.3

378.80

284.04

pmol/l

—

Emphysema

253

1.79

3.37

1.2

1.3

227.35

276.68

pmol/l

0.52

221

Parkinson's disease, excluding more controls

439

1.57

3.36

1.1

1.4

246.62

279.92

pmol/l

0.62

377

Open wound of lower leg

660

1.48

3.36

1.5

1.4

345.60

316.36

pmol/l

0.31

574

Dentofacial anomalies [including malocclusion]

490

3318

1.19

3.36

1.4

332.69

407.33

pmol/l

0.90

436

2916

Haemorrhage in early pregnancy

182

1341

1.33

3.35

1.4

445.32

398.81

pmol/l

0.19

165

1198

Haemangioma, any site

359

1.65

3.34

1.4

389.52

344.60

pmol/l

0.32

319

Other viral diseases

245

1916

1.27

3.33

1.3

1.4

359.41

490.71

pmol/l

0.98

218

1669

Preparatory care for dialysis

148

2.05

3.32

1.3

1.4

502.03

345.29

pmol/l

0.70

130

Eating disorder

306

1.71

3.31

1.3

1.5

525.72

811.79

pmol/l

0.41

275

Any dementia

131

1254

0.72

3.31

1.1

1.3

271.86

273.69

pmol/l

0.03

111

1051

Dementia

160

1472

0.75

3.31

1.1

1.3

263.26

271.41

pmol/l

0.15

130

1234

Otitis externa

146

1072

1.37

3.31

1.4

306.36

439.59

pmol/l

0.72

128

920

Postprocedural musculoskeletal disorders, not elsewhere classified

292

1.73

3.30

1.1

1.3

297.33

317.28

pmol/l

0.20

251

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

345

1.66

3.30

1.3

1.4

777.65

315.48

pmol/l

0.53

303

Other eating disorders

155

2.01

3.29

1.3

1.4

465.60

503.96

pmol/l

0.14

139

Other viral diseases, not elsewhere classified

173

1297

1.33

3.29

1.3

1.4

343.86

554.82

pmol/l

1.15

153

1129

Injuries to unspecified part of trunk, limb or body region

415

1.60

3.28

1.3

1.4

292.35

321.05

pmol/l

0.25

355

Endometriosis of pelvic peritoneum

102

671

1.45

3.27

1.5

1.4

529.82

337.01

pmol/l

0.56

605

Superficial injury of wrist and hand

129

930

1.39

3.27

1.3

1.4

328.17

571.78

pmol/l

0.91

119

816

Cardiomyopathy, other and unspecified

301

1.71

3.25

1.1

1.3

343.32

275.59

pmol/l

0.64

260

Delirium, not induced by alcohol and other psychoactive substances

447

1.57

3.24

1.2

1.3

307.20

282.91

pmol/l

0.21

375

Seronegative rheumatoid arthritis

512

1.53

3.23

1.3

407.01

361.05

pmol/l

0.26

441

Other disorders of breast

593

1.49

3.22

1.4

1.3

667.99

335.86

pmol/l

0.61

521

Retinal detachments and breaks

224

1755

1.28

3.21

1.5

1.3

259.40

362.68

pmol/l

1.01

191

1492

Assault

585

1.49

3.21

1.4

292.48

348.32

pmol/l

0.66

519

Other encephalitis

2.29

3.21

1.2

1.4

5493.07

376.08

pmol/l

0.47

In situ neoplasms

238

1879

1.27

3.21

1.3

342.27

390.22

pmol/l

0.21

217

1612

Eating disorders

386

1.61

3.20

1.2

1.5

501.33

704.92

pmol/l

0.36

346

Tumor necrosis factor alpha inhibitors

102

709

1.44

3.19

1.4

306.82

372.11

pmol/l

0.60

625

Herpesviral [herpes simplex] infections

490

1.54

3.18

1.3

1.4

317.62

321.32

pmol/l

0.03

425

Alcohol-induced chronic pancreatitis

259

1.75

3.14

1.1

1.4

294.11

313.94

pmol/l

0.12

227

Palmar fascial fibromatosis [Dupuytren]

613

1.47

3.13

1.2

1.3

252.26

288.67

pmol/l

0.71

523

Anogenital herpesviral [herpes simplex] infection

230

1.79

3.12

1.4

414.12

370.64

pmol/l

0.30

202

Polycystic ovarian syndrome

166

1.94

3.09

1.6

1.3

493.07

459.63

pmol/l

0.14

146

Zoster [herpes zoster]

328

2653

1.22

3.08

1.4

1.3

288.91

303.93

pmol/l

0.38

288

2282

Wide developmental disorders, excluding more controls

2.29

3.07

1.9

1.5

423.10

375.60

pmol/l

0.17

Diabetic retinopathy, strict definition

151

996

1.35

3.06

1.3

237.42

316.96

pmol/l

1.96

115

855

Overexertion and strenuous or repetitive movements

431

1.56

3.06

1.4

267.05

314.56

pmol/l

0.70

373

Other/unspecified synovitis and tenosynovitis

487

1.53

3.05

1.1

1.3

244.31

313.89

pmol/l

1.47

429

Tonsillectomy and adenotomy

378

2186

1.21

3.03

1.5

1.4

879.42

384.50

pmol/l

0.73

333

1935

Chronic ulcer of skin, not elsewhere classified

247

1.75

3.03

1.3

345.11

309.26

pmol/l

0.17

216

Allergic urticaria

338

1.64

3.03

1.4

259.35

337.47

pmol/l

1.42

298

Postmenopausal bleeding

180

728

1.32

3.03

1.2

1.3

292.61

274.38

pmol/l

0.34

159

646

Myopia

520

1.51

3.02

1.3

1.4

373.08

563.40

pmol/l

0.45

460

Congenital malformations of the circulatory system

631

1.45

3.01

1.4

384.37

351.30

pmol/l

0.24

547

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

161

1.94

3.00

1.3

1.5

190.40

402.43

pmol/l

4.26

144

Antenatal screening

677

0.68

2.99

1.3

1.4

390.28

369.92

pmol/l

0.17

612

Peripheral artery operations in Hilmo

457

1.54

2.98

1.1

1.4

257.98

288.85

pmol/l

0.38

383

Gestational diabetes (for exclusion)

221

1208

1.28

2.98

1.4

1.5

772.69

454.93

pmol/l

0.32

197

1085

Ganglion

133

981

1.36

2.97

1.3

1.4

330.83

332.79

pmol/l

0.02

121

861

Acute and subacute iridocyclitis

125

914

1.37

2.95

1.5

1.3

330.21

451.64

pmol/l

0.53

113

793

Disorders of pituitary gland, other and/or unspecified

4.84

2.95

1.6

1.1

243.25

267.71

pmol/l

—

Inflammatory diseases of the central nervous system

333

1.63

2.94

1.4

2294.69

312.11

pmol/l

0.50

291

Haemangioma and lymphangioma, any site

380

1.59

2.94

1.4

407.26

342.77

pmol/l

0.50

335

Pleural effusion

622

1.45

2.93

1.2

1.3

481.39

292.24

pmol/l

0.75

517

Seborrhoeic dermatitis

404

1.57

2.93

1.7

1.4

334.47

337.94

pmol/l

0.02

348

Unspecified maternal hypertension

3.50

2.91

1.5

239.73

487.89

pmol/l

1.36

Superficial injury of head

147

1104

1.34

2.91

1.3

273.02

330.73

pmol/l

1.09

128

951

Diseases of external ear

217

1717

1.27

2.91

1.4

1.3

295.91

395.31

pmol/l

0.88

190

1474

Benign neoplasm: Endocrine gland, other/unspecified

5.64

2.91

1.0

212.14

344.77

pmol/l

—

Artificial joint re-operation

296

1.67

2.91

1.3

301.05

295.91

pmol/l

0.04

251

Uterine polyps

397

1.57

2.90

1.3

306.98

295.98

pmol/l

0.11

350

Psoriatic and enteropathic arthropathies

509

1.50

2.90

1.5

1.4

342.34

379.48

pmol/l

0.24

433

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

104

740

1.41

2.89

1.3

1.4

415.42

514.90

pmol/l

0.28

653

Other viral diseases, not elsewhere classified

117

847

1.38

2.89

1.4

373.42

372.18

pmol/l

0.01

100

740

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

186

1446

1.29

2.88

1.4

303.80

521.55

pmol/l

1.42

160

1253

Fracture of shoulder and upper arm

233

1860

1.25

2.87

1.4

1.3

306.78

369.95

pmol/l

0.50

202

1583

Spondylopathies (FG)

600

1.46

2.87

1.3

1.4

224.04

378.93

pmol/l

2.62

515

Malignant melanoma of skin, including Hilmo

625

1.45

2.87

1.3

334.25

293.16

pmol/l

0.51

523

Mental retardation, excluding more controls

112

2.10

2.86

1.0

1.3

241.00

434.95

pmol/l

1.24

105

Other/unspecified enthesopathies, not elsewhere classified

336

1.62

2.85

1.2

1.3

597.15

305.81

pmol/l

0.38

301

Papulosquamous disorders

261

2115

1.24

2.85

1.4

1.3

303.15

360.58

pmol/l

0.56

231

1826

Follicular cysts of skin and subcutaneous tissue

119

869

1.37

2.85

1.2

1.3

490.67

336.54

pmol/l

0.39

108

752

Superficial injury of ankle and foot

495

1.50

2.85

1.4

256.81

354.69

pmol/l

2.39

439

Myeloproliferative diseases (CML excluded)

298

1.65

2.84

1.1

1.3

301.79

313.19

pmol/l

0.09

259

Degenerative diseases of the nervous system

112

1129

0.73

2.83

1.2

1.3

241.58

273.47

pmol/l

0.62

943

Thyrotoxicosis with diffuse goitre

611

1.45

2.81

1.4

1.3

317.49

349.11

pmol/l

0.24

524

Bell's palsy

481

1.50

2.79

1.3

1.4

313.38

324.23

pmol/l

0.08

417

Acute suppurative otitis media

155

1101

1.32

2.79

1.5

989.90

410.59

pmol/l

0.43

137

971

Unspecified misadventure during surgical and medical care

209

1.78

2.79

1.2

1.4

325.41

325.98

pmol/l

0.00

181

Other fall from one level to another

139

1043

1.34

2.79

1.6

1.3

335.57

429.65

pmol/l

0.42

117

893

Sequelae of injuries of head

180

1.85

2.78

1.6

1.4

3406.00

352.65

pmol/l

0.48

154

Patellar tendinitis

3.11

2.78

1.8

1.3

259.50

490.85

pmol/l

1.00

Spondyloarthritis

107

771

1.39

2.78

1.3

1.4

226.35

347.86

pmol/l

2.58

661

Infective dermatitis

490

1.50

2.77

1.1

1.4

349.86

363.51

pmol/l

0.07

426

Malignant melanoma of skin

466

1.51

2.77

1.3

333.62

298.51

pmol/l

0.32

395

Perineal laceration during delivery

622

0.62

2.75

1.4

1.5

387.85

543.25

pmol/l

1.24

564

Polymyalgia rheumatica

540

1.47

2.75

1.2

1.3

305.81

284.25

pmol/l

0.24

459

Paracetamol or NSAID medication

348

1.44

2.74

1.4

1.5

367.67

395.37

pmol/l

0.12

304

Malignant melanoma, including Hilmo

106

765

1.39

2.74

1.3

321.38

296.17

pmol/l

0.33

640

Other disorders starting during childhood or adolescence

165

1.87

2.73

1.4

1.6

258.67

451.63

pmol/l

1.64

145

Use of antiglaucoma preparations and miotics

294

1.64

2.71

1.4

1.3

312.49

287.12

pmol/l

0.19

245

Hypertrophic scar

189

1.81

2.71

1.5

1.4

362.24

349.30

pmol/l

0.08

164

Other coagulation defects

280

1.65

2.67

1.3

1.4

297.76

386.44

pmol/l

0.95

245

Haemolytic anaemias

119

2.04

2.67

1.3

1.4

400.32

332.89

pmol/l

0.51

106

Crohn disease

560

1.45

2.67

1.6

1.4

425.84

312.18

pmol/l

0.88

488

Single delivery by forceps and vacuum extractor

454

0.62

2.66

1.3

1.5

365.12

418.58

pmol/l

0.50

405

Respiratory insufficiency

272

1.66

2.65

1.2

1.3

265.66

267.79

pmol/l

0.01

232

Suicide or other Intentional self-harm

157

1210

1.30

2.64

1.3

1.4

353.05

512.50

pmol/l

0.66

134

1058

Pedal cyclist injured in other and unspecified transport accidents

488

1.48

2.63

1.2

1.4

317.16

319.61

pmol/l

0.02

425

Dementia, including avohilmo

181

1581

0.79

2.63

1.1

1.3

263.03

272.44

pmol/l

0.20

147

1329

Kela-code for severe mental illness

238

1929

1.24

2.63

1.3

1.4

438.49

453.09

pmol/l

0.06

195

1679

Other otitis externa (chronic)

251

1.68

2.62

1.2

1.4

333.79

334.38

pmol/l

0.00

221

Malignant melanoma

629

1.42

2.61

1.4

1.3

319.09

288.84

pmol/l

0.35

525

Other viral diseases

185

1454

1.27

2.60

1.4

378.68

527.26

pmol/l

0.80

162

1269

Urethral stricture

199

1.77

2.60

1.5

1.3

373.40

272.63

pmol/l

1.00

168

Later onset COPD

151

921

1.31

2.59

1.1

1.3

239.06

265.87

pmol/l

0.51

121

761

Adhesive capsulitis of shoulder

105

765

1.38

2.59

1.5

1.3

298.82

302.19

pmol/l

0.03

666

Unspecified acute lower respiratory infection

656

1.41

2.57

1.4

324.68

472.23

pmol/l

0.45

561

Hypertensive encephalopathy

7.35

2.57

1.4

1.3

352.00

330.00

pmol/l

—

Diagnoses used for exclusion with ILD

157

1215

1.30

2.57

1.3

1023.84

323.96

pmol/l

0.55

134

1039

Car occupant injured in other and unspecified transport accidents

116

860

1.35

2.56

1.4

472.24

450.11

pmol/l

0.04

100

746

Other and unspecified mood [affective] disorders

268

1.65

2.56

1.3

1.5

400.33

338.64

pmol/l

0.41

245

Alcohol dependence

164

1278

1.29

2.55

1.2

1.4

332.29

390.59

pmol/l

0.30

133

1106

Vestibular neuronitis

380

1.53

2.51

1.4

1.3

333.61

301.07

pmol/l

0.25

332

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

189

1503

1.26

2.50

1.4

1.3

301.73

398.17

pmol/l

0.71

171

1275

Oesophagitis

195

1.76

2.47

1.3

1.4

483.72

291.44

pmol/l

0.56

168

Specific development disorders of speech and language

202

1.73

2.46

1.4

1.5

362.93

390.35

pmol/l

0.11

179

Colonic or urogenital fistula

174

1373

1.27

2.46

1.4

1.3

380.61

405.33

pmol/l

0.09

158

1167

Benign neoplasm: Ascending colon

629

1.41

2.45

1.3

285.84

331.32

pmol/l

0.42

533

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

629

1.41

2.45

1.3

279.32

344.01

pmol/l

0.73

548

Female infertility

180

859

1.27

2.44

1.4

1101.80

343.77

pmol/l

0.70

153

780

Pleural plaque

311

1.58

2.43

1.2

1.3

238.46

256.63

pmol/l

0.20

251

Coagulation defects, purpura and other haemorrhagic conditions

117

877

1.34

2.43

1.4

389.66

359.73

pmol/l

0.11

104

747

Dermatophytosis

403

3454

1.17

2.42

1.3

1.4

830.77

331.53

pmol/l

0.81

352

2989

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

178

1.78

2.42

1.4

1.5

264.72

466.39

pmol/l

1.91

157

Skin changes due to chronic exposure to nonionizing radiation

227

1704

1.23

2.42

1.3

284.89

291.91

pmol/l

0.12

200

1434

Hydronephrosis

440

1.48

2.42

1.8

1.4

503.86

300.70

pmol/l

0.60

376

Meralgia paraesthetica

124

1.95

2.41

1.4

249.89

381.02

pmol/l

1.31

111

Hypermetropia

257

1.64

2.41

1.3

1.5

365.94

409.66

pmol/l

0.24

226

Hypothalamic dysfunction, including iatrogenic, not elsewhere classified

6.62

2.41

1.6

1.0

797.40

248.88

pmol/l

—

Benign neoplasm: Transverse colon

465

1.47

2.41

1.2

1.4

309.49

295.42

pmol/l

0.09

397

Other disorders of patella

110

818

1.35

2.41

1.4

309.54

365.78

pmol/l

0.75

711

Acne

383

1.52

2.41

1.4

1.5

366.23

677.99

pmol/l

0.61

339

Chondropathies

683

1.38

2.38

1.3

1.4

327.77

320.17

pmol/l

0.08

592

Benign neoplasm: Brain, unspecified

4.21

2.38

1.0

1.1

154.43

325.06

pmol/l

—

Bullous disorders

205

1.72

2.37

1.3

277.50

320.72

pmol/l

0.34

178

Pilonidal cyst

345

1.54

2.37

1.3

1.5

294.33

342.94

pmol/l

0.58

302

Benign neoplasm: Cranial nerves

104

2.04

2.37

1.4

249.56

353.45

pmol/l

1.24

Other disorders of penis

369

1.52

2.37

1.6

1.4

239.31

567.65

pmol/l

0.63

314

Procreative management

224

1521

1.23

2.36

1.5

1.4

422.80

415.98

pmol/l

0.02

197

1349

Mixed and other personality disorders

330

1.55

2.35

1.3

1.4

395.58

350.80

pmol/l

0.36

293

Polyp of the female genital tract

192

878

1.26

2.34

1.4

1.3

284.12

305.65

pmol/l

0.60

169

785

Use of memantine

877

0.71

2.34

1.1

1.2

254.37

259.22

pmol/l

0.06

724

Use of other anti-dementia drugs

877

0.71

2.34

1.1

1.2

254.38

259.22

pmol/l

0.06

724

Injuries to the elbow and forearm

474

3625

1.15

2.34

1.4

1.3

371.57

379.67

pmol/l

0.04

404

3174

Abnormal spermatozoa

501

1.44

2.34

1.4

1.3

237.43

280.88

pmol/l

0.95

416

Psoriasis

187

1499

1.25

2.33

1.4

1.3

293.32

389.80

pmol/l

0.72

163

1275

241

1817

1.22

2.33

1.3

289.16

292.02

pmol/l

0.05

213

1535

Endometriosis of rectovaginal septum and vagina

291

1.59

2.33

1.3

325.28

319.33

pmol/l

0.05

258

5-aminosalicylic acid

133

1022

1.31

2.33

1.4

301.98

415.22

pmol/l

0.58

116

884

Assault by bodily force

323

1.56

2.32

1.4

1.5

233.64

382.04

pmol/l

3.76

284

Bronchitis, not specified as acute or chronic

339

1.54

2.32

1.3

1.4

272.31

281.13

pmol/l

0.09

292

Superficial injury of abdomen, lower back and pelvis

670

1.38

2.31

1.4

378.97

325.33

pmol/l

0.58

577

Parkinson's disease, strict definition, excluding more controls

415

1.47

2.31

1.1

1.4

242.03

277.74

pmol/l

0.70

354

Pyogenic arthritis

253

1.63

2.30

1.3

404.06

336.32

pmol/l

0.32

211

Peritonsillar abscess

129

990

1.31

2.29

1.4

259.75

376.49

pmol/l

2.28

117

864

Lateral epicondylitis

604

1.40

2.28

1.3

1.4

334.20

321.32

pmol/l

0.11

530

Early lumbar disc prolapse, operated

397

1.49

2.28

1.3

1.4

357.48

659.66

pmol/l

0.62

351

Diseases of middle ear and mastoid

365

2552

1.17

2.27

1.4

595.87

408.52

pmol/l

0.30

320

2222

Mental retardation

126

1.91

2.27

1.0

1.4

241.00

420.27

pmol/l

1.20

114

Coeliac disease

521

1.43

2.27

1.3

1.4

1676.65

365.27

pmol/l

0.46

455

Stomatitis and related lesions

124

948

1.31

2.27

1.5

1.4

335.17

347.30

pmol/l

0.10

111

817

Complications predominantly related to the puerperium

161

1274

1.27

2.26

1.3

1.4

366.13

497.09

pmol/l

0.85

149

1124

Arthropathic psoriasis

489

1.44

2.24

1.5

1.4

343.68

306.29

pmol/l

0.43

426

L02BA Anti-estrogens

858

0.68

2.24

1.5

1.3

481.12

349.61

pmol/l

0.28

752

Contact with nonpowered hand tool

142

1.84

2.23

1.7

1.5

341.10

351.98

pmol/l

0.05

121

Medical abortion

420

1963

1.16

2.23

1.3

369.57

394.21

pmol/l

0.14

361

1760

Disorders of optic nerve and visual pathways

383

1.50

2.22

1.3

1.4

247.37

344.56

pmol/l

2.18

338

Acute nasopharyngitis (common cold)

536

1.41

2.22

1.3

1.4

299.93

298.33

pmol/l

0.02

467

Anogenital herpesviral [herpes simplex] infection

416

1.47

2.21

1.3

1.5

381.27

636.36

pmol/l

0.53

373

Amiodarone users

408

1.48

2.21

1.2

1.4

309.82

289.44

pmol/l

0.19

346

Heterophoria

311

1.55

2.21

1.2

1.5

266.37

396.40

pmol/l

2.08

274

Maltreatment syndromes

180

1.73

2.19

1.5

409.20

411.70

pmol/l

0.01

156

Other diseases of arteries and capillaries

336

1.52

2.19

1.2

1.4

262.72

325.15

pmol/l

0.71

292

Streptococcal septicaemia

320

1.54

2.19

1.1

1.3

343.85

306.20

pmol/l

0.14

273

Duodenal ulcer

426

1.46

2.17

1.3

351.82

321.22

pmol/l

0.22

352

Other and unspecified disorders of autonomic nervous system

4.42

2.17

1.5

1.3

450.17

246.50

pmol/l

—

Acquired clawhand, clubhand, clawfoot and clubfoot

3.78

2.17

1.6

1.3

625.14

377.68

pmol/l

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

4.37

2.16

1.0

1.1

592.83

242.29

pmol/l

—

Rheumatoid arthritis, including avohilmo

244

2030

1.20

2.16

1.3

325.73

378.06

pmol/l

0.45

214

1752

Radial styloid tenosynovitis [de Quervain]

219

1.65

2.15

1.2

1.3

323.56

349.34

pmol/l

0.20

202

Inflammatory bowel disease

201

1641

1.23

2.15

1.4

359.14

483.75

pmol/l

0.69

179

1411

Ulcerative colitis

152

1203

1.27

2.15

1.4

1.3

363.19

413.08

pmol/l

0.22

135

1036

Other degenerative diseases of the nervous system

142

828

1.28

2.14

1.3

1.4

252.34

351.74

pmol/l

1.42

119

717

Mental retardation, wide definition

136

1.84

2.14

1.0

1.4

237.60

408.84

pmol/l

1.25

123

Event of undetermined intent

235

1.63

2.14

1.2

1.5

465.39

359.57

pmol/l

0.34

201

Other noninflammatory disorders of vagina

298

1.55

2.13

1.3

347.38

332.99

pmol/l

0.10

264

Superficial injuries involving multiple body regions

2.12

2.13

1.2

1.4

135.25

407.23

pmol/l

4.19

Hypertrophic disorders of skin

212

1.66

2.13

1.5

1.4

398.50

342.98

pmol/l

0.39

187

Any death

322

2699

0.85

2.12

1.4

1.3

280.34

333.65

pmol/l

0.65

259

2320

Open wound of wrist and hand

283

2336

1.19

2.11

1.3

1.4

327.28

438.45

pmol/l

0.99

231

2023

Presbycusis

482

1.42

2.11

1.2

1.3

263.15

253.72

pmol/l

0.11

402

Essential (haemorrhagic) thrombocythaemia

145

1.81

2.11

1.0

1.4

281.79

328.81

pmol/l

0.31

126

Congenital malformation of biliary tract

5.20

2.09

1.0

1.4

183.40

304.90

pmol/l

—

Idiopathic hypoparathyroidism

5.18

2.09

1.4

1.1

206.40

308.90

pmol/l

—

Congenital malformations of larynx

5.17

2.09

1.4

253.60

1135.00

pmol/l

—

Sequelae of injuries of lower limb

397

1.47

2.09

1.2

1.4

229.40

315.94

pmol/l

2.28

343

Contusion of ankle

131

1.84

2.08

1.3

1.5

285.78

360.11

pmol/l

0.56

114

Malignant neoplasm of skin

313

1825

1.18

2.06

1.3

281.39

344.43

pmol/l

0.57

284

1566

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

317

1.52

2.06

1.4

1.3

272.71

318.22

pmol/l

0.49

273

Suppurative and unspecified otitis media

216

1580

1.21

2.05

1.5

1.4

809.50

457.03

pmol/l

0.33

186

1385

Vasomotor and allergic rhinitis

236

1931

1.20

2.05

1.3

1.4

345.18

357.41

pmol/l

0.13

199

1685

Crowding of teeth, including avohilmo

274

1.51

2.05

1.5

465.44

407.15

pmol/l

0.34

242

Ulcerative colitis, NAS

617

1.37

2.04

1.4

364.68

298.66

pmol/l

0.89

539

Rash and other nonspecific skin eruption

399

1.46

2.04

1.3

305.54

304.11

pmol/l

0.01

342

Amputation

366

1.48

2.04

1.2

1.3

241.02

287.10

pmol/l

0.52

308

Primary_lymphoid and hematopoietic malignant neoplasms

141

1114

1.27

2.04

1.2

1.3

310.36

321.19

pmol/l

0.10

126

942

Benign neoplasm of ovary

112

861

1.31

2.01

1.4

1.3

301.68

338.16

pmol/l

0.48

101

753

Congenital malformations of heart and great arteries

550

1.38

2.01

1.3

1.5

342.21

358.88

pmol/l

0.11

478

Fall on and from ladder

287

1.54

2.00

1.4

258.18

279.23

pmol/l

0.29

246

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

385

2646

1.15

2.00

1.5

1.3

411.80

386.29

pmol/l

0.12

342

2328

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

145

1139

1.26

1.99

2.0

1.3

265.15

371.25

pmol/l

0.58

124

960

Any dementia, excluding more controls

126

1106

0.78

1.99

1.1

1.3

275.86

266.72

pmol/l

0.14

106

924

Other specified and unspecified personality disorders

377

1.47

1.98

1.2

1.4

466.02

343.75

pmol/l

0.55

336

Cardiomyopathies, Primary/intrinsic

469

1.41

1.96

1.1

1.4

313.43

510.44

pmol/l

0.42

395

Open wound of head

336

2793

1.16

1.96

1.3

1.4

349.01

353.12

pmol/l

0.03

278

2420

Other maternal disorders predominantly related to pregnancy

373

2025

1.16

1.95

1.4

652.37

372.91

pmol/l

0.51

330

1819

Severe visual impairment, binocular

4.64

1.95

1.4

1.0

17432.80

266.27

pmol/l

—

Nonsuppurative otitis media

129

878

1.27

1.92

1.3

1.4

1128.77

374.85

pmol/l

0.49

116

770

Keratitis

224

1875

1.20

1.90

1.4

1.3

301.64

460.54

pmol/l

1.28

190

1610

Ascites

275

1.53

1.89

1.2

1.3

453.78

323.04

pmol/l

0.75

238

Viral hepatitis

275

1.53

1.89

1.3

1.5

278.78

378.91

pmol/l

1.40

242

Actinic keratosis

214

1651

1.20

1.89

1.3

275.23

293.51

pmol/l

0.36

187

1387

Acne vulgaris

309

1.49

1.85

1.5

1.4

309.51

410.13

pmol/l

0.92

273

Acute laryngitis and tracheitis

467

1.39

1.85

1.3

1.5

317.95

364.63

pmol/l

0.70

415

Wide developmental disorders

115

1.83

1.82

1.9

1.4

423.10

325.98

pmol/l

0.42

Carcinoma in situ of skin

335

1.47

1.82

1.4

1.3

223.21

279.96

pmol/l

1.18

279

Other disorders of iris and ciliary body

1.97

1.80

1.8

1.4

344.22

341.16

pmol/l

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

377

1.44

1.80

1.2

1.4

311.44

308.52

pmol/l

0.03

324

Sulfasalazine

175

1440

1.22

1.79

1.4

1.3

856.58

405.44

pmol/l

0.39

163

1249

326

0.55

1.79

1.2

1.3

299.54

287.71

pmol/l

0.04

281

Hallux rigidus

676

1.32

1.78

1.2

1.3

283.02

310.80

pmol/l

0.52

576

Propionic acid derivatives

172

704

1.23

1.77

1.4

327.15

372.67

pmol/l

0.40

145

613

Other viral hepatitis

232

1.56

1.76

1.3

1.5

280.26

396.94

pmol/l

1.43

204

Simple and mucopurulent chronic bronchitis

124

1.78

1.76

1.4

382.74

369.68

pmol/l

0.03

112

Herpesviral [herpes simplex] infections

152

1236

1.23

1.76

1.3

1.4

296.52

399.28

pmol/l

1.98

128

1072

Fracture of skull and facial bones

130

1039

1.25

1.76

1.3

1.4

1064.31

338.83

pmol/l

0.49

118

899

Use of rivastigmine

532

0.65

1.75

1.1

1.3

222.26

257.48

pmol/l

0.69

444

Alzheimer’s disease (Early onset)

136

0.37

1.75

1.0

1.3

170.00

287.03

pmol/l

—

117

Cramp and spasm

162

1.68

1.75

1.4

334.62

371.77

pmol/l

0.19

141

Cardiomyopathy (excluding other)

489

1.37

1.74

1.1

1.4

313.43

510.66

pmol/l

0.44

406

Pregnancy with abortive outcome

429

1972

1.14

1.74

1.3

1.4

446.62

394.43

pmol/l

0.24

372

1768

Mucosal proctocolitis

558

1.35

1.73

1.5

1.4

369.52

309.23

pmol/l

0.44

484

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

3.93

1.72

1.2

1.1

350.00

343.69

pmol/l

—

Rheumatic fever with heart involvement

3.92

1.72

1.4

1.0

486.80

269.62

pmol/l

—

Injury of muscle and tendon at shoulder and upper arm level

219

1849

1.19

1.72

1.3

290.19

360.81

pmol/l

0.60

195

1563

Injuries involving multiple body regions

125

1.77

1.72

1.3

1.4

166.88

404.71

pmol/l

3.30

108

Hypersomnia

2.32

1.71

1.9

1.6

297.09

405.69

pmol/l

0.65

Acute epiglottitis

2.32

1.71

1.4

341.09

410.74

pmol/l

0.25

Seropositive rheumatoid arthritis, wide

164

1349

1.22

1.71

1.3

316.90

320.27

pmol/l

0.04

145

1162

Other maltreatment syndromes

118

1.79

1.71

1.1

1.5

333.40

409.83

pmol/l

0.36

100

Exposure to other and unspecified inanimate mechanical forces

283

1.49

1.69

1.4

1.5

247.86

344.33

pmol/l

1.59

247

Ethmoidectomy

587

1.33

1.68

1.3

1.4

1641.59

318.16

pmol/l

0.48

499

Mixed specific developmental disorders

2.07

1.67

1.8

1.5

222.57

507.43

pmol/l

1.02

Fitting and adjustment of other devices

208

1581

1.19

1.67

1.2

1.3

313.99

299.88

pmol/l

0.18

175

1332

Psoriasis vulgaris

111

877

1.27

1.67

1.4

280.04

339.29

pmol/l

0.78

748

Female infertility, cervical, vaginal, other or unspecified origin

159

845

1.23

1.67

1.4

1103.30

345.23

pmol/l

0.60

137

767

Atrophic disorders of skin

693

1.30

1.66

1.3

333.54

352.59

pmol/l

0.15

607

Autoimmune hepatitis

2.84

1.66

1.4

1.1

301.00

263.08

pmol/l

—

Seborrhoeic keratosis

135

1093

1.24

1.65

1.7

1.3

327.18

315.62

pmol/l

0.13

121

938

Acquired absence of organs, not elsewhere classified

2.28

1.65

1.5

1.1

438.45

304.73

pmol/l

0.72

Demyelinating diseases of the central nervous system

351

1.43

1.64

1.4

283.59

353.91

pmol/l

0.72

313

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

299

1757

1.16

1.64

1.3

272.73

342.34

pmol/l

0.62

275

1507

Plantar fascial fibromatosis

427

1.39

1.64

1.3

1.4

257.06

316.08

pmol/l

0.60

387

Other or unspecified common variable immunodeficiency

3.68

1.63

1.2

1.1

264.00

337.93

pmol/l

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

739

1.29

1.62

1.5

1.4

319.32

432.87

pmol/l

1.51

650

Renal agenesis and other reduction defects of kidney

3.63

1.62

1.6

1.1

421.40

878.43

pmol/l

—

Nosocomial condition (hospital)

3.63

1.62

1.0

272.60

204.00

pmol/l

—

Scoliosis

327

1.44

1.62

1.3

392.40

346.80

pmol/l

0.29

284

Other hammer toe(s) (acquired)

107

779

1.27

1.62

1.2

1.3

275.31

291.86

pmol/l

0.30

664

FESS (DNB20)

557

1.33

1.61

1.3

1.4

1731.84

320.95

pmol/l

0.49

470

Lyme disease

133

1632

0.81

1.61

1.3

306.60

385.14

pmol/l

0.54

121

1405

Unspecified chronic bronchitis

113

1.78

1.60

1.5

1.3

266.00

279.42

pmol/l

0.11

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

159

1314

1.21

1.60

1.3

314.21

322.35

pmol/l

0.10

143

1133

Epiphora

1.97

1.60

1.2

1.3

345.40

307.29

pmol/l

0.16

Autism spe, excluding more controls

2.01

1.59

1.9

1.4

510.64

347.41

pmol/l

0.50

IBD patients in KELA-register

136

1108

1.23

1.58

1.4

338.96

508.16

pmol/l

0.69

121

967

Polycystic ovarian syndrome, broad definition

396

1.39

1.58

1.6

1.4

844.69

507.26

pmol/l

0.49

353

Benign neoplasm: Skin of other and unspecified parts of face

456

1.36

1.57

1.2

1.4

295.56

303.25

pmol/l

0.08

387

Other spirochaetal diseases

135

1647

0.82

1.55

1.3

304.06

383.97

pmol/l

0.56

123

1416

Nummular dermatitis

322

1.43

1.55

1.4

275.84

306.46

pmol/l

0.30

278

Benign leiomyoma with endometriosis

101

798

1.27

1.55

1.2

1.3

340.98

336.78

pmol/l

0.03

697

Labour and delivery complicated by fetal stress [distress]

733

0.78

1.54

1.5

405.04

482.93

pmol/l

0.71

665

Congenital malformations of cardiac septa

248

1.49

1.54

1.4

1.5

310.35

406.34

pmol/l

0.80

215

Focal brain injury

184

1.58

1.54

1.0

1.3

275.74

277.27

pmol/l

0.01

160

Injury of blood vessels at abdomen, lower back and pelvis level

3.41

1.53

1.4

1.0

321.20

325.80

pmol/l

—

Other/unspecified seropositive rheumatoid arthritis

160

1330

1.21

1.53

1.3

314.21

321.47

pmol/l

0.09

143

1147

Disorders of purine and pyrimidine metabolism

3.39

1.53

1.2

1.1

350.00

312.47

pmol/l

—

Other spirochaetal diseases

138

1676

0.82

1.52

1.3

300.20

381.40

pmol/l

0.59

126

1442

Nontoxic single thyroid nodule

307

1.44

1.52

1.4

1.3

267.11

291.36

pmol/l

0.20

266

Benign lipomatous neoplasm of other sites/unspecified

358

1.40

1.50

1.3

1.4

317.89

307.99

pmol/l

0.09

301

Deviated nasal septum

199

1689

1.18

1.50

1.5

1.4

304.21

310.99

pmol/l

0.09

180

1437

Other overlap syndromes

2.09

1.50

1.2

1.4

346.00

397.74

pmol/l

0.15

Spirochaetal infections, other/unspecified

136

1649

0.82

1.48

1.3

302.61

383.61

pmol/l

0.57

124

1419

Lesion of lateral popliteal nerve

171

1.59

1.46

1.1

1.5

297.52

351.70

pmol/l

0.36

153

Benign neoplasm: Sigmoid colon

112

903

1.24

1.46

1.3

323.60

319.47

pmol/l

0.03

101

759

Benign mammary dysplasia

663

1.29

1.46

1.4

1.2

266.46

305.15

pmol/l

0.69

575

Superficial injury of forearm

394

1.38

1.46

1.5

1.4

403.58

352.81

pmol/l

0.35

348

Other respiratory diseases principally affecting the interstitium

752

1.27

1.45

1.2

1.3

299.33

288.98

pmol/l

0.11

629

Scabies

611

1.30

1.45

1.3

1.4

389.82

360.29

pmol/l

0.28

545

Primary ovarian failure

2.05

1.44

1.2

1.3

485.75

401.29

pmol/l

0.14

Excessive attrition of teeth

357

3174

1.13

1.44

1.4

307.45

417.06

pmol/l

1.56

320

2767

Superficial injury of thorax

647

1.29

1.43

1.3

1.4

231.96

309.29

pmol/l

3.11

554

Viral haemorrhagic fevers, not elsewhere classified/unspecified

735

1.27

1.43

1.2

1.3

426.92

313.26

pmol/l

0.47

632

Benign neoplasm: Skin of eyelid, including canthus

718

1.27

1.43

1.3

292.09

335.85

pmol/l

0.49

615

Agranulocytosis

490

1.33

1.43

1.3

539.36

372.52

pmol/l

0.37

427

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

253

1.47

1.43

1.4

288.71

317.40

pmol/l

0.21

221

Other osteochondropathies

270

1.45

1.41

1.4

347.97

345.72

pmol/l

0.01

239

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

270

1.45

1.41

1.2

1.5

330.45

371.83

pmol/l

0.43

235

Macular cyst

103

1.76

1.41

1.2

1.3

241.00

291.71

pmol/l

0.45

Reactive arthropathies

371

1.38

1.41

1.1

1.4

337.86

324.11

pmol/l

0.11

320

Pollen allergy

103

816

1.25

1.40

1.4

1.5

375.69

553.33

pmol/l

0.67

727

Acute and transient psychotic disorders

509

1.32

1.40

1.3

1.4

401.05

375.73

pmol/l

0.09

448

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

649

3805

1.09

1.40

1.3

1.4

360.92

367.69

pmol/l

0.05

561

3310

Other specified/unspecified hearing loss

338

1.40

1.39

1.3

374.12

327.42

pmol/l

0.24

290

Use of interferon beta-1a

1.91

1.39

1.2

1.4

231.83

456.42

pmol/l

2.42

Exposure to other and unspecified man-made environmental factors

2.09

1.39

1.3

1.4

309.91

421.06

pmol/l

0.36

Endometriosis diagnosis and infertility diagnosis occurring together

458

1.34

1.39

1.5

1.4

639.70

407.23

pmol/l

0.34

410

Degenerative macular diseases

484

1.33

1.39

1.2

1.3

261.96

302.47

pmol/l

0.62

410

Defects in the complement system

2.65

1.37

1.0

1.5

668.17

443.96

pmol/l

—

Purpura and other haemorrhagic conditions

581

1.29

1.37

1.3

445.28

307.82

pmol/l

0.42

497

Varicose veins

397

2686

1.12

1.36

1.2

1.3

287.47

334.51

pmol/l

0.59

336

2331

Drug-induced tremor

2.98

1.36

1.4

1.1

372.40

257.82

pmol/l

—

Excessive earwax

337

2924

1.13

1.36

1.3

314.84

342.49

pmol/l

0.28

295

2503

Septal defects

234

1.47

1.36

1.4

1.5

318.83

410.16

pmol/l

0.68

204

Pediculosis, acariasis and other infestations

732

1.26

1.36

1.3

1.4

383.79

354.90

pmol/l

0.33

646

Early lumbar disc prolapse operation

460

1.33

1.35

1.3

1.4

349.68

354.76

pmol/l

0.03

406

Conductive hearing loss, unspecified

340

1.39

1.35

1.3

1.4

289.17

309.76

pmol/l

0.17

294

Alcoholic liver disease

417

1.35

1.2

1.4

467.74

313.40

pmol/l

1.15

362

Bitten or struck by other mammals

469

1.33

1.35

1.3

1.4

356.70

364.20

pmol/l

0.05

410

Graves disease, strict definition

426

1.34

1.5

1.4

272.13

322.87

pmol/l

1.14

376

Presence of other devices

124

1017

1.22

1.34

1.3

390.51

308.56

pmol/l

0.91

107

858

Congenital malformations of uterus and cervix

1.98

1.33

1.1

1.4

211.75

501.28

pmol/l

3.55

Phlebitis and thrombophlebitis (not including DVT)

136

1132

1.20

1.33

1.2

1.3

307.26

422.11

pmol/l

0.63

116

966

Other Crohn's disease

274

1.43

1.33

1.2

1.4

298.61

329.94

pmol/l

0.30

238

Postpartum haemorrhage due to retained placenta

500

0.70

1.33

1.3

1.4

272.83

658.57

pmol/l

1.18

443

Endometriosis ASRM stages 1,2

106

861

1.23

1.32

1.4

518.17

526.81

pmol/l

0.01

760

Maternal care for known or suspected abnormality of pelvic organs

148

842

1.20

1.32

1.5

1.4

1217.46

414.18

pmol/l

0.64

135

760

Other specified/unspecified bacterial intestinal infections

258

1.44

1.31

1.3

1.4

393.88

337.27

pmol/l

0.33

219

Allergic rhinitis

179

1512

1.17

1.30

1.4

355.86

467.06

pmol/l

0.78

154

1322

Autism spe

1.85

1.30

1.9

1.4

510.64

291.82

pmol/l

0.76

Benign neoplasm: Other parts of oropharynx

2.39

1.30

1.0

1.2

216.00

369.59

pmol/l

—

Metatarsalgia

403

1.34

1.30

1.2

1.3

2273.33

328.71

pmol/l

0.50

360

Viral warts

403

1.34

1.30

1.4

372.52

338.08

pmol/l

0.34

348

Lesion of plantar nerve

259

1.44

1.29

1.5

1.3

320.61

326.11

pmol/l

0.04

228

Contact with blunt object, undetermined intent

2.81

1.29

1.4

1.3

441.80

417.56

pmol/l

—

Other (seronegative) rheumatoid arthritis, wide

110

900

1.23

1.29

1.4

1.3

356.52

326.60

pmol/l

0.26

780

Other menopausal disorders

167

795

1.19

1.29

1.3

330.69

296.95

pmol/l

0.51

152

712

Etanercept

268

1.42

1.28

1.2

1.5

354.55

345.83

pmol/l

0.03

237

Other and unspecified psoriasis

268

1.42

1.28

1.4

224.84

323.01

pmol/l

1.82

236

Pedal cyclist injured in transport accident

131

1092

1.20

1.27

1.3

1.4

300.04

432.52

pmol/l

0.74

117

946

Outcome of delivery

507

0.77

1.27

1.2

1.4

460.46

384.12

pmol/l

0.59

458

Family history of malignant neoplasm

483

1.31

1.27

1.2

1.4

287.61

375.01

pmol/l

0.82

426

Benign neoplasm: Rectosigmoid junction

138

1.60

1.26

1.2

1.4

211.21

332.09

pmol/l

1.66

124

Benign neoplasm: Vulva

1.83

1.26

1.9

1.4

368.37

365.81

pmol/l

0.01

Traction detachment of retina

2.43

1.25

1.2

1.1

198.17

321.20

pmol/l

—

Other retinal artery occlusion

1.87

1.24

1.2

287.23

263.49

pmol/l

0.16

Unspecified privation

459

1.31

1.23

1.3

1.4

314.76

306.72

pmol/l

0.06

396

Male infertility

171

1.53

1.23

1.6

1.4

270.14

340.34

pmol/l

0.56

151

Ulcer of oesophagus

245

1.43

1.23

1.1

1.4

230.96

299.37

pmol/l

0.69

213

Allergic contact dermatitis

609

1.27

1.23

1.2

1.4

327.87

381.45

pmol/l

0.47

540

Puerperal sepsis

636

1.26

1.23

1.2

1.3

325.82

353.27

pmol/l

0.21

562

Malignant neoplasm of oropharynx

1.98

1.22

1.3

1.5

249.00

365.96

pmol/l

1.01

Alcohol abuse, main dg, excluding more controls

636

1.26

1.22

1.2

1.4

301.68

465.04

pmol/l

0.51

554

Lichen sclerosus et atrophicus

486

1.30

1.22

1.4

1.3

319.60

357.43

pmol/l

0.24

428

Open wound of ankle and foot

434

1.32

1.21

1.2

1.4

248.30

323.54

pmol/l

1.28

372

6-mercaptopurine

116

1.65

1.21

1.8

1.5

346.47

489.05

pmol/l

0.65

Inflammatory bowel disease, strict (require KELA)

136

1144

1.19

1.21

1.4

338.96

512.78

pmol/l

0.75

121

996

Drug-induced neutropenia

297

1.39

1.20

1.4

738.53

328.45

pmol/l

0.68

256

Anti-inflammatory and antirheumatic products, non-steroids

165

704

1.18

1.20

1.4

310.82

372.67

pmol/l

0.67

139

613

Schizophrenia or delusion

189

1635

1.16

1.20

1.3

1.4

393.51

469.42

pmol/l

0.34

152

1420

Endometriosis of ovary

736

1.24

1.19

1.3

474.72

319.22

pmol/l

0.39

658

Postpartum haemorrhage

100

1025

0.82

1.19

1.5

333.62

457.97

pmol/l

1.94

925

Schizophrenia, schizotypal and delusional disorders

190

1646

1.16

1.18

1.3

1.4

392.55

468.11

pmol/l

0.34

153

1431

Chronic diseases of tonsils and adenoids

529

3063

1.09

1.18

1.4

518.64

335.05

pmol/l

0.48

462

2684

Conduct disorder

1.89

1.18

1.1

1.4

445.00

397.23

pmol/l

0.15

Follow-up examination after treatment for malignant neoplasms

384

1.33

1.18

1.2

311.35

251.17

pmol/l

0.75

326

Left bundle-branch block

265

1.40

1.16

1.4

1.3

247.39

278.82

pmol/l

0.33

229

Other enthesopathy of foot (+metatarsalgia)

447

1.30

1.15

1.2

1.4

2111.53

325.31

pmol/l

0.50

398

Other keratitis

491

1.29

1.15

1.3

1.4

358.67

322.35

pmol/l

0.38

427

Eustachian salpingitis and obstruction

300

1.37

1.14

1.2

1.5

306.64

376.05

pmol/l

0.76

267

Acute alcohol intoxication

141

1198

1.18

1.14

1.3

1.4

305.72

406.01

pmol/l

0.56

114

1030

Abrasion of teeth

209

1830

1.14

1.4

1.3

310.03

403.29

pmol/l

0.85

188

1586

Macular pucker

715

1.23

1.13

1.2

1.3

287.65

331.73

pmol/l

0.38

604

Subarachnoid haemorrhage

413

1.31

1.13

1.4

1.3

265.70

292.55

pmol/l

0.35

359

Carcinoma in situ of skin of trunk

103

1.66

1.13

1.3

223.88

239.71

pmol/l

0.15

Reactive arthropathies, FINNGEN

267

1.39

1.12

1.2

1.4

350.19

346.72

pmol/l

0.02

233

Benign neoplasm of thyroid gland

127

1.58

1.12

1.3

1.4

286.15

329.70

pmol/l

0.33

115

Fracture at wrist and hand level

206

1801

1.14

1.11

1.4

294.00

456.69

pmol/l

1.28

180

1560

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

105

871

1.21

1.11

1.5

1.3

298.98

290.45

pmol/l

0.09

735

Maternal care for other conditions predominantly related to pregnancy

111

908

1.20

1.10

1.4

1.5

375.65

451.04

pmol/l

0.78

819

Coxarthrosis, primary

361

2767

1.11

1.10

1.2

1.3

274.00

328.66

pmol/l

0.75

321

2366

Childhood asthma (age<16), excluding more controls

374

1.29

1.09

1.5

480.43

386.00

pmol/l

0.43

340

Other disorders of the genitourinary system

602

1.25

1.09

1.4

1.3

286.36

337.49

pmol/l

0.45

514

Benign neoplasm of mouth and pharynx

469

1.28

1.08

1.2

1.3

271.48

301.04

pmol/l

0.47

405

Spontaneous abortion

284

1711

1.12

1.08

1.3

1.4

373.69

411.86

pmol/l

0.18

254

1545

Behavioural disorders, excluding more controls

1.87

1.07

1.1

1.3

421.45

377.06

pmol/l

0.13

Suppurative and necrotic conditions of lower respiratory tract

186

1.46

1.06

1.6

1.5

267.43

324.97

pmol/l

0.46

162

Vasomotor rhinitis (mode)

296

1.36

1.06

1.2

1.4

297.79

330.12

pmol/l

0.28

256

Autism

1.72

1.05

1.9

1.4

510.64

312.27

pmol/l

0.67

Parkinson's disease, including avohilmo

668

1.23

1.05

1.1

1.3

243.81

279.17

pmol/l

0.76

559

Viral warts

120

1015

1.18

1.04

1.3

1.4

329.02

355.66

pmol/l

0.29

107

888

Ectopic pregnancy

103

860

1.20

1.04

1.5

1.4

820.59

478.05

pmol/l

0.50

771

Other strabismus

123

1040

1.18

1.03

1.2

1.4

369.04

389.85

pmol/l

0.11

109

911

Congenital malformations of genital organs

383

1.30

1.01

1.4

274.31

362.06

pmol/l

2.23

346

Malignant neoplasm of oesophagus, including Hilmo

108

0.46

1.01

1.2

1.4

291.00

317.10

pmol/l

—

severe traumatic brain injury, does not include concussion

116

982

1.18

1.01

1.2

1.3

259.71

399.83

pmol/l

0.72

821

Malignant neoplasm of bladder, including Hilmo

427

1.28

1.01

1.1

1.3

257.81

279.11

pmol/l

0.28

349

Congenital malformations of breast

1.89

1.00

1.4

1.5

275.57

453.83

pmol/l

—

Other pulmonary heart/vessel disease

147

1.50

1.00

1.0

1.3

197.76

282.64

pmol/l

1.33

126

Other appendicitis

334

1.32

1.00

1.2

1.4

188.95

315.12

pmol/l

4.33

289

Diabetic retinopathy

269

1502

1.12

1.00

1.3

273.03

301.56

pmol/l

0.63

220

1294

Suggestive for eosinophilic asthma

378

1.30

0.99

1.4

2338.41

273.13

pmol/l

0.49

327

Childhood asthma (age<16)

380

1.27

0.99

1.5

480.43

383.85

pmol/l

0.44

346

Orchitis and epididymitis

343

1.32

0.99

1.9

1.4

322.07

292.80

pmol/l

0.29

289

Corneal ulcer

105

883

1.19

0.99

1.5

1.3

289.19

341.84

pmol/l

0.73

770

Single spontaneous delivery

208

1247

0.88

0.99

1.3

344.22

364.06

pmol/l

0.24

185

1093

Neuroendocrine tumor and carcinoma of small intestine

1.85

0.99

1.4

1.5

311.56

286.22

pmol/l

—

Malignant neoplasm of tonsil

1.85

0.99

1.2

1.4

263.33

374.47

pmol/l

—

Benign neoplasm of eye and adnexa

432

1.28

0.98

1.7

1.3

273.76

307.67

pmol/l

0.55

374

Sudden idiopathic hearing loss

432

1.28

0.98

1.4

1.3

249.11

287.40

pmol/l

0.70

368

Recurrent aphthous stomatitis , including avohilmo

638

1.23

0.98

1.5

1.4

329.49

354.64

pmol/l

0.17

546

Arthropod-borne viral fevers and viral haemorrhagic fevers

100

839

1.19

0.97

1.2

1.4

417.93

350.21

pmol/l

0.25

715

Congenital malformations of breast

1.81

0.97

1.4

1.5

275.57

462.44

pmol/l

—

Malignant neoplasm of colon, including Hilmo

830

1.19

0.96

1.1

1.3

365.93

291.11

pmol/l

0.28

693

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

658

1.22

0.96

1.1

1.3

426.92

457.37

pmol/l

0.07

553

LSIL lesion of the cervix uteri, vagina or vulva

640

1.22

0.96

1.6

1.4

393.26

614.01

pmol/l

0.70

572

Deep endometriosis

416

1.28

0.95

1.4

1.3

344.67

331.06

pmol/l

0.13

362

Childhood allergy (age < 16)

430

1.25

0.95

1.6

1.5

491.91

672.59

pmol/l

0.32

383

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

750

1.20

0.95

1.4

339.71

329.52

pmol/l

0.10

652

Hallux valgus (acquired)

203

1292

1.13

0.95

1.3

428.12

324.69

pmol/l

0.37

181

1127

Hidradenitis suppurativa

117

1.54

0.94

1.3

1.4

266.61

412.60

pmol/l

1.73

100

Chalazion

462

1.26

0.93

1.6

1.4

317.28

309.51

pmol/l

0.06

405

Other peripheral vascular diseases

312

1.32

0.93

1.2

1.4

244.00

348.08

pmol/l

1.88

274

Malignant neoplasm of oropharynx, including Hilmo

1.73

0.93

1.3

1.4

231.75

342.87

pmol/l

1.06

Complications of labour and delivery

344

2096

0.91

0.92

1.3

1.4

638.22

370.02

pmol/l

0.43

298

1880

Postpartum hemorraghe, all women as controls

100

1162

0.85

0.92

1.5

333.62

538.26

pmol/l

1.47

1039

Presbyopia

278

1.34

0.92

1.4

1.5

288.50

340.14

pmol/l

0.74

250

Carcinoma in situ of skin of ear and external auricular canal

2.16

0.91

1.0

1.2

285.17

235.13

pmol/l

—

Pneumonia due to Streptococcus pneumoniae

134

1.50

0.91

1.4

789.54

353.90

pmol/l

0.93

122

Strabismus

149

1297

1.15

0.91

1.2

1.4

366.44

373.24

pmol/l

0.04

131

1119

L02BB Anti-androgens

305

1.31

0.90

3.4

1.3

224.57

252.50

pmol/l

0.36

243

Ankylosing hyperostosis [Forestier]

1.92

0.89

1.1

1.2

191.50

394.25

pmol/l

—

Valvular operations

556

1.23

0.88

1.2

1.4

317.88

279.28

pmol/l

0.37

463

Infliximab

1.80

0.88

1.0

1.2

398.00

312.72

pmol/l

—

Migraine without aura, drug-induced

1.88

0.87

1.3

776.13

458.16

pmol/l

—

Nasal polyp

107

914

1.17

0.87

1.3

1210.09

327.41

pmol/l

0.47

778

Other and unspecified nonorganic psychotic disorders

105

896

1.17

0.87

1.3

1.4

467.91

437.42

pmol/l

0.08

796

Acute appendicitis, with complications

109

934

1.17

0.86

1.3

1.4

280.49

422.25

pmol/l

0.70

797

Entropion and trichiasis of eyelid

299

1.31

0.85

1.1

1.3

247.38

276.88

pmol/l

0.41

255

Contact with machinery

459

1.24

0.85

1.2

1.4

287.05

319.29

pmol/l

0.37

388

Maternal care related to the fetus and amniotic cavity and possible delivery problems

220

1438

0.90

0.85

1.3

1.4

390.34

389.43

pmol/l

0.01

195

1297

Endovascular or surgical operations to intracerebral aneurysms

239

1.34

0.84

1.1

1.4

234.14

326.50

pmol/l

1.73

212

Malignant neoplasm of prostate, including Hilmo

151

786

1.14

0.83

1.8

1.3

250.65

413.67

pmol/l

0.65

123

647

Non-allergic asthma

353

1.28

0.83

1.2

1.4

365.47

336.35

pmol/l

0.18

305

Deep bite

403

1.24

0.83

1.4

365.00

359.87

pmol/l

0.03

356

Convalescence

214

1.36

0.82

1.6

1.4

404.47

359.96

pmol/l

0.31

184

Effects of foreign body entering through natural orifice

135

1181

1.14

0.82

1.3

1.4

265.18

416.79

pmol/l

1.01

120

1013

Lung cancer and mesothelioma

700

1.18

0.81

1.3

281.70

296.26

pmol/l

0.12

586

Spirochaetal infections, other/unspecified

373

1.26

0.81

1.4

1.3

249.45

309.84

pmol/l

1.14

319

Melanocytic naevi of lower limb, including hip

172

1.40

0.81

1.5

1.4

468.84

350.69

pmol/l

0.55

151

Other malignant neoplasms of skin (=non-melanoma skin cancer)

265

1651

1.10

0.81

1.3

264.62

344.91

pmol/l

0.69

242

1408

Other epidermal thickening

147

1.43

0.80

1.1

1.4

328.56

340.19

pmol/l

0.04

128

Caries in Clefts patients

1.83

0.79

1.0

1.4

217.83

407.64

pmol/l

—

Rubella [German measles]

148

0.61

0.79

1.4

374.56

306.66

pmol/l

—

127

Other/unspecified reactive arthropathies

251

1.32

0.78

1.2

1.5

369.22

341.31

pmol/l

0.17

221

Other mental disorders due to brain damage and dysfunction and to physical disease

483

1.22

0.78

1.3

1.4

285.69

290.36

pmol/l

0.04

408

Injury of muscle and tendon at hip and thigh level

429

1.24

0.78

1.4

309.49

314.63

pmol/l

0.03

375

Other disorders of skin and subcutaneous tissue, not elsewhere classified

620

1.20

0.78

1.3

311.29

334.87

pmol/l

0.14

538

False labour

167

925

1.13

0.77

1.5

497.40

436.11

pmol/l

0.22

148

833

Postpartum hemorraghe, parous women as controls

100

987

0.86

0.77

1.5

1.4

333.62

526.61

pmol/l

1.12

886

Other embolism and thrombosis

603

1.20

0.76

1.3

345.44

303.48

pmol/l

0.52

515

Benign neoplasm: Choroid

261

1.31

0.76

1.6

1.4

261.43

323.97

pmol/l

1.00

226

Pleural plaque with presence of asbestos

244

1.32

0.75

1.1

1.4

268.96

246.70

pmol/l

0.16

191

Foreign body or object entering through skin

227

1.33

0.74

1.4

1.5

262.84

356.59

pmol/l

1.03

199

Mandibular hypoplasia

2.02

0.73

1.6

1.0

219.00

309.60

pmol/l

—

Use of biperiden

207

0.67

0.72

1.1

1.4

262.38

347.27

pmol/l

—

180

Diseases of tongue

255

1.30

0.71

1.3

349.81

300.28

pmol/l

0.25

219

Paralytic strabismus

264

1.29

0.71

1.4

1.3

332.79

312.30

pmol/l

0.12

226

Enterobiasis

1.59

0.71

1.2

1.4

470.22

410.24

pmol/l

—

Malignant neoplasm of stomach, including Hilmo

194

1.34

0.71

1.1

1.4

354.10

329.54

pmol/l

0.11

166

Contraceptive management

217

1673

0.91

0.71

1.4

342.54

400.61

pmol/l

0.42

184

1493

Superficial injury of hip and thigh

618

1.18

0.70

1.2

1.3

290.14

309.76

pmol/l

0.30

526

Malignant neoplasm of tonsil, including Hilmo

1.56

0.70

1.2

1.4

263.33

373.58

pmol/l

—

Other specified/unspecified deforming dorsopathies

1.56

0.70

1.6

1.3

386.22

448.80

pmol/l

—

Delivery

215

1249

0.91

0.70

1.3

349.46

365.08

pmol/l

0.18

191

1095

Myocardial infarction, with ST-elevation

702

1.17

0.69

1.2

1.3

189.66

289.50

pmol/l

4.33

583

Wet age-related macular degeneration

663

1.17

0.69

1.2

1.3

328.21

264.87

pmol/l

0.75

551

Medicines for HER+ breast cancer

186

1947

0.90

0.69

1.3

351.95

320.62

pmol/l

0.19

164

1722

Other specified and unspecified disorders of eye and adnexa

135

1.41

0.69

1.8

1.3

435.24

358.92

pmol/l

0.25

120

Tongue abnormality

248

1.29

0.69

1.3

1.4

357.28

328.84

pmol/l

0.12

213

Hereditary motor and sensory neuropathy

1.86

0.68

1.2

137.20

371.26

pmol/l

—

malignant neoplasm of female genital organs

699

1.17

0.68

1.1

1.3

298.32

294.88

pmol/l

0.03

611

Behavioural disorders

1.60

0.68

1.1

1.5

421.45

390.44

pmol/l

0.09

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

102

1.47

0.66

1.3

248.53

493.44

pmol/l

1.35

Other infective otitis externa

223

1.30

0.66

1.6

1.4

332.24

337.14

pmol/l

0.02

194

Other specified disorders of external ear

128

1.41

0.65

1.2

1.3

270.61

335.76

pmol/l

0.48

112

Acute alcohol intoxication, ICD10

109

959

1.14

0.65

1.2

1.4

318.95

446.88

pmol/l

0.57

822

1.62

0.65

1.5

1.3

341.60

406.73

pmol/l

—

Small cell lung cancer, helper endpoint

1.62

0.65

1.0

1.4

102.80

260.67

pmol/l

—

Raynaud syndrome

358

1.23

0.65

1.2

1.4

257.50

344.30

pmol/l

1.57

315

Embedded and impacted teeth

104

975

0.88

0.63

1.3

1.5

386.86

508.83

pmol/l

0.54

867

Fracture of forearm

340

2904

1.07

0.63

1.4

1.3

392.99

392.56

pmol/l

0.00

293

2545

Hepatocellular carcinoma, including Hilmo

1.50

0.63

1.0

1.3

471.38

270.66

pmol/l

0.45

Dysplasia of cervi uteri

123

790

1.13

0.63

1.6

1.4

740.06

346.86

pmol/l

1.01

107

712

Basal cell carcinoma

249

1586

1.09

0.63

1.3

252.33

349.02

pmol/l

0.86

231

1349

Primary open-angle glaucoma, strict

135

1205

1.12

0.63

1.3

277.28

297.90

pmol/l

0.27

116

1021

Alzheimer’s disease (Late onset), excluding more controls

359

0.82

0.62

1.1

1.4

229.65

267.20

pmol/l

0.71

309

Maternal care for other known or suspected fetal problems

124

697

1.13

0.62

1.4

1.5

1241.60

439.40

pmol/l

0.48

107

630

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

851

1.14

0.62

1.4

332.01

351.45

pmol/l

0.17

741

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

683

1.16

0.62

1.3

323.46

295.33

pmol/l

0.33

572

Complications of the puerperium, not elsewhere classified

147

1.36

0.61

1.3

1.4

319.25

394.47

pmol/l

0.54

130

Disorders of tooth development and eruption

620

1.15

0.61

1.3

1.4

276.87

504.34

pmol/l

0.78

539

Other interstitial pulmonary diseases

637

1.16

0.61

1.2

1.3

309.73

284.47

pmol/l

0.25

528

ILD, hospital admissions

628

1.16

0.61

1.2

1.3

305.89

282.63

pmol/l

0.23

521

Other disorders of amniotic fluid and membranes

595

1.17

0.61

1.5

397.36

440.02

pmol/l

0.29

536

Osteonecrosis due to drugs

1.58

0.60

1.1

1.5

550.25

260.98

pmol/l

—

Infections with a predominantly sexual mode of transmission

165

1495

1.10

0.60

1.4

447.48

455.33

pmol/l

0.02

140

1317

Diabetic neuropathy

672

1.16

0.60

1.2

1.3

255.02

294.45

pmol/l

0.59

550

Malignant cancer of tonsil and base of tongue, including Hilmo

1.51

0.60

1.2

1.5

225.75

388.06

pmol/l

1.42

Ulcerative colitis (strict definition, require KELA)

788

1.14

0.60

1.4

339.71

324.88

pmol/l

0.16

684

Placenta praevia

186

0.70

0.59

1.2

1.4

380.08

462.08

pmol/l

0.23

167

Inguinal hernia

346

2163

1.07

0.59

1.3

1.4

562.37

313.29

pmol/l

0.41

298

1854

Failure and rejection of transplanted organs and tissues

1.52

0.58

1.0

1.4

380.75

419.82

pmol/l

—

Interstitial lung disease endpoints

640

1.16

0.58

1.2

1.3

309.73

283.61

pmol/l

0.26

531

Interstitial lung disease

640

1.16

0.58

1.2

1.3

309.73

283.61

pmol/l

0.26

531

Other mosquito-borne viral fevers

0.00

0.58

0.0

1.3

—

387.30

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

264

1.25

0.58

1.3

1.5

397.20

354.83

pmol/l

0.18

230

Secondary uncertain malignant neoplasm

549

1.17

0.56

1.3

331.25

296.80

pmol/l

0.31

457

Alzheimer’s disease (Early onset), excluding more controls

0.57

0.56

1.0

1.3

170.00

267.71

pmol/l

—

LSIL lesion of the cervix uteri

476

1.18

0.55

1.4

390.27

701.04

pmol/l

0.76

430

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

253

1.25

0.55

1.6

1.5

3633.37

419.89

pmol/l

0.47

224

Inflammatory diseases of prostate (prostatitis)

486

1.17

0.55

1.3

1.4

331.78

507.04

pmol/l

0.37

405

Primary open-angle glaucoma

163

1438

1.10

0.54

1.3

277.48

299.40

pmol/l

0.33

143

1211

Other diseases caused by chlamydiae

1.51

0.54

2.1

1.4

334.33

446.31

pmol/l

—

Vascular dementia (mixed)

1.58

0.54

1.0

1.3

391.67

235.86

pmol/l

—

Basal cell carcinoma, including avohilmo

260

1667

1.08

0.53

1.3

263.04

344.50

pmol/l

0.72

240

1422

Stenosis and insufficiency of lacrimal passages

377

1.20

0.53

1.3

287.73

317.75

pmol/l

0.38

325

Malignant cancer of tonsil and base of tongue

1.52

0.52

1.2

1.5

245.60

422.00

pmol/l

—

Retinal detachment with retinal break

582

1.15

0.52

1.6

1.3

260.96

299.03

pmol/l

0.59

489

Abnormal findings in secretions and smears from cervix uteri vagina vulva

295

2087

1.07

0.52

1.5

1.4

458.02

411.41

pmol/l

0.18

267

1863

Alcohol abuse, main dg

704

1.14

0.52

1.3

1.4

301.68

462.80

pmol/l

0.56

608

Certain zoonotic bacterial diseases

100

0.60

0.51

1.8

1.4

248.83

345.17

pmol/l

—

Bacterial pneumoniae

220

1799

1.08

0.51

1.3

313.11

370.52

pmol/l

0.44

191

1542

Calcific tendinitis of shoulder

242

1.24

0.51

1.1

1.3

202.42

314.11

pmol/l

3.22

222

Ulcerative rectosigmoiditis

324

1.21

0.50

1.4

373.39

308.47

pmol/l

0.49

281

Injury of eye and orbit

640

1.14

0.50

1.4

302.53

305.69

pmol/l

0.03

568

Other disorders of veins

240

2224

1.07

0.50

1.3

433.66

363.54

pmol/l

0.28

201

1943

Organic, including symptomatic, mental disorders

245

1869

0.93

0.50

1.2

1.3

289.57

294.75

pmol/l

0.08

202

1579

Small cell lung cancer, including Hilmo

1.50

0.49

1.0

1.4

102.80

279.09

pmol/l

—

Small cell lung cancer

1.50

0.49

1.0

1.4

102.80

279.09

pmol/l

—

Inflammatory disease of cervix uteri

261

1.23

0.49

1.2

1.3

260.30

301.21

pmol/l

0.43

228

Malignant neoplasm of breast, ER-negative, including Hilmo

121

1045

1.10

0.48

1.2

1.3

489.61

300.34

pmol/l

0.42

107

919

Benign neoplasm: Anus and anal canal

1.40

0.48

1.6

1.4

163.54

307.52

pmol/l

2.57

Malignant neoplasm of stomach

163

1.29

0.48

1.0

1.4

293.75

323.38

pmol/l

0.14

141

Endometriosis ASRM stages 3,4

126

1146

1.10

0.48

1.4

442.70

472.23

pmol/l

0.07

117

1008

Diabetic maculopathy

766

1.12

0.47

1.3

241.25

319.95

pmol/l

1.51

647

L02BG Aromatase inhibitors

152

1650

0.92

0.47

1.3

364.43

309.60

pmol/l

0.30

134

1460

Other diseases caused by chlamydiae

1.44

0.46

1.9

1.4

377.71

474.67

pmol/l

—

Foreign body entering into or through eye or natural orifice

310

1.20

0.45

1.4

1.5

430.37

327.28

pmol/l

0.32

269

Hydrocele

421

1.17

0.45

1.4

265.35

536.96

pmol/l

0.56

351

Non-small cell lung cancer, squamous, helper endpoint

141

0.71

0.44

1.0

1.3

324.00

254.92

pmol/l

—

119

Foreign body on external eye

676

1.13

0.44

1.4

228.13

467.36

pmol/l

0.95

581

Obstructed labour due to malposition and malpresentation of fetus

1011

0.90

0.44

1.3

1.5

406.50

456.45

pmol/l

0.30

912

Tuberculosis, IBD comorbidity

247

1.22

0.44

1.4

1.3

240.13

313.08

pmol/l

0.71

214

Parkinson's disease

648

1.13

0.44

1.1

1.3

246.62

278.50

pmol/l

0.59

541

Lichen planus

592

1.13

0.43

1.3

305.80

343.70

pmol/l

0.27

514

Anomalies of dental arch relationship, including avohilmo

101

824

1.11

0.43

1.4

363.99

489.73

pmol/l

0.44

730

Exposure to other specified electric current

1.41

0.43

1.2

1.4

270.36

405.29

pmol/l

1.32

Infections with a predominantly sexual mode of transmission

214

1865

1.07

0.43

1.3

1.4

421.63

493.77

pmol/l

0.27

185

1644

Seropositive rheumatoid arthritis, strict definition

716

1.12

0.42

1.2

1.3

299.93

347.98

pmol/l

0.51

616

Diseases caused by chlamydiae

1.43

0.42

2.3

1.4

362.38

451.85

pmol/l

—

Hepatocellular carcinoma

1.43

0.42

1.0

1.4

620.50

287.09

pmol/l

—

Long labour

108

1015

0.91

0.42

1.5

349.02

451.59

pmol/l

1.42

101

918

ILD, hospital admissions 1, main diag only

565

1.13

0.42

1.2

1.3

313.61

282.04

pmol/l

0.28

470

Maxillary hypoplasia

0.00

0.41

0.0

1.0

—

233.93

—

Colon adenocarcinoma

472

1.15

0.41

1.1

1.3

265.26

292.24

pmol/l

0.34

396

Atrioventricular septal defect

0.00

0.41

0.0

1.3

—

285.73

—

Drowning and submersion while in natural water

0.00

0.41

0.0

1.1

—

232.27

—

ILD medications: nintedanib

0.00

0.41

0.0

1.1

—

310.07

—

Injury of muscle and tendon at wrist and hand level

623

1.13

0.41

1.5

1.4

279.43

475.65

pmol/l

0.64

537

Mucinous and mucinous cystic tumor of rectum

0.00

0.41

0.0

1.6

—

314.38

—

Typhoid and paratyphoid fevers

0.00

0.41

0.0

1.1

—

265.63

—

Maternal care for known or suspected malpresentation of fetus

615

0.89

0.41

1.4

1.5

486.13

451.76

pmol/l

0.21

558

Down's syndrome

0.00

0.41

0.0

1.3

—

779.41

—

Tuberculosis, wide

250

1.20

0.40

1.4

1.3

240.13

310.16

pmol/l

0.68

217

Other abnormal products of conception

170

1046

1.08

0.40

1.4

1.5

417.65

495.59

pmol/l

0.29

153

953

Postmenopausal atrophic vaginitis

146

744

1.08

0.39

1.2

1.3

250.81

279.36

pmol/l

0.81

133

660

Haemorrhagic disorder due to circulating anticoagulants

1.43

0.39

1.0

1.1

179.00

231.73

pmol/l

—

Malignant neoplasm of rectum, including Hilmo

522

1.13

0.39

1.3

266.66

295.84

pmol/l

0.43

442

Viral haemorrhagic fevers, not elsewhere classified/unspecified

316

1.17

0.39

1.4

341.03

323.66

pmol/l

0.09

269

Special screening examination for infectious and parasitic diseases

117

792

1.09

0.37

1.5

1.4

399.00

344.27

pmol/l

0.55

705

malignant neoplasm of male genital organs

143

807

1.08

0.37

1.9

1.3

256.88

410.59

pmol/l

0.61

119

662

Pedal cyclist injured in collision with motor vehicle

112

0.71

0.37

1.3

1.4

249.25

377.58

pmol/l

—

100

Ulcerative colitis (strict definition, all Crohn cases excluded)

657

1.11

0.37

1.3

1.4

338.82

318.98

pmol/l

0.20

573

Injury of urinary and pelvic organs

1.39

0.37

1.7

1.3

253.00

361.40

pmol/l

—

Injuries to the hip and thigh

261

2243

1.05

0.35

1.3

269.93

352.60

pmol/l

1.01

221

1922

Other inflammation of vagina/vulva

123

0.73

0.35

1.7

1.4

438.78

392.92

pmol/l

—

111

Tooth agenesis EXCLUDE clefts and syndromes

123

0.73

0.35

1.7

1.5

351.00

447.71

pmol/l

—

107

Malignant neoplasm of prostate

137

762

1.08

0.34

1.9

1.3

254.48

409.75

pmol/l

0.58

114

626

358

1.15

0.34

1.5

312.24

821.45

pmol/l

1.10

322

Diseases caused by chlamydiae

1.34

0.34

2.0

1.4

422.33

487.03

pmol/l

—

Cysts of oral region, not elsewhere classified

219

1.19

0.33

1.2

1.5

278.01

341.73

pmol/l

0.68

187

Erectile dysfunction

285

0.84

0.32

2.0

1.4

211.61

264.11

pmol/l

0.83

233

Dislocation, sprain and strain of joints and ligaments of head

143

0.77

0.32

1.5

1.4

299.09

377.00

pmol/l

0.75

123

Supervision of high-risk pregnancy

639

0.92

0.31

1.3

1.4

382.90

407.24

pmol/l

0.18

576

Pedal cyclist injured in noncollision transport accidents

503

1.11

0.31

1.2

1.4

301.11

320.30

pmol/l

0.14

436

Schizoaffective disorder

314

1.15

0.31

1.2

1.5

598.20

355.34

pmol/l

0.72

280

Drug-induced osteoporosis

1.33

0.31

1.4

1.5

236.43

367.31

pmol/l

—

Premature rupture of membranes

721

0.92

0.30

1.4

1.5

401.71

433.22

pmol/l

0.24

651

Lichen ruber planus, wide definition including periferal and oral lichen planus

121

1129

1.07

0.30

1.3

302.45

321.02

pmol/l

0.22

111

973

Glucosamine medication

274

2089

1.05

0.30

1.3

269.93

294.72

pmol/l

0.63

228

1811

Fourth [trochlear] nerve palsy

1.34

0.30

1.4

1.3

252.20

317.06

pmol/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

392

1.12

0.29

1.3

1.4

328.61

312.47

pmol/l

0.09

334

Urethritis and urethral syndrome

1.32

0.28

1.8

1.5

381.60

356.45

pmol/l

—

Routine general health check-up of defined subpopulation

1.32

0.28

1.3

1.2

221.70

310.61

pmol/l

—

Non-small cell lung cancer, squamous

129

0.77

0.28

1.0

1.3

324.00

253.89

pmol/l

—

108

Bacterial pneumonia, not elsewhere classified

203

1702

1.05

0.27

1.2

1.3

288.21

375.47

pmol/l

0.74

180

1455

Parkinson's disease, strict definition

585

1.10

0.27

1.1

1.3

242.03

277.68

pmol/l

0.68

489

Malignant neoplasm of bronchus and lung

667

0.92

0.27

1.1

1.3

258.62

282.34

pmol/l

0.38

553

Burns and corrosions

614

1.09

0.27

1.3

1.4

308.47

322.85

pmol/l

0.07

531

Chromosomal abnormalities, not elsewhere classified

1.23

0.27

1.0

1.4

325.25

556.73

pmol/l

—

Malignant neoplasm of digestive organs

179

1487

0.95

0.27

1.2

1.3

291.13

354.20

pmol/l

0.41

153

1259

Malignant neoplasm of breast, HER-negative

104

954

1.07

0.26

1.2

1.3

516.91

292.54

pmol/l

0.43

831

Sequelae of infectious and parasitic diseases

281

1.14

0.26

1.2

1.4

325.88

338.72

pmol/l

0.07

245

Infections of genitourinary tract in pregnancy

395

1.12

0.26

1.3

1.4

431.99

439.54

pmol/l

0.02

351

All dysplastic lesions of the cervix uteri, vagina or vulva

153

1428

1.06

0.26

1.6

1.4

634.60

458.37

pmol/l

0.42

136

1274

Memory loss

367

1.12

0.26

1.2

1.3

331.76

302.13

pmol/l

0.30

311

Myocardial infarction, unclassifiable

748

1.07

0.25

1.2

1.3

251.51

297.66

pmol/l

0.85

621

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

403

0.89

0.25

1.2

1.3

234.89

302.30

pmol/l

0.97

341

Toxic effects of substances chiefly nonmedicinal as to source

483

1.10

0.24

1.2

1.4

369.17

318.06

pmol/l

0.22

421

Lung diseases due to external agents

531

1.09

0.24

1.3

2020.59

284.55

pmol/l

0.51

449

Use of levodopa decarboxylase inhibitor

570

1.09

0.24

1.2

1.3

220.68

276.69

pmol/l

1.31

472

Viral agents as the cause of diseases classified to other chapters

0.73

0.24

1.2

1.4

296.50

382.84

pmol/l

—

Malignant neoplasm of bladder

208

1.15

0.23

1.0

1.3

248.76

290.12

pmol/l

0.26

170

L01XE Protein kinase inhibitors

209

1.15

0.23

1.2

1.4

302.05

313.28

pmol/l

0.06

183

Malignant neoplasm of rectum

400

0.90

0.22

1.3

1.4

252.12

303.61

pmol/l

0.69

340

Malignant neoplasm of breast, HER-positive

169

1379

0.95

0.22

1.3

285.41

299.38

pmol/l

0.29

148

1223

Non-small cell lung cancer

376

0.90

0.22

1.1

1.3

315.31

299.99

pmol/l

0.13

315

Postpartum care and examination

425

0.92

0.22

1.3

1.5

520.16

400.95

pmol/l

0.77

386

Family history of other specific disorders

1.22

0.22

1.2

488.00

331.10

pmol/l

—

Lichen planus, including avohilmo

102

962

1.06

0.22

1.4

1.3

304.61

325.19

pmol/l

0.21

830

Explosion and rupture of other specified pressurized devices

0.00

0.21

0.0

1.0

—

234.82

—

Drug-induced acute pancreatitis

0.00

0.21

0.0

1.1

—

253.40

—

Noninfective disorders of pinna

0.00

0.21

0.0

1.1

—

238.70

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

0.21

0.0

1.0

—

285.50

—

Reduction defects of upper limb

0.00

0.21

0.0

1.0

—

208.36

—

Eclampsia

0.00

0.21

0.0

1.6

—

454.80

—

Hypertension, portal

0.00

0.21

0.0

1.0

—

262.50

—

Henoch-Schönlein purpura nephritis (HSPN)

0.00

0.21

0.0

1.1

—

240.36

—

Use of riluzole

0.00

0.21

0.0

1.1

—

250.55

—

Actinomycosis

0.00

0.21

0.0

1.0

—

273.20

—

Listeriosis

0.00

0.21

0.0

1.1

—

233.55

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

0.21

0.0

1.3

—

995.42

—

Exposure to ignition or melting of other clothing and apparel

0.00

0.21

0.0

1.0

—

256.67

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

0.21

0.0

1.2

—

286.42

—

Liver disorders in diseases classified elsewhere

0.00

0.21

0.0

1.1

—

247.17

—

Labyrinthine fistula

0.00

0.21

0.0

1.0

—

270.83

—

Other and unspecified syphilis

0.00

0.21

0.0

1.2

—

258.58

—

Epileptic seizures related to drugs

0.00

0.21

0.0

1.0

—

346.50

—

Thalassaemia

0.00

0.21

0.0

1.2

—

294.58

—

Acute thyroiditis

0.00

0.21

0.0

1.0

—

240.92

—

Benign neoplasm: Hypopharynx

0.00

0.21

0.0

1.0

—

274.25

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

1.18

0.21

2.0

1.6

168.80

665.14

pmol/l

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

0.21

0.0

1.4

—

1059.33

—

Gastrointestinal stromal tumor and sarcoma

1.16

0.21

1.0

1.4

269.60

421.22

pmol/l

—

Congenital malformations of nose

0.00

0.21

0.0

1.2

—

312.62

—

Coronary artery bypass grafting

117

826

1.06

0.21

1.2

1.4

260.30

273.76

pmol/l

0.19

100

695

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

0.21

0.0

1.2

—

269.85

—

Reduction defects of upper limb

0.00

0.21

0.0

1.0

—

214.85

—

Other and unspecified syphilis

0.00

0.21

0.0

1.2

—

246.08

—

Adenocarcinomas of cervix

0.00

0.21

0.0

1.2

—

338.69

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

0.21

0.0

1.4

—

996.62

—

Other infections specific to the perinatal period

0.00

0.21

0.0

1.7

—

285.69

—

Problems related to social environment

1.25

0.20

1.1

1.4

498.10

386.31

pmol/l

—

Other congenital malformations of integument

0.00

0.20

0.0

1.1

—

251.14

—

Retrobulbar neuritis in diseases classified elsewhere

0.00

0.20

0.0

1.2

—

402.71

—

Traumatic ischaemia of muscle

1.25

0.20

1.5

1.4

297.00

394.51

pmol/l

—

Personal history of certain other diseases

1.23

0.20

1.3

1.4

346.50

389.61

pmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

271

0.88

0.20

1.5

1.4

485.33

368.93

pmol/l

0.42

241

Infective bursitis

1.21

0.19

1.4

1.3

292.17

338.25

pmol/l

0.16

Medical treatment for female infertility

922

1.06

0.19

1.4

1.5

537.37

562.05

pmol/l

0.05

834

Maternal care for known or suspected fetal abnormality and damage

607

0.93

0.19

1.5

480.27

445.51

pmol/l

0.16

548

Malignant neoplasm of breast, ER-positive, including Hilmo

173

1388

0.96

0.19

1.3

287.66

299.16

pmol/l

0.23

152

1230

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

270

0.89

0.19

1.5

1.4

485.33

741.19

pmol/l

0.29

242

Persons encountering health services in circumstances related to reproduction

340

2354

0.97

0.19

1.4

322.74

378.36

pmol/l

0.62

290

2085

Bacterial pneumonia (organism specified)

230

2016

1.03

0.19

1.3

316.69

364.91

pmol/l

0.39

200

1717

Non-Hodgkin lymphoma, all, including Hilmo

581

0.93

0.18

1.2

1.3

282.45

294.46

pmol/l

0.14

487

Fracture of femur

125

1084

1.05

0.17

1.3

230.73

309.39

pmol/l

1.64

101

912

Normal-pressure hydrocephalus

167

1.14

0.17

1.2

1.3

261.18

250.92

pmol/l

0.08

140

Other superficial mycoses

427

1.08

0.16

1.2

1.5

310.42

348.56

pmol/l

0.30

380

Dilated cardiomyopathy

495

1.07

0.16

1.2

1.4

318.21

294.29

pmol/l

0.17

420

Mixed conductive and sensorineural hearing loss

515

1.07

0.16

1.3

234.66

290.16

pmol/l

0.96

441

Inguinal hernia, unilateral

1.20

0.16

1.4

510.45

311.89

pmol/l

0.36

Inguinal of femoral hernia, unilateral

1.20

0.16

1.4

510.45

311.89

pmol/l

0.36

Femoral hernia, unilateral

1.20

0.16

1.4

510.45

311.89

pmol/l

0.36

Pedestrian injured in collision with car, pick-up truck or van

1.10

0.15

1.3

302.62

332.06

pmol/l

—

Viral agents as the cause of diseases classified to other chapters

0.79

0.15

1.2

1.4

296.50

379.81

pmol/l

—

Burn and corrosion of hip and lower limb, except ankle and foot

0.79

0.15

1.2

1.4

142.50

426.63

pmol/l

—

Torsion of testis

0.76

0.15

1.5

582.50

314.84

pmol/l

—

Other and unspecified acute skin changes due to ultraviolet radiation

1.13

0.15

1.2

1.4

198.67

345.43

pmol/l

—

Carcinoma in situ of cervix uteri

363

1.08

0.13

1.6

1.4

832.00

643.12

pmol/l

0.14

327

Tooth eruption problems

544

1.06

0.13

1.4

1.5

454.08

584.80

pmol/l

0.30

486

Hydrocephalus

305

1.08

0.13

1.3

1.4

253.04

303.86

pmol/l

0.62

258

Obstructed labour due to maternal pelvic abnormality

765

0.95

0.13

1.1

1.3

328.03

369.02

pmol/l

0.34

684

Malignant neoplasm of breast, HER2-negative

243

1554

1.02

0.11

1.3

384.70

332.13

pmol/l

0.20

215

1378

Non-small cell lung cancer, adenocarcinoma, helper endpoint

220

1.09

0.11

1.1

1.3

313.50

270.43

pmol/l

0.38

186

Retinal breaks without detachment

813

0.96

0.11

1.6

1.3

265.31

344.25

pmol/l

1.22

695

Squamous cell neoplasms and carcinomas of the skin

271

0.92

0.11

1.2

1.3

328.42

256.92

pmol/l

0.36

224

DVT of lower extremities

896

1.04

0.11

1.3

301.19

327.64

pmol/l

0.28

753

Malignant neoplasm of colon

622

1.05

0.10

1.2

1.3

258.00

295.25

pmol/l

0.62

519

Coxarthrosis, primary, with hip surgery

254

2331

1.02

0.10

1.2

1.3

263.43

333.51

pmol/l

0.83

224

1984

Ill-defined and unknown causes of mortality

290

0.93

0.10

1.2

1.3

195.34

280.71

pmol/l

0.94

244

Adenocarcinoma and papilloma adenocarcinoma of rectum

382

0.94

0.10

1.2

1.3

234.89

303.81

pmol/l

0.99

321

Retained placenta and membranes, without haemorrhage

584

1.05

0.10

1.4

1990.87

424.61

pmol/l

0.45

525

Family history of other conditions

1.14

0.10

1.2

1.4

619.00

422.28

pmol/l

—

Injury of muscle and tendon at lower leg level

673

1.04

0.10

1.4

1.3

295.08

459.61

pmol/l

0.55

573

Delivery, wide proxy

180

978

0.98

0.09

1.4

1.3

356.73

368.85

pmol/l

0.11

158

853

Caries of enamel

559

4080

0.99

0.09

1.4

349.40

383.13

pmol/l

0.35

502

3563

Other predominantly sexually transmitted diseases, not elsewhere classified

931

1.03

0.09

1.4

1.5

496.37

527.35

pmol/l

0.05

823

Non-small cell lung cancer, adenocarcinoma

223

1.08

0.09

1.1

1.3

313.50

307.36

pmol/l

0.04

189

Other assisted single delivery

1.05

0.08

1.7

1.4

2923.17

340.94

pmol/l

—

Colorectal adenocarcinoma

861

1.03

0.08

1.1

1.3

253.04

282.31

pmol/l

0.56

722

Malignant neoplasm of cervix uteri

1.03

0.08

1.2

1.3

427.67

335.29

pmol/l

—

Other disorders of cornea

420

1.05

0.08

1.2

1.4

288.16

318.16

pmol/l

0.36

364

Other infestations

0.79

0.08

1.2

1.4

322.00

376.11

pmol/l

—

Malignant neoplasm of tongue

0.84

0.07

1.3

1.4

333.17

336.17

pmol/l

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

440

1.04

0.07

1.2

1.3

321.61

274.67

pmol/l

0.45

361

Recurrent dislocation and subluxation of joint

284

1.06

0.07

1.2

1.4

245.60

358.19

pmol/l

2.44

252

Status post-ami

115

856

1.02

0.07

1.2

1.4

259.04

273.86

pmol/l

0.25

722

Malignant neoplasm of liver and intrahepatic bile ducts

1.03

0.07

1.1

1.3

602.67

271.61

pmol/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.12

0.07

1.0

1.4

308.20

383.05

pmol/l

—

Atrial septal defect, secundum type

0.86

0.06

1.9

1.4

387.25

494.59

pmol/l

—

Rare circulating lymphoid malignancy, including Hilmo

100

0.90

0.06

1.2

1.4

594.22

401.90

pmol/l

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

250

1597

1.01

0.06

1.3

387.36

332.81

pmol/l

0.22

220

1415

Malignant neoplasm of breast, including Hilmo

250

1597

1.01

0.06

1.3

387.36

332.81

pmol/l

0.22

220

1415

Burns and corrosions of external body surface, specified by site

464

1.03

0.05

1.3

1.4

315.86

326.13

pmol/l

0.04

401

Non-small cell lung cancer, including Hilmo

597

1.03

0.05

1.2

1.3

322.16

285.69

pmol/l

0.48

496

Other ill-defined and unspecified causes of mortality

262

0.95

0.04

1.2

1.3

208.88

270.82

pmol/l

0.56

220

Divergent concomitant strabismus

288

1.04

0.04

1.1

1.5

678.04

377.46

pmol/l

0.61

256

Non-follicular lymphoma

382

0.97

0.04

1.2

1.4

260.45

300.84

pmol/l

0.58

329

HSIL lesion of the cervix uteri

815

0.98

0.04

1.6

1.5

862.52

533.12

pmol/l

0.43

728

Impacted teeth

716

0.98

0.04

1.3

1.5

396.06

548.67

pmol/l

0.50

635

Impacted cerumen

412

0.97

0.04

1.5

1.3

217.35

299.88

pmol/l

1.97

347

Alzheimer disease, excluding more controls

444

0.98

0.03

1.1

1.4

243.38

269.90

pmol/l

0.51

382

Malignant neoplasm of breast

243

1571

1.01

0.03

1.3

387.69

332.68

pmol/l

0.21

215

1394

Single delivery by caesarean section

548

0.98

0.03

1.3

1.5

1486.98

446.79

pmol/l

0.51

490

Mental and behavioural disorders due to use of other stimulants, including caffeine

1.09

0.03

1.2

1.5

231.20

409.92

pmol/l

—

Malignant neoplasm of respiratory system and intrathoracic organs

759

0.99

0.02

1.1

1.3

253.36

279.07

pmol/l

0.50

627

Pregnancy examination and test

479

0.99

0.02

1.5

2031.84

390.25

pmol/l

0.66

437

Schizophrenia

730

1.01

0.02

1.3

1.4

321.67

350.67

pmol/l

0.21

644

Other predominantly sexually transmitted diseases, not elsewhere classified

780

0.99

0.02

1.4

1.5

543.02

555.41

pmol/l

0.02

697

HSIL lesion of the cervix uteri, vagina or vulva

910

1.01

0.02

1.5

774.11

523.95

pmol/l

0.36

814

Persistent delusional disorders

308

0.97

0.02

1.3

1.4

282.33

342.12

pmol/l

0.59

267

All dysplastic lesions of the cervix uteri

122

1220

0.99

0.01

1.6

1.4

713.01

482.67

pmol/l

0.45

108

1095

Sequelae of other and unspecified infectious and parasitic diseases

217

0.97

0.01

1.1

1.4

315.25

374.96

pmol/l

0.50

192

Colorectal cancer

106

1028

1.01

0.01

1.2

1.3

258.26

381.67

pmol/l

0.64

861

Malignant neoplasm of bronchus and lung, including Hilmo

802

0.99

0.01

1.3

281.58

280.71

pmol/l

0.01

668

Pregnancy, childbirth and the puerperium

154

800

1.01

0.01

1.4

1.3

353.59

346.69

pmol/l

0.07

138

703

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

334

1.02

0.00

1.2

1.4

237.79

351.41

pmol/l

2.96

292

Oral lichen planus

104

0.96

0.00

1.0

1.4

257.00

335.22

pmol/l

—

Use of selegiline

144

0.97

0.00

1.1

1.4

196.75

264.47

pmol/l

—

126

Motorcycle rider injured in noncollision transport accidents

108

1.02

0.00

1.1

1.5

207.45

398.46

pmol/l

3.01

Primary coxarthrosis, bilateral

143

1428

1.00

0.00

1.2

1.3

284.99

304.82

pmol/l

0.27

124

1208

Benign neoplasm of breast

569

1.00

0.00

1.3

283.14

364.90

pmol/l

0.80

497

ILD-related respiratory insufficiency

107

1.03

0.00

1.2

1.3

377.18

280.65

pmol/l

0.49

Unspecified urinary incontinence

367

1.01

0.00

1.2

1.3

354.61

305.19

pmol/l

0.59

310

Erythrasma

0.00

0.0

1.1

—

221.57

—

Familial chondrocalcinosis

0.00

0.0

1.2

—

334.20

—

Huntington disease

0.00

0.0

1.0

—

222.86

—

Neuralgic amyotrophy

0.00

0.0

1.0

—

268.50

—

Thyroid crisis or storm

0.00

0.0

1.0

—

191.50

—

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

0.0

1.2

—

207.50

—

Abscess of mediastinum

0.00

0.0

1.5

—

247.67

—

Polyp of middle ear

0.00

0.0

1.5

—

254.00

—

Rheumatoid lung disease

0.00

0.0

1.0

—

332.25

—

Biliary cirrhosis, NAS

0.00

0.0

1.0

—

285.50

—

Crohn's disease (strict) with PSC

0.00

0.0

1.0

—

323.75

—

Other nonautoimmune haemolytic anaemias

0.00

0.0

1.0

—

264.50

—

Cyst of spleen

0.00

0.0

1.0

—

239.11

—

Alport

0.00

0.0

1.2

—

269.33

—

Other and unspecified postprocedural disorders of eye and adnexa

0.00

0.0

1.0

—

255.33

—

Calcium deposit in bursa

0.00

0.0

1.0

—

256.57

—

Exposure to electric transmission lines

0.00

0.0

1.0

—

183.40

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

0.0

1.0

—

294.57

—

Flexion deformity

0.00

0.0

1.2

—

328.33

—

Defect, injury or illness of skull

0.00

0.0

1.0

—

229.60

—

Microcephaly

0.00

0.0

1.7

—

1767.17

—

Upper arm

0.00

0.0

1.0

—

259.78

—

Need for immunization against certain single viral diseases

0.00

0.0

1.0

—

266.88

—

Other drug-induced osteomalacia in adults

0.00

0.0

1.0

—

410.75

—

Pneumoconiosis due to other inorganic dusts

0.00

0.0

1.0

—

192.80

—

Congenital malformation of optic disc

0.00

-0.00

0.0

1.2

—

197.40

—

Malignant neoplasm of peripheral nerves and autonomic nervous system

0.00

-0.00

0.0

1.0

—

220.71

—

Chronic postrheumatic arthropathy [Jaccoud]

0.00

-0.00

0.0

1.0

—

328.20

—

Craniosynostosis EXCLUDE syndromes

0.00

-0.00

0.0

1.4

—

221.89

—

Other and unspecified disorders of lacrimal system

0.00

-0.00

0.0

1.2

—

300.60

—

Choroidal detachment

0.00

-0.00

0.0

1.0

—

262.33

—

Reduction defects of unspecified limb

0.00

-0.00

0.0

1.0

—

203.33

—

General autosomal fish scale disease

0.00

-0.00

0.0

1.0

—

215.00

—

Congenital absence of the vagina

0.00

-0.00

0.0

1.0

—

181.00

—

Cyst of iris, ciliary body and anterior chamber

0.00

-0.00

0.0

1.1

—

240.38

—

Malignant neoplasm of other and unspecified urinary organs

0.00

-0.00

0.0

1.0

—

259.67

—

Bradycardia, unspecified, drug-induced

0.00

-0.00

0.0

1.0

—

290.00

—

Intentional self-harm by jumping or lying before moving object

0.00

-0.00

0.0

1.0

—

284.33

—

Exposure to high-pressure jet

0.00

-0.00

0.0

1.0

—

259.80

—

Solar urticaria

0.00

-0.00

0.0

1.0

—

208.50

—

Telogen effluvium

0.00

-0.00

0.0

1.1

—

241.11

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

-0.00

0.0

1.1

—

407.43

—

Chondrolysis

0.00

-0.00

0.0

1.0

—

264.00

—

Macrocephaly

0.00

-0.00

0.0

1.7

—

1755.00

—

Nightmares

0.00

-0.00

0.0

1.1

—

238.11

—

Congenital mitral valve regurgitation

0.00

-0.00

0.0

1.1

—

234.50

—

Defect, injury or illness of face

0.00

-0.00

0.0

1.2

—

215.60

—

Hypospadias with an incomplete glans penis

0.00

-0.00

0.0

1.5

—

201.88

—

Degenerative macular diseases, drug-induced

0.00

-0.00

0.0

1.0

—

260.50

—

Other congenital malformations of posterior segment of eye (coloboma)

0.00

-0.00

0.0

1.2

—

1790.50

—

Other congenital malformations of integument

0.00

-0.00

0.0

1.1

—

274.22

—

Lichenoid drug reaction

0.00

-0.00

0.0

1.1

—

328.11

—

Cicatricial pemphigoid

0.00

-0.00

0.0

1.0

—

251.00

—

Malignant neoplasm of other and unspecified parts of tongue

0.88

-0.00

1.4

382.60

339.97

pmol/l

—

Dislocations, sprains and strains involving multiple body regions

0.00

-0.00

0.0

1.0

—

220.29

—

Sweet's syndrome

0.00

-0.00

0.0

1.0

—

261.20

—

Occupant of railway train or railway vehicle injured in transport accident

0.00

-0.00

0.0

1.0

—

351.33

—

Squamous cell neoplasms and carcinoma of rectum

0.00

-0.00

0.0

1.0

—

304.60

—

Pemphigus vulgaris

0.00

-0.00

0.0

1.0

—

239.22

—

Onychogryphosis

0.00

-0.00

0.0

1.0

—

209.17

—

Lumbosacral spina bifida and hydrocephalus

0.00

-0.00

0.0

1.0

—

140.80

—

Febrile neutrophilic dermatosis [Sweet]

0.00

-0.00

0.0

1.0

—

261.20

—

Café au lait spots

0.00

-0.00

0.0

1.1

—

192.00

—

Congenital glaucoma

0.00

-0.00

0.0

1.6

—

175.00

—

Other congenital malformations of eye

0.00

-0.00

0.0

1.5

—

1739.17

—

Cutaneous autosensitization

0.00

-0.00

0.0

1.0

—

253.86

—

Beta thalassaemia

0.00

-0.00

0.0

1.0

—

177.20

—

Chronic bullous disease of childhood

0.00

-0.00

0.0

1.0

—

213.00

—

Pneumoconiosis due to dust containing silica

0.00

-0.00

0.0

1.0

—

173.29

—

Aggressive periodontitis

0.99

-0.00

1.1

1.4

146.29

306.42

pmol/l

—

Female pelvic inflammatory disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.8

—

560.75

—

Use of trihexyphenidyl

0.00

-0.00

0.0

1.0

—

306.20

—

Turner's syndrome

0.00

-0.00

0.0

1.0

—

219.86

—

Helminthiases

1.00

-0.00

1.2

1.4

369.17

386.33

pmol/l

—

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

0.00

-0.00

0.0

1.2

—

251.67

—

Colorectal squamous cell carcinoma

0.00

-0.00

0.0

1.0

—

304.60

—

Folliculitis decalvans

0.00

-0.00

0.0

1.0

—

213.50

—

Sphingolipidosis, other/unspecified

0.00

-0.00

0.0

1.0

—

369.00

—

Unspecified multiple injuries

0.00

-0.00

0.0

1.1

—

316.63

—

Other and unspecified thalassaemias

0.00

-0.00

0.0

1.0

—

209.25

—

Cardiomyopathy due to drugs and other external agents

0.00

-0.00

0.0

1.0

—

309.33

—

Aortic arch syndrome [Takayasu]

0.00

-0.00

0.0

1.1

—

299.63

—

Other mosquito-borne viral fevers

0.00

-0.00

0.0

1.0

—

143.50

—

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

0.00

-0.00

0.0

1.0

—

227.22

—

Intentional self-harm by drowning and submersion

0.00

-0.00

0.0

1.0

—

334.67

—

Cyclic neutropenia

0.00

-0.00

0.0

1.0

—

245.71

—

Brain mixed glioma

0.00

-0.00

0.0

1.0

—

273.43

—

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

0.00

-0.00

0.0

1.0

—

215.20

—

Carcinoma in situ of skin of lip

0.00

-0.00

0.0

1.2

—

319.00

—

Sequelae of poisoning by drugs, medicaments and biological substances

0.00

-0.00

0.0

1.0

—

305.50

—

Carcinoma in situ of larynx

0.00

-0.00

0.0

1.0

—

198.20

—

Benign neoplasm: Respiratory system, unspecified

0.00

-0.00

0.0

1.0

—

196.29

—

Benign neoplasm: Urethra

0.00

-0.00

0.0

1.0

—

273.50

—

Yaws

0.00

-0.00

0.0

1.1

—

277.11

—

Digeorge syndrome

0.00

-0.00

0.0

1.2

—

2069.00

—

Methaemoglobinaemia

0.00

-0.00

0.0

1.0

—

266.67

—

Traumatic amputation of ankle and foot

0.00

-0.00

0.0

1.0

—

205.67

—

Venous complications and haemorrhoids in pregnancy

1.02

-0.00

1.2

1.6

552.00

451.98

pmol/l

—

Congenital edentulism

0.00

-0.00

0.0

1.2

—

200.40

—

Maxillary retrognathism

0.89

-0.00

3.0

1.4

265.00

433.75

pmol/l

—

Polydactyly

0.00

-0.00

0.0

1.0

—

191.17

—

Rickettsioses

0.00

-0.00

0.0

1.0

—

297.57

—

Other effects of reduced temperature

0.00

-0.00

0.0

1.0

—

297.00

—

Haemophagocytic lymphohistiocytosis

0.00

-0.00

0.0

1.0

—

231.00

—

Acrodermatitis continua

0.00

-0.00

0.0

1.0

—

190.67

—

Other and specified injuries of hip and thigh

1.00

-0.00

1.3

1.4

270.57

332.46

pmol/l

—

Central nervous system disorder causing precocious puberty

0.00

-0.00

0.0

1.1

—

319.00

—

Lipodystrophy, not elsewhere classified

0.00

-0.00

0.0

1.0

—

412.60

—

Single ventricle heart

0.00

-0.00

0.0

1.6

—

194.80

—

Sequelae of hyperalimentation

0.00

-0.00

0.0

1.2

—

184.20

—

Disease of thymus, other/unspecified

0.00

-0.00

0.0

1.0

—

231.57

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

-0.00

0.0

1.0

—

288.60

—

Kyphoscoliotic heart disease

0.00

-0.00

0.0

1.0

—

290.00

—

Victim of lightning

0.00

-0.00

0.0

1.0

—

266.00

—

Keratosis punctata

0.00

-0.00

0.0

1.0

—

281.67

—

Other infestations

0.00

-0.00

0.0

1.0

—

279.17

—

Myxoedema coma

0.00

-0.00

0.0

1.0

—

190.20

—

Profound mental retardation

0.00

-0.00

0.0

1.4

—

292.13

—

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

0.00

-0.00

0.0

1.0

—

245.50

—

Other conditions originating in the perinatal period

0.00

-0.00

0.0

1.6

—

161.71

—

Dysplastic lesion of the vagina of unknown severity

0.00

-0.00

0.0

1.0

—

234.80

—

Respiratory disorders in diseases classified elsewhere

0.98

-0.00

1.0

1.2

662.60

291.70

pmol/l

—

Thyrotoxicosis from ectopic thyroid tissue

0.00

-0.00

0.0

1.0

—

189.00

—

Injury of blood vessels at ankle and foot level

0.00

-0.00

0.0

1.0

—

304.50

—

Convulsions of newborn

0.00

-0.00

0.0

1.8

—

139.20

—

Obstetric embolism

0.00

-0.00

0.0

1.8

—

685.33

—

Benign neoplasm: Renal pelvis

0.00

-0.00

0.0

1.0

—

240.20

—

Induced delusional disorder

0.00

-0.00

0.0

1.0

—

210.40

—

Kidney diseases associated to Fabry's disease

0.00

-0.00

0.0

1.0

—

411.17

—

Postprocedural disorders of eye and adnexa, not elsewhere classified

0.00

-0.00

0.0

1.0

—

264.78

—

Mental and behavioural disorders due to use of volatile solvents

0.00

-0.00

0.0

1.0

—

271.22

—

Constitutional tall stature

0.00

-0.00

0.0

1.7

—

304.33

—

Hypotony of eye

0.00

-0.00

0.0

1.0

—

259.80

—

Benign neoplasm: Lacrimal gland and duct

0.00

-0.00

0.0

1.2

—

291.40

—

Injury of muscle and tendon at ankle and foot level

0.97

-0.00

1.1

1.4

437.56

421.63

pmol/l

—

Severe mental retardation

0.00

-0.00

0.0

1.4

—

230.67

—

Cerebral arteritis

0.00

-0.00

0.0

1.0

—

267.33

—

Choroidal haemorrhage and rupture

0.00

-0.00

0.0

1.0

—

255.67

—

Contact urticaria

0.00

-0.00

0.0

1.0

—

204.14

—

Disorders of olfactory nerve

0.00

-0.00

0.0

1.0

—

227.40

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

-0.00

0.0

1.0

—

261.29

—

Vitreous prolapse

0.00

-0.00

0.0

1.0

—

295.00

—

Psoriatic arthropathies, strict definition

0.00

-0.00

0.0

1.0

—

186.00

—

Disorders of glossopharyngeal nerve

0.00

-0.00

0.0

1.0

—

329.40

—

Congenital malformations of nose

0.00

-0.00

0.0

1.2

—

259.67

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Aldosterone [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS